Tredegar Corporation Second Quarter Form 10-Q
 
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 

 
FORM 10-Q
 
(Mark One)
x
 
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
For the quarterly period ended June 30, 2002
 
OR
 
¨
 
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
For the transition period from                    to                     
 
Commission file number 1-10258
 

 
Tredegar Corporation
(Exact Name of Registrant as Specified in its Charter)
 
Virginia
(State or Other Jurisdiction of
Incorporation or Organization)
 
54-1497771
(I.R.S. Employer
Identification No.)
 
1100 Boulders Parkway
Richmond, Virginia
(Address of Principal Executive Offices)
 
23225
(Zip Code)
 
Registrant’s telephone number, including area code: (804) 330-1000
 

 
Indicate by check whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes  x  No  ¨
 
The number of shares of Common Stock, no par value, outstanding as of July 29, 2002: 38,369,640.
 


 
PART I—FINANCIAL INFORMATION
 
Item 1.    Financial Statements.
 
TREDEGAR CORPORATION
 
CONSOLIDATED BALANCE SHEETS
(In Thousands)
(Unaudited)
 
    
June 30,
2002

    
Dec. 31,
2001

 
ASSETS
                 
Current assets:
                 
Cash and cash equivalents
  
$
96,544
 
  
$
96,810
 
Accounts and notes receivable
  
 
99,683
 
  
 
79,274
 
Income taxes recoverable
  
 
2,094
 
  
 
5,410
 
Inventories
  
 
41,237
 
  
 
45,316
 
Deferred income taxes
  
 
15,934
 
  
 
16,022
 
Prepaid expenses and other
  
 
5,263
 
  
 
2,880
 
    


  


Total current assets
  
 
260,755
 
  
 
245,712
 
    


  


Property, plant and equipment, at cost
  
 
516,955
 
  
 
534,491
 
Less accumulated depreciation and amortization
  
 
260,120
 
  
 
267,148
 
    


  


Net property, plant and equipment
  
 
256,835
 
  
 
267,343
 
    


  


Net non-current assets of Therics held for sale
  
 
10,001
 
  
 
—  
 
Venture capital investments
  
 
123,123
 
  
 
155,084
 
Other assets and deferred charges
  
 
67,084
 
  
 
60,404
 
Goodwill and other intangibles
  
 
132,143
 
  
 
136,488
 
    


  


Total assets
  
$
849,941
 
  
$
865,031
 
    


  


LIABILITIES AND SHAREHOLDERS’ EQUITY
                 
Current liabilities:
                 
Accounts payable
  
$
44,482
 
  
$
46,507
 
Accrued expenses
  
 
49,044
 
  
 
47,637
 
Current portion of long-term debt
  
 
30,000
 
  
 
5,000
 
    


  


Total current liabilities
  
 
123,526
 
  
 
99,144
 
Long-term debt
  
 
229,401
 
  
 
259,498
 
Deferred income taxes
  
 
18,324
 
  
 
18,985
 
Other noncurrent liabilities
  
 
9,692
 
  
 
9,505
 
    


  


Total liabilities
  
 
380,943
 
  
 
387,132
 
    


  


Shareholders’ equity:
                 
Common stock, no par value
  
 
108,113
 
  
 
107,104
 
Common stock held in trust for savings restoration plan
  
 
(1,212
)
  
 
(1,212
)
Unrealized gain on available-for-sale securities
  
 
2,360
 
  
 
8,314
 
Foreign currency translation adjustment
  
 
(5,287
)
  
 
(6,007
)
Loss on derivative financial instruments
  
 
(1,568
)
  
 
(2,708
)
Retained earnings
  
 
366,592
 
  
 
372,408
 
    


  


Total shareholders’ equity
  
 
468,998
 
  
 
477,899
 
    


  


Total liabilities and shareholders’ equity
  
$
849,941
 
  
$
865,031
 
    


  


See accompanying notes to financial statements.

2


 
TREDEGAR CORPORATION
 
CONSOLIDATED STATEMENTS OF INCOME
(In Thousands)
(Unaudited)
 
    
Second Quarter
Ended June 30

    
Six Months
Ended June 30

 
    
2002

    
2001

    
2002

    
2001

 
Revenues:
                                   
Gross sales
  
$
200,554
 
  
$
199,869
 
  
$
378,006
 
  
$
394,027
 
Freight
  
 
4,051
 
  
 
3,998
 
  
 
7,794
 
  
 
7,685
 
    


  


  


  


Net sales
  
 
196,503
 
  
 
195,871
 
  
 
370,212
 
  
 
386,342
 
Other income (expense), net
  
 
(17,266
)
  
 
2,237
 
  
 
(26,962
)
  
 
(3,688
)
    


  


  


  


Total
  
 
179,237
 
  
 
198,108
 
  
 
343,250
 
  
 
382,654
 
    


  


  


  


Costs and expenses:
                                   
Cost of goods sold
  
 
153,968
 
  
 
159,740
 
  
 
291,368
 
  
 
315,381
 
Selling, general and administrative
  
 
14,471
 
  
 
12,608
 
  
 
27,804
 
  
 
25,680
 
Research and development
  
 
5,058
 
  
 
5,069
 
  
 
10,674
 
  
 
9,304
 
Amortization of intangibles
  
 
11
 
  
 
1,242
 
  
 
78
 
  
 
2,456
 
Interest
  
 
2,310
 
  
 
3,232
 
  
 
4,498
 
  
 
7,273
 
Unusual items
  
 
268
 
  
 
(971
)
  
 
1,264
 
  
 
629
 
    


  


  


  


Total
  
 
176,086
 
  
 
180,920
 
  
 
335,686
 
  
 
360,723
 
    


  


  


  


Income from continuing operations before income taxes
  
 
3,151
 
  
 
17,188
 
  
 
7,564
 
  
 
21,931
 
Income taxes
  
 
1,040
 
  
 
4,158
 
  
 
2,563
 
  
 
5,866
 
    


  


  


  


Income from continuing operations
  
 
2,111
 
  
 
13,030
 
  
 
5,001
 
  
 
16,065
 
Discontinued operations:
                                   
Loss from operations of Molecumetics (including expected loss on disposal of $3,900 in 2002)
  
 
(5,446
)
  
 
(917
)
  
 
(7,753
)
  
 
(2,051
)
Income from discontinued energy segment
  
 
—  
 
  
 
1,396
 
  
 
—  
 
  
 
1,396
 
    


  


  


  


Income (loss) from discontinued operations
  
 
(5,446
)
  
 
479
 
  
 
(7,753
)
  
 
(655
)
    


  


  


  


Net income (loss)
  
$
(3,335
)
  
$
13,509
 
  
$
(2,752
)
  
$
15,410
 
    


  


  


  


Earnings (loss) per share:
                                   
Basic:
                                   
Continuing operations
  
$
.06
 
  
$
.34
 
  
$
.13
 
  
$
.42
 
Discontinued operations
  
 
(.14
)
  
 
.02
 
  
 
(.20
)
  
 
(.01
)
    


  


  


  


Net income (loss)
  
$
(.08
)
  
$
.36
 
  
$
(.07
)
  
$
.41
 
    


  


  


  


Diluted:
                                   
Continuing operations
  
$
.05
 
  
$
.34
 
  
$
.13
 
  
$
.42
 
Discontinued operations
  
 
(.14
)
  
 
.01
 
  
 
(.20
)
  
 
(.02
)
    


  


  


  


Net income (loss)
  
$
(.09
)
  
$
.35
 
  
$
(.07
)
  
$
.40
 
    


  


  


  


Shares used to compute earnings (loss) per share:
                                   
Basic
  
 
38,270
 
  
 
38,055
 
  
 
38,219
 
  
 
38,053
 
Diluted
  
 
39,111
 
  
 
38,838
 
  
 
38,990
 
  
 
38,818
 
Dividends per share
  
$
.04
 
  
$
.04
 
  
$
.08
 
  
$
.08
 
 
See accompanying notes to financial statements.

3


 
TREDEGAR CORPORATION
 
CONSOLIDATED STATEMENTS OF CASH FLOWS
(In Thousands)
(Unaudited)
 
    
Six Months
Ended June 30

 
    
2002

    
2001

 
Cash flows from operating activities:
                 
Net income (loss)
  
$
(2,752
)
  
$
15,410
 
Adjustments for noncash items:
                 
Loss (gain) from discontinued operations
  
 
6,000
 
  
 
(1,396
)
Depreciation
  
 
16,459
 
  
 
16,099
 
Amortization of intangibles
  
 
78
 
  
 
2,456
 
Deferred income taxes
  
 
1,748
 
  
 
(179
)
Accrued pension income and postretirement benefits
  
 
(4,862
)
  
 
(5,108
)
Loss on venture capital investments
  
 
27,388
 
  
 
4,861
 
Changes in assets and liabilities:
                 
Accounts and notes receivable
  
 
(18,965
)
  
 
(3,318
)
Inventories
  
 
4,345
 
  
 
4,080
 
Income taxes recoverable
  
 
3,316
 
  
 
629
 
Prepaid expenses and other
  
 
(185
)
  
 
(135
)
Accounts payable
  
 
(1,838
)
  
 
3,458
 
Accrued expenses and income taxes payable
  
 
(1,455
)
  
 
528
 
Other, net
  
 
(1,450
)
  
 
2,164
 
    


  


Net cash provided by operating activities
  
 
27,827
 
  
 
39,549
 
    


  


Cash flows from investing activities:
                 
Capital expenditures
  
 
(13,851
)
  
 
(22,109
)
Venture capital investments
  
 
(11,137
)
  
 
(9,108
)
Proceeds from the sale of venture capital investments
  
 
6,408
 
  
 
26,792
 
Proceeds from property disposals and divestitures
  
 
89
 
  
 
353
 
Other, net
  
 
(2,450
)
  
 
(1,724
)
    


  


Net cash used in investing activities
  
 
(20,941
)
  
 
(5,796
)
    


  


Cash flows from financing activities:
                 
Dividends paid
  
 
(3,064
)
  
 
(3,043
)
Net (decrease) increase in borrowings
  
 
(5,097
)
  
 
(3,607
)
Proceeds from exercise of stock options (including related income tax benefits realized)
  
 
1,009
 
  
 
152
 
    


  


Net cash used in financing activities
  
 
(7,152
)
  
 
(6,498
)
    


  


Increase (decrease) in cash and cash equivalents
  
 
(266
)
  
 
27,255
 
Cash and cash equivalents at beginning of period
  
 
96,810
 
  
 
44,530
 
    


  


Cash and cash equivalents at end of period
  
$
96,544
 
  
$
71,785
 
    


  


 
See accompanying notes to financial statements.

4


 
TREDEGAR CORPORATION
 
NOTES TO THE CONSOLIDATED INTERIM FINANCIAL STATEMENTS
(Unaudited)
 
1.  In the opinion of management, the accompanying consolidated financial statements of Tredegar Corporation and Subsidiaries (“Tredegar”) contain all adjustments necessary to present fairly, in all material respects, Tredegar’s consolidated financial position as of June 30, 2002, and the consolidated results of operations and cash flows for the six months ended June 30, 2002 and 2001. All such adjustments are deemed to be of a normal recurring nature. These financial statements should be read in conjunction with the consolidated financial statements and related notes included in Tredegar’s Annual Report on Form 10-K for the year ended December 31, 2001. The results of operations for the six months ended June 30, 2002 are not necessarily indicative of the results to be expected for the full year.
 
Certain previously reported amounts have been reclassified to conform to the current presentation.
 
2.  The Financial Accounting Standards Board issued two new standards that primarily affect the accounting for acquisitions initiated after June 30, 2001, and the accounting for goodwill. We adopted these standards effective January 1, 2002. These standards prohibit amortization of goodwill but require annual impairment reviews that may result in the recognition of losses. We have reclassified from intangible assets to goodwill approximately $396,000 related to Therics’ workforce, which no longer qualifies as a separately identifiable intangible asset. We have made determinations as to what our reporting units are and what amounts of goodwill, intangible assets, other assets and liabilities should be allocated to those reporting units. We completed the transitional impairment test, which did not result in impairment of recorded goodwill. In accordance with this statement, amortization of goodwill was discontinued as of January 1, 2002. A reconciliation of previously reported net income and earnings per share to the amounts adjusted for the exclusion of goodwill amortization, net of related income taxes, is as follows:
 
    
Quarter
Ended
June 30,
2001

  
Six Months
Ended
June 30,
2001

(In Thousands, except per share data)
         
Reported net income
  
$
13,509
  
$
15,410
Goodwill amortization, net of tax
  
 
757
  
 
1,498
    

  

Adjusted net income
  
$
14,266
  
$
16,908
    

  

Basic earnings per share as reported
  
$
.36
  
$
.41
Adjustment to basic earnings per share
  
 
.02
  
 
.04
    

  

Adjusted basic earnings per share
  
$
.38
  
$
.45
    

  

Diluted earnings per share as reported
  
$
.35
  
$
.40
Adjustment to diluted earnings per share
  
 
.02
  
 
.04
    

  

Adjusted diluted earnings per share
  
$
.37
  
$
.44
    

  

5


The carrying value of goodwill at January 1, 2002, of $134.7 million was comprised of $100.7 million related to Film Products, $30.5 million related to Aluminum Extrusions and $3.5 million related to Therics. The goodwill related to Therics has been included in “Net non-current assets of Therics held for sale” in the consolidated balance sheet at June 30, 2002.
 
3.  See pages 13 through 16 for information on unusual items recognized during the quarter and six months ended June 30, 2002 and 2001.
 
On March 22, 2002, we announced our intent to divest our two biotechnology units, Molecumetics and Therics. The long-lived assets for Therics ($10 million at June 30, 2002) have been separately classified in the accompanying balance sheet as “Net non-current assets of Therics held for sale.”
 
Operations at Molecumetics were ceased on July 2, 2002, while efforts to sell its technology and tangible assets continue. The operating results of Molecumetics have been reported as discontinued operations and results for prior periods have been restated. Cash flows for Molecumetics have not been separately disclosed in the accompanying statement of cash flows. For the six months ended June 30, 2002 and 2001, the operating losses for Molecumetics were $12 million and $3.2 million, respectively, while revenue was $515,000 and $2.9 million, respectively. Discontinued operations for the second quarter of 2002 include an expected loss on the disposal of Molecumetics of $6 million ($3.9 million after taxes). The assets of Molecumetics (approximately $1.7 million), have been included in “Prepaid expenses and other” in the consolidated balance sheet at June 30, 2002.
 
Discontinued operations for the second quarter of 2001 also include an after-tax gain of $1.4 million related to the reversal of an income tax contingency accrual upon favorable conclusion of IRS examinations through 1997. The accrual was originally recorded in conjunction with the sale of The Elk Horn Coal Corporation in 1994.
 
4.  A summary of our venture capital activities for the quarter and six months ended June 30, 2002 and 2001, is provided below:
 
    
Second Quarter
Ended June 30

    
Six Months
Ended June 30

 
    
2002

    
2001

    
2002

    
2001

 
    
(In Thousands)
 
Carrying value, beginning of period
  
$
139,298
 
  
$
199,457
 
  
$
155,084
 
  
$
232,259
 
Activity for period (pre-tax):
                                   
New investments
  
 
5,547
 
  
 
4,757
 
  
 
11,137
 
  
 
9,108
 
Proceeds from the sale of investments
  
 
(1,235
)
  
 
(17,910
)
  
 
(6,408
)
  
 
(28,242
)
Realized gains
  
 
222
 
  
 
11,617
 
  
 
3,943
 
  
 
18,862
 
Realized losses, write-offs and write-downs
  
 
(17,853
)
  
 
(9,830
)
  
 
(31,330
)
  
 
(23,723
)
Increase (decrease) in net unrealized gain on available-for-sale securities
  
 
(2,856
)
  
 
10,385
 
  
 
(9,303
)
  
 
(9,788
)
    


  


  


  


Carrying value, end of period
  
$
123,123
 
  
$
198,476
 
  
$
123,123
 
  
$
198,476
 
    


  


  


  


 
Our remaining unfunded commitments to private venture capital funds totaled approximately $35 million at June 30, 2002, and $36.7 million at December 31, 2001.
 
A schedule of investments is provided on the following two pages.
 

6


TREDEGAR CORPORATION
 
Schedule of Investments at June 30, 2002 and December 31, 2001
(In Thousands, Except Per-Share Amounts)
 
                   
Public Common Stock or
Equivalents at 6/30/02

   
6/30/02(f)

 
12/31/01(f)

Investment

 
Symbol

 
Yrs.
Held(a)

 
Description

 
Web Site
(www.)

 
Shares
Held

 
Closing
Price

  
Estimated Restricted Stock Dis-
count(c)

   
Estimated
Fair
Value(b)

   
Carrying
Value(b)

 
Cost
Basis

 
Estimated
Fair
Value(b)

   
Carrying
Value(b)

 
Cost
Basis

Securities of Public Companies Held:
                                                                        
Illumina, Inc.
 
ILMN
 
    3.6    
 
Fiber optic sensor technology ford drug
    screening
 
illumina.com
 
813
 
$
6.72
  
0
%
 
$
5,466
 
 
$
5,466
 
$
1,933
 
$
10,749
 
 
$
10,749
 
$
2,173
Adolor Corporation
 
ADLR
 
3.6
 
Develops pain-management therapeutic     drugs
 
adolor.com
 
—  
 
 
—  
  
0
%
 
 
—  
 
 
 
—  
 
 
—  
 
 
3,704
 
 
 
3,704
 
 
844
Vascular Solutions
 
VASC
 
4.5
 
Vascular access site closure system
 
vascularsolutions.com
 
861
 
 
1.80
  
0
%
 
 
1,549
 
 
 
1,549
 
 
2,429
 
 
2,401
 
 
 
2,401
 
 
2,429
SignalSoft Corporation
 
SGSF
 
4.3
 
Wireless caller location detection
    software
 
signalsoftcorp.com
 
—  
 
 
—  
  
0
%
 
 
—  
 
 
 
—  
 
 
—  
 
 
1,835
 
 
 
1,835
 
 
1,330
Photon Dynamics, Inc.(e)
 
PHTN
 
4.1
 
Test and repair systems for flat panel
    display industry
 
photondynamics.com
 
21
 
 
30.00
  
20
%
 
 
502
 
 
 
502
 
 
940
 
 
763
 
 
 
387
 
 
940
Cisco Systems, Inc.(e)
 
CSCO
 
3.0
 
Worldwide leader in networking for the     Internet
 
cisco.com
 
—  
 
 
—  
  
0
%
 
 
—  
 
 
 
—  
 
 
—  
 
 
245
 
 
 
245
 
 
200
Nortel Networks Corporation(e)
 
NT
 
4.3
 
Networking solutions and services
 
nortelnetworks.com
 
—  
 
 
—  
  
0
%
 
 
—  
 
 
 
—  
 
 
—  
 
 
151
 
 
 
148
 
 
117
CardioGenesis Corporation
 
CGCP
 
8.1
 
Coronary revascularization
 
eclipsesurg.com
 
—  
 
 
—  
  
0
%
 
 
—  
 
 
 
—  
 
 
—  
 
 
132
 
 
 
132
 
 
616
Openwave Systems, Inc.(e)
 
OPWV
 
2.6
 
Infrastructure applications for the Internet
 
openwave.com
 
—  
 
 
—  
  
0
%
 
 
—  
 
 
 
—  
 
 
—  
 
 
14
 
 
 
14
 
 
7
                   
 

  

 


 

 

 


 

 

Total securities of public companies held
                                  
 
7,517
 
 
 
7,517
 
 
5,302
 
 
19,994
 
 
 
19,615
 
 
8,656
                   
 

  

 


 

 

 


 

 

Securities of Private Companies Held:
                                                                        
CryoGen
     
6.8
 
Micro-cryogenic catheters for medical     applications
 
cryogen-inc.com
                  
 
2,339
 
 
 
2,339
 
 
3,910
 
 
2,339
 
 
 
2,339
 
 
3,910
Sensitech Inc.
     
5.3
 
Perishable product mgmt. solutions
 
sensitech.com
                  
 
3,197
 
 
 
2,333
 
 
2,333
 
 
3,197
 
 
 
2,333
 
 
2,333
Songbird Medical, Inc.
     
4.9
 
Disposable hearing aids
                      
 
2,743
 
 
 
2,743
 
 
5,582
 
 
3,303
 
 
 
3,303
 
 
5,215
Appliant, Inc.
     
4.7
 
Software tools for managing executable     software
 
appliant.com
                  
 
995
 
 
 
995
 
 
3,899
 
 
6,439
 
 
 
3,899
 
 
3,899
HemoSense
     
4.6
 
Point of care blood coagulation time test     device
 
hemosense.com
                  
 
2,771
 
 
 
2,485
 
 
2,485
 
 
2,771
 
 
 
2,485
 
 
2,485
Moai Technologies, Inc.
     
4.5
 
System for holding auctions on the
    Internet
 
moai.com
                  
 
—  
 
 
 
—  
 
 
2,021
 
 
—  
 
 
 
—  
 
 
2,021
Babycare, Ltd.
     
4.4
 
Direct retailing of baby care products in     China
                      
 
—  
 
 
 
—  
 
 
1,009
 
 
—  
 
 
 
—  
 
 
1,009
NovaLux, Inc.
     
4.1
 
Blue-green light lasers
 
novalux.com
                  
 
2,618
 
 
 
2,618
 
 
10,149
 
 
10,149
 
 
 
10,149
 
 
10,149
Xcyte Therapies, Inc.
     
3.9
 
Develops drugs to treat cancer & other     disorders
 
xcytetherapies.com
                  
 
4,634
 
 
 
4,634
 
 
4,634
 
 
4,634
 
 
 
4,634
 
 
4,634
Advanced Diagnostics, Inc.
     
3.6
 
3-D medical imaging equipment
                      
 
2,637
 
 
 
2,621
 
 
2,621
 
 
2,137
 
 
 
2,121
 
 
2,121
EndoVasix, Inc.
     
3.4
 
Device for treatment of ischemic strokes
 
endovasix.com
                  
 
926
 
 
 
926
 
 
4,126
 
 
800
 
 
 
800
 
 
4,000
eWireless, inc.
     
3.4
 
Technology linking cell phone users &     advertising
 
ewireless.com
                  
 
—  
 
 
 
—  
 
 
2,250
 
 
—  
 
 
 
—  
 
 
2,250
Cooking.com, Inc.
     
3.3
 
Sales of cooking-related items over the     Internet
 
cooking.com
                  
 
974
 
 
 
974
 
 
4,500
 
 
1,500
 
 
 
1,500
 
 
4,500
MediaFlex.com
     
3.2
 
Internet-based printing & publishing
 
mediaflex.com
                  
 
—  
 
 
 
—  
 
 
3,500
 
 
—  
 
 
 
—  
 
 
3,500
eBabyCare Ltd.
     
3.1
 
Sales of babycare products over the     Internet in China
                      
 
—  
 
 
 
—  
 
 
314
 
 
—  
 
 
 
—  
 
 
314
Kodiak Technologies, Inc.
     
3.0
 
Cooling products for organ & pharma     transport
 
kodiaktech.com
                  
 
2,010
 
 
 
2,010
 
 
2,432
 
 
2,202
 
 
 
2,202
 
 
2,202
Artemis Medical, Inc.
     
3.0
 
Medical devices for breast cancer surgery
                      
 
3,681
 
 
 
2,880
 
 
2,880
 
 
3,267
 
 
 
2,467
 
 
2,467
CEPTYR, Inc.
     
2.9
 
Develops small molecule drugs
 
ceptyr.com
                  
 
1,750
 
 
 
1,750
 
 
1,750
 
 
1,750
 
 
 
1,750
 
 
1,750
ThinkFree.com
     
2.7
 
Java-based software complementary to     Microsoft Office
 
thinkfree.com
                  
 
741
 
 
 
741
 
 
1,491
 
 
741
 
 
 
741
 
 
1,491
BroadRiver Communications
     
2.6
 
Local DSL provider
 
purepacket.com
                  
 
—  
 
 
 
—  
 
 
4,779
 
 
—  
 
 
 
—  
 
 
4,779
Quarry Technologies, Inc.
     
2.6
 
Technology for delivery of differentiated     service levels
 
quarrytech.com
                  
 
2,716
 
 
 
2,716
 
 
4,195
 
 
2,567
 
 
 
2,567
 
 
4,046
FastTrack Systems, Inc.
     
2.4
 
Clinical trial data management
    information systems
                      
 
7,182
 
 
 
5,479
 
 
5,479
 
 
7,182
 
 
 
5,479
 
 
5,479
Riveon, Inc.
     
2.4
 
Web-based data mining software for     business managers
                      
 
—  
 
 
 
—  
 
 
1,990
 
 
—  
 
 
 
—  
 
 
1,990
MedManage Systems Inc.
     
2.2
 
Management of prescription drug
    sampling programs
 
medmanagesystems.com
                  
 
3,049
 
 
 
3,049
 
 
6,095
 
 
5,200
 
 
 
5,200
 
 
5,200
Infinicon, Inc.
     
2.0
 
Manufacturer of infiniband input/output     products
 
infiniconsys.com
                  
 
6,985
 
 
 
6,985
 
 
6,985
 
 
4,573
 
 
 
4,573
 
 
4,573
Cbyon, Inc.
     
2.0
 
Provider of software image data to assist     surgeons
 
cbyon.com
                  
 
2,118
 
 
 
2,118
 
 
5,000
 
 
4,178
 
 
 
4,178
 
 
4,178
Extreme Devices
     
1.8
 
Manufacturer of integrated, solid-state     electron source
                      
 
5,000
 
 
 
5,000
 
 
5,000
 
 
5,000
 
 
 
5,000
 
 
5,000
Locus Discovery, Inc.
     
1.6
 
Computational chemogenomics
    technology
 
locusdiscovery.com
                  
 
6,333
 
 
 
4,000
 
 
4,000
 
 
6,333
 
 
 
4,000
 
 
4,000
eTunnels Inc.
     
1.5
 
VPNs across all ISPs and companies
 
etunnels.com
                  
 
4,619
 
 
 
4,619
 
 
4,619
 
 
3,748
 
 
 
3,748
 
 
3,748
Elixir
     
1.5
 
Evaluation technology for anti-aging     compounds
                      
 
2,827
 
 
 
2,827
 
 
2,827
 
 
2,827
 
 
 
2,827
 
 
2,827
                                    


 

 

 


 

 

Total securities of private companies held
                                  
 
72,845
 
 
 
66,842
 
 
112,855
 
 
86,837
 
 
 
78,295
 
 
106,070
                                    


 

 

 


 

 

Limited partnership interests in private venture capital funds (period held of 1.3—9.5 years) (d)
                      
 
53,183
 
 
 
48,764
 
 
67,292
 
 
64,889
 
 
 
57,174
 
 
75,247
                                    


 

 

 


 

 

Total investments
                      
 
133,545
 
 
$
123,123
 
$
185,449
 
 
171,720
 
 
$
155,084
 
$
189,973
                                            

 

         

 

Estimated tax cost (benefit) on assumed disosal at fair value
                      
 
(18,685
)
             
 
(6,571
)
           
                                    


             


           
Estimated net asset value (“NAV”)
                      
$
152,230
 
             
$
178,291
 
           
                                    


             


           

See notes on page 8.

7


 
TREDEGAR CORPORATION
 
Schedule of Investments at June 30, 2002 and December 31, 2001
(In Thousands, Except Per-Share Amounts)
 
Notes:
 
(a)
 
The period held for an investment in a company or a venture capital fund is computed using the initial investment date and the current valuation date. If a company has merged with another company, then the initial investment date is the date of the investment in the predecessor company.
(b)
 
Amounts are shown net of carried interest estimated using realized and unrealized net gains to date. Amounts may change due to changes in estimated carried interest, and such changes are not expected to be material. Carried interest is the portion of value payable to portfolio managers based on realized net gains and is a customary incentive in the venture capital industry.
(c)
 
Restricted securities are securities for which an agreement exists not to sell shares for a specified period of time, usually 180 days. Also included within the category of restricted securities are unregistered securities, the sale of which must comply with an exemption to the Securities Act of 1933 (usually SEC Rule 144). These unregistered securities are either the same class of stock that is registered and publicly traded or are convertible into a class of stock that is registered and publicly traded.
(d)
 
At June 30, 2002, Tredegar had ownership interests in 28 venture capital funds, including an indirect interest in the following public companies, among others (disposition of shares held by venture funds, including distributions to limited partners, is at the sole discretion of the general partner of the fund):
 
    
Symbol

  
Description

    
Indirect
Interest in Common
Shares

  
Closing
Price

    
Average
Restricted
Stock Dis-count

    
Indirect

Indirect Investment

                     
Estimated
Fair
Value

  
Cost Basis

Illumina, Inc.
  
ILMN
  
Fiber optic sensor technology for drug screening (illumina.com)
    
203
  
$
6.72
    
20
%
  
$
1,090
  
$
333
Adolor Corporation
  
ADLR
  
Develops pain-management therapeutic drugs (adolor.com)
    
88
  
 
11.26
    
20
%
  
 
791
  
 
411
Array Biopharma
  
ARRY
  
Drug discovery research using innovative chemistry (arraybiopharma.com)
    
96
  
 
9.64
    
20
%
  
 
743
  
 
240
Seattle Genetics
  
SGEN
  
Biopharmaceuticals for treatment of cancers (seattlegenetics.com)
    
104
  
 
5.21
    
20
%
  
 
432
  
 
200
 
(e)
 
Public company stock received from the acquisition of a private company in the portfolio.
(f)
 
Our portfolio is subject to risks typically associated with investments in technology start-up companies, which include business failure, illiquidity and stock market volatility.

8


 
5.  Comprehensive income (loss), defined as net income (loss) and other comprehensive income (loss), was a loss of $2.4 million for the second quarter of 2002 and income of $20.6 million for the second quarter of 2001. Comprehensive income (loss) was a loss of $6.8 million for the first six months of 2002 and income of $9.1 million for the first six months of 2001. Other comprehensive income (loss) includes changes in unrealized gains and losses on available-for-sale securities, foreign currency translation adjustments and unrealized gains and losses on derivative financial instruments recorded net of deferred income taxes directly in shareholders’ equity.
 
6.  The components of inventories are as follows:
 
    
June 30,
2002

  
Dec. 31,
2001

    
(In Thousands)
Finished goods
  
$
7,310
  
$
8,407
Work-in-process
  
 
8,596
  
 
4,560
Raw materials
  
 
14,784
  
 
21,800
Stores, supplies and other
  
 
10,547
  
 
10,549
    

  

Total
  
$
41,237
  
$
45,316
    

  

 
7.  Basic earnings per share is computed by dividing net income by the weighted average number of shares of common stock outstanding. Diluted earnings per share is computed by dividing net income by the weighted average common and potentially dilutive common equivalent shares outstanding, determined as follows:
 
    
Second Quarter
Ended June 30

  
Six Months
Ended June 30

    
2002

  
2001

  
2002

  
2001

    
(In Thousands)
Weighted average shares outstanding used to compute basic earnings per share
  
38,270
  
38,055
  
38,219
  
38,053
Incremental shares issuable upon the assumed exercise of stock options
  
841
  
783
  
771
  
765
    
  
  
  
Shares used to compute diluted earnings per share
  
39,111
  
38,838
  
38,990
  
38,818
    
  
  
  
 
Incremental shares issuable upon the assumed exercise of outstanding stock options are computed using the average market price during the related period.
 
8.  Our effective tax rate from continuing operations for the quarter ended June 30, 2002 was 33% and for the six months ended June 30, 2002 was 33.9% compared with 24.2% and 26.7% in the same periods of the prior year, respectively. The prior year effective tax rate from continuing operations was low due primarily to the $1.9 million tax benefit related to the reversal of income tax contingency accruals upon favorable conclusion of IRS examinations through 1997.

9


 
9.  On April 30, 2002, we completed a $100 million 364-day revolving credit facility and terminated our $275 million revolver that would have matured in July 2002. The new facility has covenants and restrictions consistent with our existing debt; the most restrictive of which is a debt-to-capitalization limitation of 50%. At June 30, 2002, this ratio was 36%. The new facility provides for interest to be charged at a base rate (generally the London Interbank Offered Rate (“LIBOR”)) plus a spread that is dependent upon our quarterly debt-to-capitalization ratio. The fully-borrowed spread over LIBOR charged at the various debt-to-capitalization levels is as follows:
 
Credit Spread Under $100 Million
364-Day Revolving Credit Facility

Debt-to-Total
Capitalization Ratio

    
Fully-Borrowed
Spread Over
LIBOR (Basis Points)

> 40% and <= 50%
    
125.0
> 30% and <= 40%
    
100.0
<= 30%
    
75.0
 
This short-term facility is an interim step to longer-term financing that we plan to initiate once the divestitures of Molecumetics and Therics have been completed.
 

10


 
Item 2.    Management’s Discussion and Analysis of Financial Condition and Results of Operations.
 
Critical Accounting Policies
 
In the ordinary course of business, we make a number of estimates and assumptions relating to the reporting of results of operations and financial position in the preparation of financial statements in conformity with generally accepted accounting principles. Actual results could differ significantly from those estimates under different assumptions and conditions. We believe the following discussion addresses our most critical accounting policies, which are those that require management’s most difficult, subjective and complex judgments, often as a result of the need to make estimates about the effect of matters that are inherently uncertain.
 
Investments
 
We have investments in private venture capital fund limited partnerships and early-stage technology companies, including the stock of privately held companies and the restricted and unrestricted stock of companies that have recently registered shares in initial public offerings. These investments individually represent voting ownership interests of less than 20%.
 
We write down or write off an investment and recognize a loss when events indicate the investment is permanently impaired. For private securities and ownership interests in private venture capital funds, permanent impairment is deemed to exist whenever the estimated fair value at quarterly valuation dates is below carrying value. For available-for-sale securities, permanent impairment is deemed to exist if analyst reports or other information on the company in which we have invested indicates that recovery of value above cost basis is unlikely within several quarters.
 
The fair value of securities of public companies is determined based on closing price quotations, subject to estimated restricted stock discounts. We estimate the fair value of securities of private companies using purchase cost, prices of recent significant private placements of securities of the same issuer, changes in financial condition and prospects of the issuer, and estimates of liquidation value. The fair value of ownership interests in private venture capital funds is based on our estimate of our distributable share of fund net assets using, among other information:
 
 
 
The general partners’ estimate of the fair value of non-marketable securities held by the funds (which is usually the indicative value from the latest round of financing or a reduced amount if events subsequent to the financing imply a lower valuation);
 
 
 
Closing bid prices of publicly traded securities held by the funds, subject to estimated restricted stock discounts; and
 
 
 
Fund formulas for allocating profits, losses and distributions.
 
Because of the inherent uncertainty associated with the valuations of restricted securities or securities for which there is no public market, estimates of fair value may differ significantly from the values that would have been used had a ready market for the securities existed. The portfolio is subject to risks typically associated with investments in technology start-up companies, which include business failure, illiquidity and stock market volatility. Furthermore, publicly traded stocks of emerging, technology-based companies usually have higher volatility and risk than the U.S. stock market as a whole.
 

11


Impairment of Long-lived Identifiable Assets
 
We regularly assess our long-lived assets for impairment when events or circumstances indicate that their carrying value may not be recoverable from future cash flows. Any necessary impairment charges are recorded when we do not believe the carrying value of the long-lived asset will be recoverable.
 
Assets to be disposed of, including assets held for sale, are reported at the lower of their carrying amount or estimated fair value less cost to sell, with an impairment loss recognized for any write-downs required.
 
Impairment of Goodwill
 
On an annual basis we assess goodwill for impairment by comparing the fair value of our reporting units to their carrying amounts. If the carrying amounts of the reporting units exceed their fair values, the deficiency identified with goodwill is recognized as an impairment charge.
 
Pension Benefits
 
We have noncontributory and contributory defined benefit (pension) plans covering most employees. Several statistical and other factors that attempt to anticipate future events are used in calculating the net benefit income or cost and benefit obligations related to the plans. These factors include assumptions about the discount rate, expected return on plan assets and rate of future compensation increases, as determined within certain guidelines. In addition, our actuarial consultants use subjective factors such as withdrawal and mortality rates to estimate the projected benefit obligation. The actuarial assumptions may differ materially from actual results due to changing market and economic conditions, higher or lower withdrawal rates or longer or shorter life spans of participants. These differences may result in a significant impact to the amount of net pension income or expense recorded in future periods.
 
Results of Operations
 
Second Quarter 2002 Compared with Second Quarter 2001
 
The net loss for the second quarter of 2002 was $3.3 million compared with net income of $13.5 million in 2001. Net income from continuing operations was $2.1 million down from $13 million in 2001 (5 cents per share versus 34 cents per share). Results in the second quarter of 2002 include $12.2 million of net after-tax losses from venture capital investments compared with a net after-tax gain of $123,000 in the prior year. Results in 2001 include an after-tax gain of $2.5 million (7 cents per share) related to the reversal of income tax contingency accruals and related interest received on tax overpayments upon favorable conclusion of certain IRS examinations. Results in 2001 also include goodwill amortization expense of $757,000 after taxes or two cents per share.
 
On March 22, 2002, we announced our intent to divest our two biotechnology units, Molecumetics and Therics. The long-lived assets for Therics ($10 million at June 30, 2002) have
 

12


 
been separately classified in the accompanying balance sheet as “Net non-current assets of Therics held for sale.”
 
Operations at Molecumetics were ceased on July 2, 2002, while efforts to sell its technology and tangible assets continue. The operating results of Molecumetics have been reported as discontinued operations. The net loss from discontinued operations of Molecumetics was $5.4 million in 2002 versus $917,000 in 2001. The second quarter of 2002 includes an expected loss on the disposal of Molecumetics of $6 million ($3.9 million after taxes) comprised of an impairment loss for equipment of $4 million and estimated miscellaneous disposal costs of $2 million. The assets of Molecumetics (approximately $1.7 million) have been included in “Prepaid expenses and other” in the consolidated balance sheet at June 30, 2002.
 
Discontinued operations for the second quarter of 2001 also include an after-tax gain of $1.4 million related to the reversal of an income tax contingency accrual upon favorable conclusion of IRS examinations through 1997. The accrual was originally recorded in conjunction with the sale of The Elk Horn Coal Corporation in 1994.
 
Efforts to sell Therics are under way as it continues to progress in its technology development efforts. Therics had net losses of $2 million in the second quarter of 2002 and $2.1 million in 2001 (5 cents per share in each period).
 
Pre-tax gains and losses from venture capital investment activities are included in “Other income (expense), net” in the consolidated statements of income on page 3 and “Venture capital investments” in the operating profit table on page 17. Operating expenses (primarily management fee expenses) for our venture capital investment activities are classified in “Selling, general and administrative expenses” (“SG&A”) in the consolidated statements of income and “Venture capital investments” in the operating profit table.
 
After-tax depreciation in the net asset value (“NAV”) of the venture capital investment portfolio during the second quarter was $15.1 million. At June 30, 2002, the NAV of the portfolio was $152.2 million. For more information on our venture capital investment activities, see pages 18 to 20 and Note 4 on pages 6 to 8.
 
Net sales in the second quarter were relatively flat compared with the prior year. Net sales in Film Products were up 7% while sales in Aluminum Extrusions declined 6%. Volume in Film Products was up 11% while volume in Aluminum Extrusions declined 4%. For more information on net sales, see the business segment review beginning on page 17.
 
The gross profit margin during the second quarter increased to 21.6% from 18.4% in 2001. The higher profit margin was driven mainly by an increase in Film Products due to improved product and customer mix as well as increased operating efficiencies. The gross profit margin in Aluminum Extrusions was up slightly despite continued pressure on both volume and price.
 
SG&A expenses in the second quarter were $14.5 million, up from $12.6 million in 2001 due primarily to increased expenses at Film Products in support of additional sales and marketing efforts. As a percentage of net sales, SG&A expenses were 7.4% in the second quarter of 2002 compared with 6.4% in 2001.
 

13


 
R&D expenses were flat at $5.1 million in both periods.
 
Unusual items in 2002 totaled $268,000 ($172,000 after income taxes) and were primarily for relocation and employee related costs related to the shutdown of the films plant in Tacoma, Washington.
 
Unusual items in 2001 include a pre-tax gain of $1 million related to interest received on tax overpayments upon favorable conclusion of IRS examinations through 1997 (included in “Corporate expenses, net” in the net sales and operating profit by segment table). Income taxes include a second-quarter tax benefit of $1.9 million related to the reversal of income tax contingency accruals upon favorable conclusion of IRS examinations through 1997.
 
Interest income, which is included in “Other income (expense), net” in the consolidated statements of income, was $496,000 in 2002 and $726,000 in 2001. Despite higher average cash and cash equivalents during the quarter, interest income was down due to a lower average tax-equivalent yield earned on cash and cash equivalents (approximately 2% in the second quarter of 2002 and approximately 4.5% in 2001). Our policy permits investment of excess cash in marketable securities that have the highest credit ratings and maturities of less than one year. The primary objectives of our policy are safety of principal and liquidity.
 
Interest expense was $2.3 million compared with $3.2 million in 2001. Average debt outstanding and interest rates for the quarters were as follows:
 
    
Second Quarter Ended
June 30,

 
    
2002

    
2001

 
    
(In Millions)
 
Floating-rate debt with interest charged on a rollover basis at one-month LIBOR:
                 
Average outstanding debt balance
  
$
175.0
 
  
$
225.0
 
Average interest rate
  
 
2.6
%
  
 
5.3
%
Floating-rate debt fixed via interest rate swaps in the second quarter of 2001 and maturing in the second quarter of 2003:
                 
Average outstanding debt balance
  
$
75.0
 
  
$
25.0
 
Average interest rate
  
 
4.8
%
  
 
4.85
%
Fixed-rate and other debt:
                 
Average outstanding debt balance
  
$
13.4
 
  
$
14.5
 
Average interest rate
  
 
7.2
%
  
 
7.2
%
    


  


Total debt:
                 
Average outstanding debt balance
  
$
263.4
 
  
$
264.5
 
Average interest rate
  
 
3.6
%
  
 
5.4
%
    


  


 
Our effective income tax rate from continuing operations was 33% compared with 24.2% in the prior year. The prior year rate was low due to the impact of the $1.9 million tax benefit related to the reversal of income tax contingency accruals upon favorable conclusion of IRS examinations as noted above. The effective income tax rate from manufacturing operations, excluding unusual items, was 35.5% in both periods.
 
Six Months 2002 Compared with Six Months 2001

14


 
The net loss for the first six months of 2002 was $2.8 million compared with net income of $15.4 million in 2001. Net income from continuing operations was $5 million in 2002, down from $16.1 million in 2001 (13 cents per share versus 42 cents per share). Results for 2002 include $19.4 million (50 cents per share) of after-tax losses from venture capital investments compared to $5.2 million (13 cents per share) in 2001. Results in 2001 include an after-tax gain of $2.5 million (seven cents per share) related to the reversal of income tax contingency accruals and related interest received on tax overpayments upon favorable conclusion of certain IRS examinations. Results in 2001 also include goodwill amortization expense of $1.5 million after taxes or four cents per share.
 
Results for 2002 include net losses from discontinued operations of Molecumetics of $7.8 million versus $2.1 million in 2001. In addition to the operating losses, discontinued operations for 2002 include an expected loss on the disposal of Molecumetics of $3.9 million after taxes.
 
Discontinued operations in 2001 also include an after-tax gain of $1.4 million related to the reversal of an income tax contingency accrual upon favorable conclusion of IRS examinations through 1997. The accrual was originally recorded in conjunction with the sale of The Elk Horn Coal Corporation in 1994.
 
The after-tax depreciation in the NAV through the first six months of this year was $29.3 million.
 
Net sales for the six months ended June 30, 2002, decreased by 4.2% compared with the same period of last year. The lower net sales are due primarily to lower volume in Aluminum Extrusions (volume down 4%). For more information on net sales, see the business segment review beginning on page 17.
 
The gross profit margin for the first six months of 2002 increased to 21.3% from 18.4% in 2001 primarily due to increased profit in Film Products due to higher volume and improved product and customer mix.
 
SG&A expenses were $27.8 million in 2002 compared with $25.7 million in 2001. The increase is primarily due to overall higher employee related costs and higher expenses in Film Products in support of additional sales and marketing efforts. As a percentage of net sales, SG&A expenses increased to 7.5% in the first six months of 2002 compared with 6.6% in the same period of 2001.
 
R&D expenses increased to $10.7 million in 2002 from $9.3 million in 2001 due to higher spending at Therics (up $814,000) and higher spending at Film Products (up $556,000).
 
Unusual items for the six months ended June 30, 2002, totaled approximately $1.3 million ($809,000 after income taxes or two cents per share) and included:
 
 
 
a pretax charge of $285,000 primarily for relocation and employee-related costs related to the shutdown of a films plant in Tacoma, Washington;
 
 
 
a pretax charge of $810,000 for severance and other employee-related costs related to the planned shutdown of a films plant in Carbondale, Pennsylvania; and

15


 
 
 
a pretax charge of $169,000 for costs incurred in the transfer of business related to the shutdown of an aluminum plant in El Campo, Texas.
 
Unusual items for the six months ended June 30, 2001, totaled $629,000 ($1.5 million after income taxes or two cents per share) and included:
 
 
 
a charge of $1.6 million ($1 million after income taxes) for severance costs related to further rationalization in the films business;
 
 
 
a gain of $1 million ($621,000 after income taxes) for interest received on tax overpayments upon favorable conclusion of IRS examinations through 1997 (included in “Corporate expenses, net” in the net sales and operating profit by segment table); and
 
 
 
an income tax benefit of $1.9 million related to the reversal of income tax contingency accruals upon favorable conclusion of IRS examinations through 1997 (included in “Income taxes” in the Consolidated Statements of Income).
 
Interest income for the six months ended June 30, 2002 was $1.1 million versus $1.4 million for the same period in 2001. The average cash and cash equivalents balance was $99 million in 2002 versus $58 million in 2001. The average tax-equivalent yield earned on cash equivalents was approximately 2% in 2002 and 4.9% in 2001.
 
Interest expense decreased to $4.5 million in 2002 from $7.3 million in 2001. Average debt outstanding and interest rates were as follows:
 
    
Six Months Ended
June 30,

 
    
2002

    
2001

 
    
(In Millions)
 
Floating-rate debt with interest charged on a rollover basis at one-month LIBOR:
                 
Average outstanding debt balance
  
$
175.0
 
  
$
225.0
 
Average interest rate
  
 
2.6
%
  
 
6.0
%
Floating-rate debt fixed via interest rate swaps in the second quarter of 2001 and maturing in the second quarter of 2003:
                 
Average outstanding debt balance
  
$
75.0
 
  
$
25.0
 
Average interest rate
  
 
4.8
%
  
 
4.85
%
Fixed-rate and other debt:
                 
Average outstanding debt balance
  
$
14.1
 
  
$
14.5
 
Average interest rate
  
 
7.2
%
  
 
7.2
%
    


  


Total debt:
                 
Average outstanding debt balance
  
$
264.1
 
  
$
264.5
 
Average interest rate
  
 
3.6
%
  
 
6.0
%
    


  


 
The effective income tax rate from continuing operations for the six months ended June 30, 2002, was 33.9% compared with 26.7% in the prior year. The prior year rate was low due to the impact of the $1.9 million tax benefit related to the reversal of income tax contingency accruals upon favorable conclusion of IRS examinations. The effective income tax rate from manufacturing operations, excluding unusual items, was 35.5% in both periods.

16


 
Business Segment Review
 
The following tables present Tredegar’s net sales and operating profit by segment for the second quarter and six months ended June 30, 2002 and 2001.
 
Net Sales by Segment
(In Thousands)
(Unaudited)
 
    
Second Quarter
Ended June 30

  
Six Months
Ended June 30

    
2002

  
2001

  
2002

  
2001

Film Products
  
$
97,285
  
$
90,743
  
$
186,194
  
$
187,573
Aluminum Extrusions
  
 
99,124
  
 
105,034
  
 
183,830
  
 
198,506
Therics
  
 
94
  
 
94
  
 
188
  
 
263
    

  

  

  

Total net sales
  
$
196,503
  
$
195,871
  
$
370,212
  
$
386,342
    

  

  

  

 
Operating Profit by Segment
(In Thousands)
(Unaudited)
 
    
Second Quarter
Ended June 30

    
Six Months
Ended June 30

 
    
2002

    
2001

    
2002

    
2001

 
Film Products:
                                   
Ongoing operations
  
$
18,705
 
  
$
12,872
 
  
$
36,797
 
  
$
27,966
 
Unusual items
  
 
(295
)
  
 
—  
 
  
 
(1,095
)
  
 
(1,600
)
    


  


  


  


Total Film Products
  
 
18,410
 
  
 
12,872
 
  
 
35,702
 
  
 
26,366
 
    


  


  


  


Aluminum Extrusions:
                                   
Ongoing operations
  
 
10,277
 
  
 
10,171
 
  
 
15,630
 
  
 
16,552
 
Unusual items
  
 
27
 
  
 
—  
 
  
 
(169
)
  
 
—  
 
    


  


  


  


Total Aluminum Extrusions
  
 
10,304
 
  
 
10,171
 
  
 
15,461
 
  
 
16,552
 
    


  


  


  


Therics
  
 
(3,134
)
  
 
(3,219
)
  
 
(6,827
)
  
 
(5,568
)
    


  


  


  


Tredegar Investments
  
 
(18,999
)
  
 
191
 
  
 
(30,201
)
  
 
(8,071
)
    


  


  


  


Total operating profit
  
 
6,581
 
  
 
20,015
 
  
 
14,135
 
  
 
29,279
 
Interest income
  
 
496
 
  
 
726
 
  
 
1,050
 
  
 
1,414
 
Interest expense
  
 
2,310
 
  
 
3,232
 
  
 
4,498
 
  
 
7,273
 
Corporate expenses, net
  
 
1,616
 
  
 
321
 
  
 
3,123
 
  
 
1,489
 
    


  


  


  


Income from continuing operations before income taxes
  
 
3,151
 
  
 
17,188
 
  
 
7,564
 
  
 
21,931
 
Income taxes
  
 
1,040
 
  
 
4,158
 
  
 
2,563
 
  
 
5,866
 
    


  


  


  


Income from continuing operations
  
 
2,111
 
  
 
13,030
 
  
 
5,001
 
  
 
16,065
 
Income (loss) from discontinued operations
  
 
(5,446
)
  
 
479
 
  
 
(7,753
)
  
 
(655
)
    


  


  


  


Net (loss) income
  
$
(3,335
)
  
$
13,509
 
  
$
(2,752
)
  
$
15,410
 
    


  


  


  


17


 
Second quarter sales in Film Products increased 7.2% to $97.3 million while operating profit, excluding unusual items, increased from $12.9 million in 2001 to $18.7 million in 2002 or 45%. On a year-to-date basis, sales in Film Products fell slightly to $186.2 million from $187.6 million while operating profit, excluding unusual items, was $36.8 million, up 31.6%. Excluding the impact of goodwill amortization expense in the prior year, operating profit was up 35.5% for the quarter and 23.5% for the first six months. The strong sales for the quarter were driven by an increase in volume of 11.4%, offset in part by a decline in selling prices, which are heavily influenced by raw material costs, of approximately 4%. The improved results for the quarter and year-to-date were driven by higher sales of new products combined with a temporary slowdown in the ongoing decline in sales of domestic backsheet products.
 
In Aluminum Extrusions, second-quarter sales were down 5.6% to $99.1 million while operating profit, excluding unusual items, was relatively flat at $10.3 million. On a year-to-date basis, sales declined 7.4% to $183.8 million while operating profit was $15.6 million, down 5.6% compared with the same period of the prior year. Sales and operating profit were negatively impacted by continued pressure on both volume and prices. The negative impact of these factors was offset by lower conversion costs, which were helped by the shutdown of our plant in El Campo, Texas.
 
For Therics, revenue was flat for the quarter and down for the six months ended June 30, 2002 compared with the same periods of the prior year. The second-quarter operating loss was $3.1 million versus $3.2 million in 2001. On a year-to-date basis, the operating loss was $6.8 million versus $5.6 million in 2001.
 
The results of Molecumetics have been reported as discontinued operations and results for prior periods have been restated. The net loss for the second quarter of 2002 was $5.4 million versus $917,000 in 2001. On a year-to-date basis, the net loss was $7.8 million versus $2.1 million in the prior year. Results for 2002 include an expected loss on the disposal of Molecumetics of $3.9 million after taxes.
 
The appreciation (depreciation) in NAV related to venture capital investment activities for the second quarter and six months ended June 30, 2002 and 2001 is summarized below:
 
    
Second Quarter
Ended June 30

  
Six Months
Ended June 30

 
    
2002

    
2001

  
2002

    
2001

 
    
(In Millions)
 
Net realized gains, losses, write-downs and related operating expenses for venture capital investments reflected in Tredegar’s consolidated statements of income (net of tax)
  
$
(12.2
)
  
$
.1
  
$
(19.4
)
  
$
(5.2
)
Change in unrealized appreciation of venture capital investments (net of tax)
  
 
(2.9
)
  
 
1.3
  
 
(9.9
)
  
 
(29.5
)
    


  

  


  


After-tax appreciation (depreciation) in NAV related to investment performance
  
$
(15.1
)
  
$
1.4
  
$
(29.3
)
  
$
(34.7
)
    


  

  


  


18


 
The following companies held directly in the portfolio, or indirectly through our interests in other venture capital funds, accounted for most of the change in NAV during the quarter and six months ended June 30, 2002:
 
             
Appreciation (Depreciation)
in Estimated NAV

 
Investment

    
Reason for Change

    
2nd Quarter
Ended
6/30/02

      
Six Months
Ended
6/30/02

 
             
(In Millions)
 
Public companies:
                            
Illumina, Inc.
    
Change in stock price
    
 
(1.7
)
    
 
(3.2
)
Universal Access, Inc.
    
Change in stock price
    
 
(0.5
)
    
 
(1.4
)
SignalSoft Corporation
    
Change in stock price (position liquidated)
    
 
0.1
 
    
 
(0.7
)
Vascular Solutions
    
Change in stock price
    
 
(0.5
)
    
 
(0.6
)
Private companies:
                            
Venture capital funds
    
Various
    
 
(5.4
)
    
 
(7.1
)
NovaLux, Inc.
    
Lower valuation of the company
    
 
(4.8
)
    
 
(4.8
)
Appliant, Inc.
    
Lower valuation of the company
    
 
—  
 
    
 
(3.5
)
MedManage Systems Inc.
    
Lower valuation of the company
    
 
—  
 
    
 
(1.9
)
Cbyon, Inc.
    
Lower valuation of the company
    
 
—  
 
    
 
(1.8
)
Songbird Medical, Inc.
    
Lower valuation of the company
    
 
(0.6
)
    
 
(0.6
)
Other public and private companies
    
Various
    
 
(0.8
)
    
 
(1.9
)
             


    


Depreciation in NAV before operating expenses
    
 
(14.2
)
    
 
(27.5
)
After-tax operating expenses
    
 
(0.9
)
    
 
(1.8
)
             


    


Depreciation in NAV related to investment performance
    
$
(15.1
)
    
$
(29.3
)
             


    


 
The cost basis, carrying value and NAV of the venture capital portfolio is reconciled below:
 
    
June 30,
2002

    
Dec. 31,
2001

 
    
(In Millions)
 
Cost basis of investments
  
$
185.4
 
  
$
190.0
 
Write-downs taken on securities held (charged to earnings)
  
 
(66.0
)
  
 
(47.9
)
Unrealized appreciation on public securities held by Tredegar (reflected directly in equity net of deferred income taxes)
  
 
3.7
 
  
 
13.0
 
    


  


Carrying value of investments reflected in the balance sheet
  
 
123.1
 
  
 
155.1
 
Unrealized appreciation in private securities held by Tredegar and in its indirect interest in all securities held by venture capital funds
  
 
10.4
 
  
 
16.6
 
    


  


Estimated fair value of venture capital investments
  
 
133.5
 
  
 
171.7
 
Estimated income tax benefit (cost) on assumed disposal at fair value
  
 
18.7
 
  
 
6.6
 
    


  


NAV of venture capital investments
  
$
152.2
 
  
$
178.3
 
    


  


 
We generated taxable capital gains in the portfolio of approximately $158 million in 2000 and $30 million in 2001. The taxable capital gains generated in 2000 and 2001 are available for the carry-back of tax-related capital losses through 2003 and 2004, respectively.

19


 
Changes in NAV for the quarter and six months ended June 30, 2002 and 2001 are summarized below:
 
    
Second Quarter
Ended June 30

    
Six Months
Ended June 30

 
    
2002

    
2001

    
2002

    
2001

 
    
(In Millions)
 
NAV at beginning of period
  
$
166.6
 
  
$
296.5
 
  
$
178.3
 
  
$
335.0
 
    


  


  


  


After-tax appreciation (depreciation) in NAV related to investment performance (net of operating expenses)
  
 
(15.1
)
  
 
1.4
 
  
 
(29.3
)
  
 
(34.7
)
After-tax operating expenses funded by Tredegar
  
 
.9
 
  
 
1.1
 
  
 
1.8
 
  
 
2.1
 
New investments
  
 
5.5
 
  
 
4.7
 
  
 
11.1
 
  
 
9.1
 
Reduction in NAV due to the sale of investments
  
 
(5.7
)
  
 
(14.7
)
  
 
(9.7
)
  
 
(22.5
)
    


  


  


  


(Decrease) increase in NAV
  
 
(14.4
)
  
 
(7.5
)
  
 
(26.1
)
  
 
(46.0
)
    


  


  


  


NAV at end of the period
  
$
152.2
 
  
$
289.0
 
  
$
152.2
 
  
$
289.0
 
    


  


  


  


 
Liquidity and Capital Resources
 
Tredegar’s total assets decreased to $849.9 million at June 30, 2002 from $865 million at December 31, 2001. The decrease is primarily due to the net of the following:
 
 
 
a decline in the carrying value of venture capital investments (decrease of $32 million) primarily due to valuation declines;
 
 
 
a decrease in inventory (down $4.1 million);
 
 
 
an increase in accounts receivable (up $20.4 million) primarily due to higher receivables in Aluminum Extrusions which were at seasonal and cyclical lows at the end of 2001; and
 
 
 
an increase in the prepaid pension asset (up $5.3 million) due to pension income recognized during the period.
 
Cash and cash equivalents was relatively flat at $96.5 million at June 30, 2002 and $96.8 million at December 31, 2001. The reasons for changes in cash and cash equivalents for the six months ended June 30, 2002 and 2001 are summarized below:
 
    
Six Months
Ended June 30

 
    
2002

    
2001

 
    
(In Thousands)
 
Cash and cash equivalents, beginning of period
  
$
96,810
 
  
$
44,530
 
    


  


Cash provided by (used in) operating activities net of capital expenditures and dividends
  
 
10,912
 
  
 
14,397
 
Proceeds from the exercise of stock options
  
 
1,009
 
  
 
152
 
Net (decrease) increase in borrowings
  
 
(5,097
)
  
 
(3,607
)
New venture capital investments, net of proceeds from disposals
  
 
(4,729
)
  
 
17,684
 
Proceeds from divestitures and property disposals
  
 
89
 
  
 
353
 
Other, net
  
 
(2,450
)
  
 
(1,724
)
    


  


Net increase (decrease) in cash and cash equivalents
  
 
(266
)
  
 
27,255
 
    


  


Cash and cash equivalents, end of period
  
$
96,544
 
  
$
71,785
 
    


  


20


 
In 2002, cash provided by continuing operating activities, net of capital expenditures and dividends was $10.9 million compared with $14.4 million in 2001. The change is primarily due to changes in the level of working capital offset in part by higher cash generated by manufacturing operations and lower capital expenditures.
 
Capital expenditures decreased from $22.1 million in 2001 to $13.9 million in 2002. Capital expenditures in 2002 reflect the normal replacement of machinery and equipment and the following key capital projects:
 
 
 
machinery and equipment to upgrade lines at the films manufacturing facility in Kerkrade, The Netherlands;
 
 
 
machinery and equipment for a new production line at the films plant in Terre Haute, Indiana;
 
 
 
expansion of capacity at the films plant in Shanghai, China; and
 
 
 
machinery and equipment purchased for the aluminum plant in Kentland, Indiana.
 
Debt outstanding of $259.4 million at June 30, 2002, consisted of a $250 million term loan, a note payable with a remaining balance of $5 million and other debt of $4.4 million. On April 30, 2002, we completed a $100 million 364-day revolving credit facility and terminated our $275 million revolver that would have matured in July 2002. The new facility has covenants and restrictions consistent with our existing debt; the most restrictive of which is a debt-to-capitalization limitation of 50%. At June 30, 2002, this ratio was 36%. The new facility provides for interest to be charged at a base rate (generally the London Interbank Offered Rate (“LIBOR”)) plus a spread that is dependent upon our quarterly debt-to-capitalization ratio (see Note 9 on page 10). This short-term facility is an interim step to longer-term financing that we plan to initiate once the divestitures of Molecumetics and Therics have been completed.
 
Our future contractual payments related to debt and operating lease obligations are summarized below:
 
    
Payments Due by Period Ending June 30,

    
2003

  
2004

  
2005

  
2006

  
Remainder

  
Total

    
(In Thousands)
Debt
  
$
30,000
  
$
66,235
  
$
100,256
  
$
62,609
  
$
301
  
$
259,401
Operating leases*
  
 
3,258
  
 
2,939
  
 
2,553
  
 
2,140
  
 
7,993
  
 
18,883
    

  

  

  

  

  

Total
  
$
33,258
  
 
69,174
  
$
102,809
  
$
64,749
  
$
8,294
  
$
278,284
    

  

  

  

  

  


*
 
Future payments for operating leases are estimated on a straight-line basis using annual calendar year obligations.
 
Quantitative and Qualitative Disclosures About Market Risk
 
Tredegar has exposure to the volatility of interest rates, polyethylene and polypropylene resin prices, aluminum ingot and scrap prices, foreign currencies, emerging markets and technology stocks.
 
Changes in resin prices, and the timing of those changes, could have a significant impact on profit margins in Film Products; however, those changes are generally followed by a corresponding change in selling prices. Profit margins in Aluminum Extrusions are sensitive to fluctuations in aluminum ingot and scrap prices, but are also generally followed by a corresponding

21


 
change in selling prices; however, there is no assurance that higher ingot costs can be passed along to customers.
 
In the normal course of business, we enter into fixed-price forward sales contracts with certain customers for the sale of fixed quantities of aluminum extrusions at scheduled intervals. To hedge our exposure to aluminum price volatility under these fixed-price arrangements, which generally have a duration of not more than 12 months, we enter into a combination of forward purchase commitments and futures contracts to acquire aluminum, based on scheduled deliveries.
 
We sell to customers in foreign markets through our foreign operations and through exports from U.S. plants. The percentage of consolidated net sales from manufacturing operations related to foreign markets for the six months ended June 30, 2002 and 2001 is presented below:
 
      
Percentage of Net Sales from Manufacturing
Operations Related to Foreign Markets*

 
      
Six Months
Ended June 30

 
      
2002

      
2001

 
      
Exports
From U.S.

      
Foreign
Operations

      
Exports
From U.S.

      
Foreign
Operations

 
Canada
    
3
%
    
18
%
    
3
%
    
15
%
Europe
    
4
 
    
8
 
    
1
 
    
7
 
Latin America
    
3
 
    
2
 
    
3
 
    
3
 
Asia
    
4
 
    
2
 
    
3
 
    
1
 
      

    

    

    

Total
    
14
%
    
30
%
    
10
%
    
26
%
      

    

    

    


*
 
Based on consolidated net sales from manufacturing operations (excluding Tredegar Biotech and Tredegar Investments).
 
We attempt to match the pricing and cost of our products in the same currency and generally view the volatility of foreign currencies and emerging markets, and the corresponding impact on earnings and cash flow, as part of the overall risk of operating in a global environment. Exports from the U.S. are generally denominated in U.S. Dollars. Our foreign currency exposure on income from foreign operations in Europe primarily relates to the Euro. We believe our exposure to the Canadian Dollar has been substantially neutralized by the U.S. Dollar-based spread (the difference between selling prices and aluminum costs) generated from Canadian casting operations and exports from Canada to the U.S.
 
We have investments in private venture capital fund limited partnerships and early-stage technology companies, including the stock of privately-held companies and the restricted and unrestricted stock of companies that have recently registered shares in initial public offerings. The portfolio is subject to risks typically associated with investments in technology start-up companies, which include business failure, illiquidity and stock market volatility. Furthermore, publicly traded stocks of emerging, technology-based companies have higher volatility and risk than the U.S. stock market as a whole. See pages 18 to 20 and Note 4 on pages 6 to 8 for more information.

22


 
Forward Looking and Cautionary Statements
 
From time to time, we may make statements that may constitute “forward-looking statements” within the meaning of the “safe-harbor” provisions of the Private Securities Litigation Reform Act of 1995. Such statements are based on our then current expectations and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those addressed in the forward-looking statements. Factors that may cause such a difference include, but are not limited to the following:
 
Film Products
 
 
 
Film Products is highly dependent on sales associated with one customer, The Procter & Gamble Company (“P&G”).    P&G comprised 31% of our net sales in 2001, 28% in 2000 and 30% in 1999. The loss or significant reduction of sales associated with P&G would have a material adverse effect on our business, as would delays in P&G rolling out products utilizing new technologies developed by Tredegar. While we have undertaken efforts to expand our customer base, there can be no assurance that such efforts will be successful, or that they will offset any delay or loss of sales and profits associated with P&G.
 
 
 
Growth of Film Products depends on our ability to develop and deliver new products, especially in the hygiene market, which comprised over 75% of Film Products’ net sales in each of the last three years.    Hygiene products are now being made with a variety of new materials, replacing traditional backsheet and other components. While we have substantial technical resources, there can be no assurance that our new products can be brought to market successfully, or if brought to market successfully, at the same level of profitability and market share of replaced films. A shift in customer preferences away from our technologies, our inability to develop and deliver new profitable products, or delayed acceptance of our new products in domestic or foreign markets, could have a material adverse effect on our business.
 
 
 
Film Products operates in a field where our significant customers and competitors have substantial intellectual property portfolios.    The continued success of this business depends on our ability not only to protect our own technologies and trade secrets, but also to develop and sell new products that do not infringe upon existing patents. Although we are not currently involved in any patent litigation, the outcome of any such action could have a significant adverse impact on Film Products.
 
 
 
As Film Products expands its hygiene business, we have greater credit risk that is inherent in broadening our customer base.
 
Aluminum Extrusions
 
 
 
Sales volume and profitability of Aluminum Extrusions is cyclical and highly dependent on economic conditions of end-use markets in the United States and Canada, particularly in the construction, distribution and transportation industries.    Our market segments are also subject to seasonal slowdowns during the winter months. From 1992 to the second quarter of 2000, profits in Aluminum Extrusions grew as a result of positive economic conditions in the markets we serve and manufacturing efficiencies. However, a slowdown in these markets in the second half of 2000 resulted in a 13% decline in sales volume and 28% decline in ongoing

23


operating profit compared with the second half of 1999. The aluminum extrusions industry continued to be affected by poor economic conditions in 2001 and the first six months of 2002. Our sales volume declined 20% and operating profit declined 52% in 2001 compared with 2000. The decline in ongoing operating profit at approximately two to three times the rate of the decline in sales volume illustrates the operating leverage inherent in our operations (fixed operating costs). Any benefits associated with cost reductions and productivity improvements may not be sufficient to offset the adverse effects on profitability from pricing and margin pressure and higher bad debts that usually accompany a downturn.
 
 
 
The markets for our products are highly competitive with product quality, service and price being the principal competitive factors.    As competitors increase capacity or reduce prices to increase business, there could be pressure to reduce prices to our customers. Aluminum Extrusions is under increasing domestic and foreign competitive pressures, including a growing presence of Chinese imports in a number of Aluminum Extrusions’ markets. This competition could result in loss of market share due to their ability to produce at lower costs and sell at lower prices. There can be no assurance that we will be able to maintain current margins and profitability. Our continued success and prospects depend on our ability to retain existing customers and participate in overall industry cross-cycle growth.
 
Therics
 
 
 
We are attempting to sell Therics, but given the current market conditions in the biotechnology sector, there is no assurance that we will be successful in those efforts.    We will continue to incur losses as we support Therics’ operations during the sale process. There is no assurance we will realize any return on our continuing investment in Therics.
 
 
 
Therics has incurred losses since inception, and we are unsure when, or if, it will become profitable.    We have not brought any drug delivery systems or bone replacement products to the point of human testing. There can be no assurance that any new drug delivery systems or bone replacement products can be brought to market successfully.
 
 
 
Our ability to develop and commercialize products will depend on our ability to internally develop preclinical, clinical, regulatory and sales and marketing capabilities, or enter into arrangements with third parties to provide those functions.    We may not be successful in developing these capabilities or entering into agreements with third parties on favorable terms. Further, our reliance upon third parties for these capabilities could reduce our control over such activities and could make us dependent upon these parties. Our inability to develop or contract for these capabilities would significantly impair our ability to develop and commercialize products. In addition, there can be no assurance that the FDA and other regulatory authorities will clear our products in a timely manner.
 
 
 
We are highly dependent on several principal members of our management and scientific staff.    The loss of key personnel would have a material adverse effect on Therics’ business and results of operations, and could inhibit product development and commercialization efforts. In addition, recruiting and retaining qualified scientific personnel to perform future R&D work is critical to our success. Competition for experienced scientists is intense. Failure to recruit and retain executive management and scientific personnel on acceptable terms could prevent us

24


from achieving our business objectives.
 
 
 
The patent positions of biotechnology firms generally are highly uncertain and involve complex legal and factual questions that can determine who has the right to develop a particular product.    No clear policy has emerged regarding the breadth of claims covered by biotechnology patents in the United States. The biotechnology patent situation outside the United States is even more uncertain and is currently undergoing review and revision in many countries. Changes in, or different interpretations of, patent laws in the United States and other countries might allow others to use our discoveries or to develop and commercialize our products without any compensation to us.
 
Tredegar Investments
 
 
 
The success, continued existence and value of the early-stage technology companies in which we invest depends on their ability to create or develop commercially viable products or businesses, and raise additional capital when needed.    The possibility that companies in which we invest will not be able to meet their milestones or commercialize their technology, product or business concept presents significant risk. Additionally, companies in which we make seed or expansion round investments will often require substantial additional equity financing to satisfy continuing working capital requirements. Each round of venture financing is typically intended to provide a company with only enough capital to reach the next stage of development. We cannot predict the circumstances or market conditions under which the companies in which we invest will seek additional capital; however, current market conditions are not favorable. Companies that are unsuccessful in raising the needed additional capital are likely to fail, leaving little or no liquidation value for investors.
 
 
 
Many of the venture capital investments we hold are illiquid.    For private companies in which we have invested, there is no secondary market for our shares and there is no assurance that one will be available in the near future. Additionally, once a company becomes publicly traded, there is generally a period of time in which we are not permitted to trade the securities (the “lock-up” period, which is generally six months).
 
 
 
The success of our venture capital investments will be significantly affected by the state of the securities markets in general and, more specifically, the market for initial public offerings, the market for communications, life science and information technology companies, and the market for mergers and acquisitions.    We anticipate that a significant portion of our returns will be realized through initial public offerings of companies in which we have invested or through merger and acquisition activity. The market for initial public offerings and merger and acquisition activity is cyclical in nature. Thus, we cannot be certain that the securities markets will be receptive to initial public offerings or merger and acquisition activity, particularly those of early-stage companies. As seen during 2001, any adverse change in the market for initial public offerings could significantly impact our ability to realize our investment objective.
 
 
 
Valuing our venture capital investments is difficult and inexact.    We value our venture capital investments based on our best estimate of the value of each individual investment. There is typically no public market for our investments in privately held companies. We will consult with venture funds and consulting firms when needed to assist in the valuation of our

25


investments. Valuation is inherently subjective. The net asset value set by management may not reflect the price at which we could sell our shares in the open market.
 
Item 3.    Quantitative and Qualitative Disclosures About Market Risk
 
See discussion under “Quantitative and Qualitative Disclosures About Market Risk” beginning on page 21.

26


 
PART II—OTHER INFORMATION
 
Item 1.    Legal Proceedings.
 
A consent order was entered into by the Environmental Protection Division, Department of Natural Resources, State of Georgia and the William L. Bonnell Company relating to alleged violations of the conditions and limitations contained in the National Pollutant Discharge Elimination System Permit No. GA0000507 (the “Permit”) for our wastewater treatment facility in Newnan, Georgia. The consent order is in effect through December 31, 2003. We are taking steps to address the permit issues associated with our wastewater treatment facility and have agreed to pay quarterly penalties until the issues are resolved. In 2001, we made payments of $62,000 pursuant to this consent order and expect total payments to be approximately $160,000 before the permit issues are fully resolved.
 
Item 4.    Submission of Matters to a Vote of Security Holders.
 
Tredegar’s Annual Meeting of Shareholders was held on April 25, 2002. The following sets forth the vote results with respect to each of the matters voted upon at the meeting:
 
(a)  Election of Directors
 
Nominee

 
No. of Votes
    “For”    

 
No. of Votes
“Withheld”

Richard W. Goodrum
 
34,222,770
 
4,032,479
Phyllis Cothran
 
34,258,913
 
3,996,336
Floyd D. Gottwald, Jr.
 
34,198,149
 
4,057,100
 
There were no broker non-votes with respect to the election of directors.
 
(b)  Approval of Auditors
 
Approval of the designation of PricewaterhouseCoopers LLP as the auditors for Tredegar for the fiscal year ending December 31, 2002:
 
No. of Votes
    “For”    

 
No. of Votes
“Against”

  
No. of
Abstentions

34,568,604
 
179,227
  
42,096
 
There were no broker non-votes with respect to the approval of auditors.

27


 
Item 6.    Exhibits and Reports on Form 8-K.
 
(a)    Exhibit No.
 
3
 
Amended By-Laws
4
 
Credit Agreement dated April 30, 2002, among Tredegar Corporation, as Borrower, Wachovia Bank, National Association, as Administrative Agent, Suntrust Bank, as Syndication Agent, and Bank of America, N.A., as Documentation Agent
 
(b)  Reports on Form 8-K.    No reports on Form 8-K have been filed for the quarter ended June 30, 2002.

28


 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
TREDEGAR CORPORATION
  (Registrant)
By:
 
/s/    D. ANDREW EDWARDS        

   
D. Andrew Edwards
Vice President,
Finance and Treasurer
(Principal Financial Officer)
 
Date:  August 6, 2002
 
By:
 
/s/    MICHELLE O. MOSIER         

   
Michelle O. Mosier
Corporate Controller
(Principal Accounting Officer)
 
Date:  August 6, 2002

29


 
EXHIBIT INDEX
 
Exhibit No.

  
Description

3
  
Amended By-Laws
4
  
Credit Agreement dated April 30, 2002, among Tredegar Corporation, as Borrower, Wachovia Bank, National Association, as Administrative Agent, Suntrust Bank, as Syndication Agent, and Bank of America, N.A., as Documentation Agent

30
Tredegar Corporation Exhibit 3 to Form 10-Q

Exhibit 3

=======================================

TREDEGAR CORPORATION

AMENDED AND RESTATED BY-LAWS

In Effect as of August 1, 2002

=======================================

TREDEGAR CORPORATION

AMENDED AND RESTATED BY-LAWS

ARTICLE I

Meeting of Shareholders

        Section 1. Places of Meetings. All meetings of the shareholders shall be held at such place, either within or without the State of Virginia, as may, from time to time, be fixed by the Board of Directors.

        Section 2. Annual Meetings. The annual meeting of the shareholders, for the election of directors and transaction of such other business as may come before the meeting, shall be held in each year on the fourth Thursday in April, at 9:30 a.m., Richmond, Virginia time, or on such other date and at such other time as the Board of Directors of the Corporation may designate from time to time.

        Section 3. Special Meetings. Special meetings of shareholders for any purpose or purposes may be called at any time by the Chairman of the Board or the President of the Corporation, or by a majority of the Board of Directors. At a special meeting no business shall be transacted and no corporate action shall be taken other than that stated in the notice of the meeting.

        Section 4. Notice of Meetings. Except as otherwise required by law, written or printed notice stating the place, day and hour of every meeting of the shareholders and, in case of a special meeting, the purpose or purposes for which the meeting is called, shall be mailed not less than ten nor more than sixty days before the date of the meeting to each shareholder of record entitled to vote at such meeting, at his address which appears in the share transfer books of the Corporation. Meetings may be held without notice if all the shareholders entitled to vote at the meeting are present in person or by proxy or if notice is waived in writing by those not present, either before or after the meeting.

        Section 5. Quorum. Except as otherwise required by the Articles of Incorporation, any number of shareholders together holding at least a majority of the outstanding shares of capital stock entitled to vote with respect to the business to be transacted, who shall be present in person or represented by proxy at any meeting duly called, shall constitute a quorum for the transaction of business. If less than a quorum shall be in attendance at the time for which a meeting shall have been called, the meeting may be adjourned from time to time by a majority of the shareholders present or represented by proxy without notice other than by announcement at the meeting.

        Section 6. Voting. At any meeting of the shareholders each shareholder of a class entitled to vote on the matters coming before the meeting shall have one vote, in person or by proxy, for each share of capital stock standing in his or her name on the books of the Corporation at the time of such meeting or on any date fixed by the Board of Directors not more than seventy (70) days prior to the meeting. Every proxy shall be in writing, dated and signed by the shareholder entitled to vote or his duly authorized attorney-in-fact.

        Section 7. Voting List. The officer or agent having charge of the stock transfer books for shares of the Corporation shall make, at least ten (10) days before each meeting of shareholders, a complete list of the shareholders entitled to vote at such meeting or any adjournment thereof, with the address of and the number of shares held by each. Such list, for a period of ten (10) days prior to such meeting, shall be kept on file at the registered office of the Corporation or at its principal place of business or at the office of its transfer agent or registrar and shall be subject to inspection by any shareholder at any time during usual business hours. Such list shall also be produced and kept open at the time and place of the meeting and shall be subject to the inspection of any shareholder during the whole time of the meeting. The original stock transfer books shall be prima facie evidence as to who are the shareholders entitled to examine such list or transfer books or to vote at any meeting of shareholders. If the requirements of this Section 7 have not been substantially complied with, the meeting shall, on the demand of any shareholder in person or by proxy, be adjourned until the requirements are complied with.

        Section 8. Shareholder Proposals. To be properly brought before an annual meeting of shareholders, business must be (i) specified in the notice of meeting (or any supplement thereto) given by or at the direction of the Board of Directors, (ii) otherwise properly brought before the meeting by or at the direction of the Board of Directors, or (iii) otherwise properly brought before the meeting by a shareholder. In addition to any other applicable requirements, for business to be properly brought before an annual meeting by a shareholder, the shareholder must have given timely notice thereof in writing to the Secretary of the Corporation. To be timely, a shareholder’s notice must be given, either by personal delivery or by United States mail, postage prepaid, to the Secretary of the Corporation not later than ninety (90) days in advance of the annual meeting. A shareholder’s notice to the Secretary shall set forth as to each matter the shareholder proposes to bring before the annual meeting (i) a brief description of the business desired to be brought before the annual meeting (including the specific proposal to be presented) and the reasons for conducting such business at the annual meeting, (ii) the name and record address of the shareholder proposing such business, (iii) the class and number of shares of the Corporation that are beneficially owned by the shareholder, and (iv) any material interest of the shareholder in such business.

        In the event that a shareholder attempts to bring business before an annual meeting without complying with the provisions of this Section 8, the Chairman of the meeting shall declare to the meeting that the business was not properly brought before the meeting in accordance with the foregoing procedures, and such business shall not be transacted.

        No business shall be conducted at the annual meeting except in accordance with the procedures set forth in this Section 8, provided, however, that nothing in this Section 8 shall be deemed to preclude discussion by any shareholder of any business properly brought before the annual meeting.

- 2 -

        Section 9. Inspectors. An appropriate number of inspectors for any meeting of shareholders may be appointed by the Chairman of such meeting. Inspectors so appointed will open and close the polls, will receive and take charge of proxies and ballots, and will decide all questions as to the qualifications of voters, validity of proxies and ballots, and the number of votes properly cast.

ARTICLE II
Directors

        Section 1. General Powers. The property, affairs and business of the Corporation shall be managed under the direction of the Board of Directors, and except as otherwise expressly provided by law, the Articles of Incorporation or these By-laws, all of the powers of the Corporation shall be vested in such Board.

        Section 2. Number of Directors. The Board of Directors shall be ten (10) in number.

        Section 3. Election of Directors.

                (a) Directors shall be elected at the annual meeting of shareholders to succeed those Directors whose terms have expired and to fill any vacancies thus existing.

                (b) Directors shall hold their offices for terms as set forth in the Articles of Incorporation and until their successors are elected. Any director may be removed from office as set forth in the Articles of Incorporation.

                (c) Any vacancy occurring in the Board of Directors may be filled by the affirmative vote of the majority of the remaining directors though less than a quorum of the Board of Directors.

                (d) A majority of the number of directors fixed by these By-laws shall constitute a quorum for the transaction of business. The act of a majority of the directors present at a meeting at which a quorum is present shall be the act of the Board of Directors.

        Section 4. Meetings of Directors. Meetings of the Board of Directors shall be held at places within or without the State of Virginia and at times fixed by resolution of the Board, or upon call of the Chairman of the Board, and the Secretary or officer performing the Secretary’s duties shall give not less than twenty-four (24) hours’ notice by letter, telegraph or telephone (or in person) of all meetings of the directors, provided that notice need not be given of regular meetings held at times and places fixed by resolution of the Board. An annual meeting of the Board of Directors shall be held as soon as practicable after the adjournment of the annual meeting of shareholders. Meetings may be held at any time without notice if all of the Directors are present, or if those not present waive notice in writing either before or after the meeting. Directors may be allowed, by resolution of the Board, a reasonable fee and expenses for attendance at meetings.

- 3 -

        Section 5. Nominations. Subject to the rights of holders of any class or series of stock having a preference over the common stock as to dividends or upon liquidation, nominations for the election of Directors shall be made by the Board of Directors or a committee appointed by the Board of Directors or by any shareholder entitled to vote in the election of Directors generally. However, any shareholder entitled to vote in the election of Directors generally may nominate one or more persons for election as Directors at a meeting only if written notice of such shareholder’s intent to make such nomination or nominations has been given, either by personal delivery or by United States mail, postage prepaid, to the Secretary of the Corporation not later than (i) with respect to an election to be held at an annual meeting of shareholders, ninety (90) days in advance of such meeting, and (ii) with respect to an election to be held at a special meeting of shareholders for the election of Directors, the close of business on the seventh day following the date on which notice of such meeting is first given to shareholders. Each notice shall set forth: (a) the name and address of the shareholder who intends to make the nomination and of the person or persons to be nominated; (b) a representation that the shareholder is a holder of record of stock of the Corporation entitled to vote at such meeting and intends to appear in person or by proxy at the meeting to nominate the person or persons specified in the notice; (c) a description of all arrangements or understandings between the shareholder and each nominee and any other person or persons (naming such person or persons) pursuant to which the nomination or nominations are to be made by the shareholder; (d) such other information regarding each nominee proposed by such shareholder as would be required to be included in a proxy statement filed pursuant to the proxy rules of the Securities and Exchange Commission, had the nominee been nominated, or intended to be nominated, by the Board of Directors; and (e) the consent of each nominee to serve as a Director of the Corporation if so elected. The Chairman of the meeting may refuse to acknowledge the nomination of any person not made in compliance with the foregoing procedure.

ARTICLE III
Committees

        Section 1. Executive Committee. The Board of Directors shall, by vote of a majority of the number of directors fixed by these By-laws, designate an Executive Committee, which shall consist of three or more directors, including the Chairman of the Board. The members of the Executive Committee shall serve until their successors are designated by the Board of Directors, until removed or until the Executive Committee is dissolved by the Board of Directors. All vacancies which may occur in the Executive Committee shall be filled by the Board of Directors.

        When the Board of Directors is not in session, the Executive Committee shall have all power vested in the Board of Directors by law, the Articles of Incorporation or these By-laws, except as otherwise provided in the Virginia Stock Corporation Act and except that the Executive Committee shall not have the power to elect the President of the Corporation. The Executive Committee shall report at the next regular or special meeting of the Board of Directors all action which the Executive Committee may have taken on behalf of the Board since the last regular or special meeting of the Board of Directors.

- 4 -

        Meetings of the Executive Committee shall be held at such places and at such times fixed by resolution of the Committee, or upon call of the Chairman of the Board. Not less than twelve (12) hours’ notice shall be given by letter, telegraph or telephone (or in person) of all meetings of the Executive Committee, provided that notice need not be given of regular meetings held at times and places fixed by resolution of the Committee and that meetings may be held at any time without notice if all of the members of the Committee are present or if those not present waive notice in writing either before or after the meeting. A majority of the members of the Executive Committee then serving shall constitute a quorum for the transaction of business at any meeting.

        Section 2. Executive Compensation Committee. The Board of Directors, at its regular annual meeting, shall designate an Executive Compensation Committee which shall consist of three or more directors who shall not be eligible for bonus, stock option or stock appreciation rights, except for awards made under a shareholder approved plan. In addition, the Board at any time may designate one or more alternate members of such Committee who shall be directors not eligible for bonus, stock option or stock appreciation rights who may act in place of any absent regular member upon invitation by the Chairman or Secretary of the Committee.

        With respect to salaries, the Executive Compensation Committee shall have and may exercise the power to fix and determine from time to time all salaries of the executive officers of the Corporation, and such further powers with respect to salaries as may from time to time be conferred by the Board of Directors.

        With respect to bonuses, the Executive Compensation Committee shall have and may exercise the powers to determine the amounts annually available for bonuses pursuant to any bonus plan or formula approved by the Board, to determine bonus awards to executive officers and to exercise such further powers with respect to bonuses as may from time to time be conferred by the Board of Directors.

        With respect to other incentive compensation, the Executive Compensation Committee shall have and may exercise such powers as may from time to time be conferred by the Board of Directors or pursuant to any plan under which such compensation is paid or awarded.

        Vacancies in the Executive Compensation Committee shall be filled by the Board of Directors, and members shall be subject to removal by the Board at any time.

        The Executive Compensation Committee shall fix its own rules of procedure. A majority of the number of regular members then serving shall constitute a quorum; and regular and alternate members present shall be counted to determine whether there is a quorum. The Executive Compensation Committee shall keep minutes of its meetings, and all action taken by it shall be reported to the Board of Directors.

- 5 -

        Section 3. Audit Committee. The Board of Directors at its regular annual meeting shall designate an Audit Committee which shall consist of three or more directors whose membership on the Committee shall meet the requirements set forth in the rules of the New York Stock Exchange, as amended from time to time. Vacancies in the Committee shall be filled by the Board of Directors with directors meeting the requirements set forth above, giving consideration to continuity of the Committee, and members shall be subject to removal by the Board at any time. The Committee shall fix its own rules of procedure and a majority of the members serving shall constitute a quorum. The Committee shall meet at least twice a year with both the internal and the Corporation’s outside auditors present at each meeting and shall keep minutes of its meetings and all action taken shall be reported to the Board of Directors. The Committee shall review the reports and minutes of any audit committees of the Corporation’s subsidiaries. The Committee shall review the Corporation’s financial reporting process, including accounting policies and procedures. The Committee shall examine the report of the Corporation’s outside auditors, consult with them with respect to their report and the standards and procedures employed by them in their audit, report to the Board the results of its study and recommend the selection of auditors for each fiscal year.

        Section 4. Nominating and Governance Committee. The Board of Directors shall designate a Nominating and Governance Committee, which shall consist of three or more directors. The primary responsibilities of the Nominating and Governance Committee shall include: (i) reviewing the composition of the Board of Directors to insure that there is a balance of appropriate skills and characteristics reflected on the Board; (ii) developing criteria for Director searches and making recommendations to the Board regarding nominees for election as directors by the shareholders at each Annual Shareholders’ Meeting, including the addition of any new Board members, after appropriate search and investigation; (iii) making such other recommendations regarding tenure and classification of directors as the Committee may deem advisable from time to time; (iv) reviewing public policy issues which affect the image of the Corporation; and (v) recommending actions to increase the Board’s effectiveness. The Committee shall fix its own rules of procedure and a majority of the members serving shall constitute a quorum.

        Section 5. Other Committees of Board. The Board of Directors, by resolution duly adopted, may establish such other committees of the Board having limited authority in the management of the affairs of the Corporation as it may deem advisable and the members, terms and authority of such committees shall be as set forth in the resolutions establishing the same.

ARTICLE IV Officers

        Section 1. Election. The officers of the Corporation shall consist of a Chairman of the Board, a Vice Chairman of the Board, a President, one or more Vice Presidents (any one or more of whom may be designated as Executive Vice Presidents or Senior Vice Presidents), a Secretary and a Treasurer. In addition, such other officers as are provided in Section 3 of this Article may from time to time be elected by the Board of Directors. All officers shall hold office until the next annual meeting of the Board of Directors or until their successors are elected. The Chairman of the Board, the Vice Chairman of the Board and the President shall be chosen from among the directors. Any two officers may be combined in the same person as the Board of Directors may determine, except that the President and Secretary may not be the same person.

- 6 -

        Section 2. Removal of Officers; Vacancies. Any officer of the Corporation may be removed summarily with or without cause, at any time by a resolution passed at any meeting by affirmative vote of a majority of the number of directors fixed by these By-laws. Vacancies may be filled at any meeting of the Board of Directors or a written consent in lieu thereof.

        Section 3. Other Officers. Other officers may from time to time be elected by the Board, including, without limitation, one or more Assistant Secretaries and Assistant Treasurers, and one or more Divisional Presidents and Divisional Vice Presidents (any one or more of whom may be designated as Divisional Executive Vice Presidents or Divisional Senior Vice Presidents).

        Section 4. Duties. The officers of the Corporation shall have such duties as generally pertain to their offices, respectively, as well as such powers and duties as are hereinafter provided and as from time to time shall be conferred by the Board of Directors. The Board of Directors may require any officer to give such bond for the faithful performance of his duties as the Board may see fit.

        Section 5. Duties of the Chairman of the Board. The Chairman of the Board shall serve as the Chairman of the Board of Directors and the Chairman of the Executive Committee. He shall be responsible for the execution of the policies of the Board of Directors and shall have direct supervision over the President, subject to the authority of the Board of Directors. The Chairman of the Board shall preside at all meetings of shareholders, the Board of Directors and the Executive Committee. In the incapacity or absence of the President, the Chairman of the Board shall perform the duties and have the authority of the President. The Chairman of the Board may sign and execute in the name of the Corporation deeds, mortgages, bonds, contracts or other instruments, except in cases where the signing and the execution thereof shall be expressly delegated by the Board of Directors or by these By-laws to some other officer or agent of the Corporation or shall be required by law otherwise to be signed or executed. In addition, he shall perform all duties incident to the office of the Chairman of the Board and such other duties as from time to time may be assigned to him by the Board of Directors.

        Section 6. Duties of Vice Chairman. In the absence or incapacity of the Chairman of the Board, the Vice Chairman shall perform the duties of the Chairman, shall have the same authority, including, but not limited to, presiding at all meetings of the Board of Directors and the Corporation’s shareholders, and shall serve as a member of all committees of the Board of which the Chairman of the Board is a member. In addition, the Vice Chairman of the Board shall perform all duties as from time to time may be assigned to him by the Board of Directors.

- 7 -

        Section 7. Duties of the President. The President shall be the chief executive officer of the Corporation, shall have direct supervision over the business of the Corporation and its several officers, subject to the authority of the Board of Directors, and shall consult with and report to the Chairman of the Board. The President may sign and execute in the name of the Corporation deeds, mortgages, bonds, contracts or other instruments, except in cases where the signing and the execution thereof shall be expressly delegated by the Board of Directors or by these By-laws to some other officer or agent of the Corporation or shall be required by law otherwise to be signed or executed. In addition, he shall perform all duties incident to the office of the President and such other duties as from time to time may be assigned to him by the Board of Directors or the Chairman of the Board.

        Section 8. Duties of the Vice Presidents. Each Vice President of the Corporation (including any Executive Vice President and Senior Vice President) shall have powers and duties as may from time to time be assigned to him by the Board of Directors, the Chairman of the Board or the President. Any Vice President of the Corporation may sign and execute in the name of the Corporation deeds, mortgages, bonds, contracts and other instruments, except in cases where the signing and execution thereof shall be expressly delegated by the Board of Directors or by these By-laws to some other officer or agent of the Corporation or shall be required by law otherwise to be signed or executed.

        Section 9. Duties of the Treasurer. The Treasurer shall have charge and custody of and be responsible for all funds and securities of the Corporation, and shall cause all such funds and securities to be deposited in such banks and depositories as the Board of Directors from time to time may direct. He shall maintain adequate accounts and records of all assets, liabilities and transactions of the Corporation in accordance with generally accepted accounting practices; shall exhibit his accounts and records to any of the directors of the Corporation at any time upon request at the office of the Corporation; shall render such statements of his accounts and records and such other statements to the Board of Directors and officers as often and in such manner as they shall require; and shall make and file (or supervise the making and filing of) all tax returns required by law. He shall in general perform all duties incident to the office of Treasurer and such other duties as from time to time may be assigned to him by the Board of Directors, the Chairman of the Board or the President.

        Section 10. Duties of the Secretary. The Secretary shall act as secretary of all meetings of the Board of Directors, the Executive Committee and all other Committees of the Board, and the shareholders of the Corporation, and shall keep the minutes thereof in the proper book or books to be provided for that purpose. He shall see that all notices required to be given by the Corporation are duly given and served; shall have custody of the seal of the Corporation and shall affix the seal or cause it to be affixed to all certificates for stock of the Corporation and to all documents the execution of which on behalf of the Corporation under its corporate seal is duly authorized in accordance with the provisions of these By-laws; shall have custody of all deeds, leases, contracts and other important corporate documents; shall have charge of the books, records and papers of the Corporation relating to its organization and management as a Corporation; shall see that the reports, statements and other documents required by law (except tax returns) are properly filed; and shall, in general, perform all the duties incident to the office of Secretary and such other duties as from time to time may be assigned to him by the Board of Directors, the Chairman of the Board or the President.

- 8 -

        Section 11. Other Duties of Officers. Any officer of the Corporation shall have, in addition to the duties prescribed herein or by law, such other duties as from time to time shall be prescribed by the Board of Directors, the Chairman of the Board or the President.

        Section 12. Duties of Divisional Officers. Divisional Presidents and Divisional Vice Presidents shall be deemed to be officers of the Corporation whose duties and authority shall relate only to the Division by which they are employed, and they may sign and execute in the name of the Corporation deeds, mortgages, bonds, contracts and other instruments authorized by the Board that relate only to the business and properties of such Division. Other divisional officers may be designated from time to time by the Board of Directors and shall serve at the pleasure of the Board and have such duties as may be assigned by the Board and such officers shall be officers of the respective divisions but shall not be deemed to be officers of the Corporation.

ARTICLE V Capital Stock

        Section 1. Certificates. The shares of capital stock of the Corporation shall be evidenced by certificates in forms prescribed by the Board of Directors and executed in any manner permitted by law and stating thereon the information required by law. Transfer agents and/or registrars for one or more classes of the stock of the Corporation may be appointed by the Board of Directors and may be required to countersign certificates representing stock of such class or classes. In the event that any officer whose signature or facsimile thereof shall have been used on a stock certificate shall for any reason cease to be an officer of the Corporation and such certificate shall not then have been delivered by the Corporation, the Board of Directors may nevertheless adopt such certificate and it may then be issued and delivered as though such person had not ceased to be an officer of the Corporation.

        Section 2. Lost, Destroyed and Mutilated Certificates. Holders of the stock of the Corporation shall immediately notify the Corporation of any loss, destruction or mutilation of the certificate therefor, and the Board of Directors may, in its discretion, cause one or more new certificates for the same number of shares in the aggregate to be issued to such stockholder upon the surrender of the mutilated certificate or upon satisfactory proof of such loss or destruction, and the deposit of a bond in such form and amount and with such surety as the Board of Directors may require.

- 9 -

        Section 3. Transfer of Stock. The stock of the Corporation shall be transferable or assignable only on the books of the Corporation by the holders in person or by attorney on surrender of the certificate for such shares duly endorsed and, if sought to be transferred by attorney, accompanied by a written power of attorney to have the same transferred on the books of the Corporation. The Corporation will recognize the exclusive right of the person registered on its books as the owner of shares to receive dividends and to vote as such owner.

        Section 4. Fixing Record Date. For the purpose of determining shareholders entitled to notice of or to vote at any meeting of the shareholders or any adjournment thereof, or entitled to receive payment for any dividend, or in order to make a determination of shareholders for any other proper purpose, the Board of Directors may fix in advance a date as the record date for any such determination of shareholders, such date in any case to be not more than seventy (70) days prior to the date on which the particular action, requiring such determination of shareholders, is to be taken. If no record date is fixed for the determination of shareholders entitled to notice of or to vote at a meeting of shareholders, or shareholders entitled to receive payment of a dividend, the date on which notice of the meeting is mailed or the date on which the resolution of the Board of Directors declaring such dividend is adopted, as the case may be, shall be the record date for such determination of shareholders. When a determination of shareholders entitled to vote at any meeting of shareholders has been made as provided in this Section 4 such determination shall apply to any adjournment thereof.

ARTICLE VI Miscellaneous Provisions

        Section 1. Seal. The seal of the Corporation shall consist of a flat-face circular die, of which there may be any number of counterparts, on which there shall be engraved in the center the words "Tredegar Corporation"

        Section 2. Fiscal Year. The fiscal year of the Corporation shall end on December 31st of each year, and shall consist of such accounting periods as may be recommended by the Treasurer and approved by the Executive Committee.

        Section 3. Books and Records. The Corporation shall keep correct and complete books and records of account and shall keep minutes of the proceedings of its shareholders and Board of Directors; and shall keep at its registered office or principal place of business, or at the office of its transfer agent or registrar a record of its shareholders, giving the names and addresses of all shareholders, and the number, class and series of the shares being held.

        Any person who shall have been a shareholder of record for at least six months immediately preceding his demand or who shall be the holder of record of at least five percent (5%) of all the outstanding shares of the Corporation, upon written demand stating the purpose thereof, shall have the right to examine, in person, or by agent or attorney at any reasonable time or times, for any proper purpose, its books and records of account, minutes and records of shareholders and to make extracts therefrom. Upon the written request of a shareholder, the Corporation shall mail to such shareholder its most recent published financial statements showing in reasonable detail its assets and liabilities and the results of its operations.

- 10 -

        The Board of Directors shall, subject to the provisions of the foregoing paragraph of this Section 3, to the provisions of Section 7 of Article I and to the laws of the State of Virginia, have the power to determine from time to time whether and to what extent and under what conditions and limitations the accounts, records and books of the Corporation, or any of them, shall be open to the inspection of the shareholders.

        Section 4. Checks, Notes and Drafts. Checks, notes, drafts and other orders for the payment of money shall be signed by such persons as the Board of Directors from time to time may authorize. When the Board of Directors so authorizes, however, the signature of any such person may be a facsimile.

        Section 5. Amendment of By-Laws. These By-laws may be amended or altered at any meeting of the Board of Directors by affirmative vote of a majority of the number of directors fixed by these By-laws. The shareholders entitled to vote in respect of the election of directors, however, shall have the power to rescind, alter, amend or repeal any By-laws and to enact By-laws which, if expressly so provided, may not be amended, altered or repealed by the Board of Directors.

        Section 6. Voting of Stock Held. Unless otherwise provided by resolution of the Board of Directors or of the Executive Committee, the Chairman of the Board, the President or any Executive Vice President shall from time to time appoint an attorney or attorneys or agent or agents of this Corporation, in the name and on behalf of this Corporation, to cast the vote which this Corporation may be entitled to cast as a shareholder or otherwise in any other corporation, any of whose stock or securities may be held in this Corporation, at meetings of the holders of the stock or other securities of such other corporation, or to consent in writing to any action by any of such other corporation, and shall instruct the person or persons so appointed as to the manner of casting such votes or giving such consent and may execute or cause to be executed on behalf of this Corporation and under its corporate seal or otherwise, such written proxies, consents, waivers or other instruments as may be necessary or proper in the premises; or, in lieu of such appointment, the Chairman of the Board, the President, any Executive Vice President or any officer or officers designated by the Board of Directors or the Executive Committee may attend in person any meetings of the holders of stock or other securities of any such other corporation and there vote or exercise any or all power of this Corporation as the holder of such stock or other securities of such other corporation.

        Section 7. Restriction on Transfer. To the extent that any provision of the Rights Agreement between the Corporation and American Stock Transfer & Trust Company, dated as of June 30, 1999, is deemed to constitute a restriction on the transfer of any securities of the Corporation, including, without limitation, the Rights, as defined therein, such restriction is hereby authorized by the By-laws of the Corporation.

        Section 8. Control Share Acquisition Statute. Article 14.1 of the Virginia Stock Corporation Act ("Control Share Acquisitions") shall not apply to acquisitions of shares of stock of the Corporation.

Tredegar Corporation Exhibit 4 to Form 10-Q

Exhibit 4

CREDIT AGREEMENT

among

TREDEGAR CORPORATION,
as Borrower,

THE LENDERS PARTIES HERETO,

WACHOVIA BANK, NATIONAL ASSOCIATION,
as Administrative Agent

SUNTRUST BANK
as Syndication Agent

and

BANK OF AMERICA, N.A.,
as Documentation Agent


Dated as of April 30, 2002




FIRST UNION SECURITIES, INC.,
acting under the tradename WACHOVIA SECURITIES,
as Book Runner and Lead Arranger

TABLE OF CONTENTS

Page

ARTICLE I      DEFINITIONS..........................................................................................................................................................1

      SECTION 1.01      DEFINED TERMS.......................................................................................................................1
      SECTION 1.02      TERMS GENERALLY...............................................................................................................11

II.      THE CREDITS.......................................................................................................................................................11

      SECTION 2.01      COMMITMENT.........................................................................................................................11
      SECTION 2.04      ALTERNATE RATE OF INTEREST..........................................................................................13
      SECTION 2.05      PREPAYMENT...........................................................................................................................14
      SECTION 2.06      RESERVE REQUIREMENTS; CHANGE IN CIRCUMSTANCES............................................14
      SECTION 2.07      CHANGE IN LEGALITY............................................................................................................15
      SECTION 2.08      INDEMNITY...............................................................................................................................16
      SECTION 2.09      PRO RATA TREATMENT..........................................................................................................16
      SECTION 2.10      SHARING OF SETOFFS............................................................................................................17
      SECTION 2.11      PAYMENTS................................................................................................................................17
      SECTION 2.12      TAXES.........................................................................................................................................18

III.      REPRESENTATIONS AND WARRANTIES.......................................................................................................20

      SECTION 3.01      ORGANIZATION; POWERS.....................................................................................................20
      SECTION 3.02      AUTHORIZATION; GOVERNMENTAL APPROVALS...........................................................21
      SECTION 3.03      ENFORCEABILITY....................................................................................................................21
      SECTION 3.04      FINANCIAL STATEMENTS......................................................................................................21
      SECTION 3.05      NO MATERIAL ADVERSE CHANGE.......................................................................................21
      SECTION 3.06      TITLE TO PROPERTIES AND POSSESSION UNDER LEASES.............................................22
      SECTION 3.07      THE SUBSIDIARIES AND THE BORROWER..........................................................................22
      SECTION 3.08      LITIGATION: COMPLIANCE WITH LAWS............................................................................22
      SECTION 3.09      AGREEMENTS...........................................................................................................................22
      SECTION 3.10      FEDERAL RESERVE REGULATIONS......................................................................................23
      SECTION 3.11      INVESTMENT COMPANY ACT;
                                     PUBLIC UTILITY HOLDING COMPANY ACT......................................................................23
      SECTION 3.12      USE OF PROCEEDS..................................................................................................................23
      SECTION 3.13      TAX RETURNS..........................................................................................................................23
      SECTION 3.14      NO MATERIAL MISSTATEMENTS.........................................................................................23
      SECTION 3.15      EMPLOYEE BENEFIT PLANS..................................................................................................23
      SECTION 3.16      ENVIRONMENTAL MATTERS................................................................................................24
      SECTION 3.17      SOLVENCY................................................................................................................................24

IV.      CONDITIONS OF LENDING..............................................................................................................................24

      SECTION 4.01      ALL BORROWINGS..................................................................................................................24
      SECTION 4.02      EFFECTIVENESS OF AGREEMENT........................................................................................25

V.      AFFIRMATIVE COVENANTS.............................................................................................................................26

      SECTION 5.01      EXISTENCE; BUSINESSES AND
                                     PROPERTIES COMPLIANCE..................................................................................................27
      SECTION 5.02      INSURANCE.............................................................................................................................27
      SECTION 5.03      OBLIGATIONS AND TAXES...................................................................................................27
      SECTION 5.04      FINANCIAL STATEMENTS, REPORTS, ETC........................................................................28
      SECTION 5.05      LITIGATION AND OTHER NOTICES.....................................................................................29
      SECTION 5.06      ERISA.........................................................................................................................................29
      SECTION 5.07      MAINTAINING RECORDS; ACCESS TO
                                     PROPERTIES AND INSPECTIONS..........................................................................................29

VI.      NEGATIVE COVENANTS..................................................................................................................................30

      SECTION 6.01      LIENS..........................................................................................................................................30
      SECTION 6.02      SALE AND LEASE-BACK TRANSACTIONS.........................................................................31
      SECTION 6.03      OBLIGATIONS OF SUBSIDIARIES.........................................................................................31
      SECTION 6.04      MERGERS, CONSOLIDATIONS AND SALES OF ASSETS..................................................32
      SECTION 6.05      DIVIDENDS AND DISTRIBUTIONS........................................................................................33
      SECTION 6.06      TRANSACTIONS WITH AFFILIATES.....................................................................................33
      SECTION 6.07      CONSOLIDATED STOCKHOLDERS' EQUITY......................................................................33
      SECTION 6.08      DEBT RATIO..............................................................................................................................33

VII.      EVENTS OF DEFAULT......................................................................................................................................33

VIII.      THE ADMINISTRATIVE AGENT.....................................................................................................................36

      SECTION 8.01      APPOINTMENT.........................................................................................................................36
      SECTION 8.02      DELEGATION OF DUTIES........................................................................................................37
      SECTION 8.03      EXCULPATORY PROVISIONS................................................................................................37
      SECTION 8.04      RELIANCE BY ADMINISTRATIVE AGENT............................................................................37
      SECTION 8.05      NOTICE OF DEFAULT..............................................................................................................38
      SECTION 8.06      NON-RELIANCE ON ADMINISTRATIVE
                                     AGENT AND OTHER LENDERS..............................................................................................38
      SECTION 8.07      ADMINISTRATIVE AGENT IN ITS INDIVIDUAL CAPACITY..............................................39
      SECTION 8.08      SUCCESSOR ADMINISTRATIVE AGENT..............................................................................39
      SECTION 8.09      NATURE OF DUTIES.................................................................................................................39

IX.      MISCELLANEOUS...............................................................................................................................................39

      SECTION 9.01      NOTICES....................................................................................................................................39
      SECTION 9.02      SURVIVAL OF AGREEMENT...................................................................................................40
      SECTION 9.03      BINDING EFFECT.....................................................................................................................40
      SECTION 9.04      SUCCESSORS AND ASSIGNS;
                                    PARTICIPATIONS; PURCHASING LENDERS.........................................................................41
      SECTION 9.05      EXPENSES; INDEMNITY..........................................................................................................44
      SECTION 9.06      RIGHT OF SETOFF....................................................................................................................45
      SECTION 9.07      APPLICABLE LAW....................................................................................................................45
      SECTION 9.08      WAIVERS; AMENDMENT........................................................................................................45
      SECTION 9.09      INTEREST RATE LIMITATION................................................................................................46
      SECTION 9.10      ENTIRE AGREEMENT...............................................................................................................46
      SECTION 9.11      WAIVER OF JURY TRIAL.........................................................................................................46
      SECTION 9.12      SEVERABILITY..........................................................................................................................47
      SECTION 9.13      COUNTERPARTS......................................................................................................................47
      SECTION 9.14      HEADINGS.................................................................................................................................47
      SECTION 9.15      CONFIDENTIALITY.................................................................................................................47
      SECTION 9.16      JURISDICTION; CONSENT TO SERVICE OF PROCESS......................................................47

SCHEDULES

Schedule 2.01      Commitments
Schedule 3.07      Subsidiaries
Schedule 6.01      Permitted Liens

Exhibit A      Form of Notice of Borrowing
Exhibit B      Form of Revolving Note
Exhibit C      Assignment and Acceptance
Exhibit D      Form of Opinion of Borrower's Counsel
Exhibit E      Form of Account Designation Letter

     CREDIT AGREEMENT (the "Agreement") dated as of April 30, 2002, among TREDEGAR CORPORATION, a Virginia corporation (the "Borrower"), the several banks and other financial institutions from time to time party hereto (the "Lenders") and WACHOVIA BANK, NATIONAL ASSOCIATION, a national banking association, as administrative agent for the Lenders (in such capacity, the "Administrative Agent").

W I T N E S S E T H:

     WHEREAS, the Borrower has requested, and the Lenders have agreed to extend, certain credit facilities to the Borrower on the terms and conditions set forth herein;

     NOW, THEREFORE, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged by the parties hereto, such parties hereby agree as follows:

ARTICLE I

DEFINITIONS

     Section 1.01 Defined Terms.

     As used in this Agreement, the following terms shall have the meanings specified below:

     "Account Designation Letter" shall mean the Notice of Account Designation Letter dated the Closing Date from the Borrower to the Administrative Agent in substantially the form attached hereto as Exhibit E.

     "Administrative Fees" shall have the meaning assigned to such term in Section 2.02(b).

     "Affiliate" shall mean, when used with respect to a specified person, another person that directly, or indirectly through one or more intermediaries, Controls or is Controlled by or is under common Control with the person specified.

     "Agent" or "Administrative Agent" shall have the meaning set forth in the first paragraph hereof.

     "Aggregate Revolving Committed Amount" means the aggregate amount of Commitments in effect from time to time, being initially ONE HUNDRED MILLION DOLLARS ($100,000,000).

     "Alternate Base Rate" shall mean, for any day, a rate per annum equal to the greater of (a) the Prime Rate in effect on such day and (b) the Federal Funds Effective Rate in effect on such day plus 1/2 of 1%. For purposes hereof: "Prime Rate" shall mean, at any time, the rate of interest per annum publicly announced from time to time by Wachovia at its principal office in Charlotte, North Carolina as its prime rate. Each change in the Prime Rate shall be effective as of the opening of business on the day such change in the Prime Rate occurs. The parties hereto acknowledge that the rate announced publicly by Wachovia as its Prime Rate is an index or base rate and shall not necessarily be its lowest or best rate charged to its customers or other banks; and "Federal Funds Effective Rate" shall mean, for any day, the weighted average of the rates on overnight federal funds transactions with members of the Federal Reserve System arranged by federal funds brokers, as published on the next succeeding Business Day by the Federal Reserve Bank of New York, or, if such rate is not so published on the next succeeding Business Day, the average of the quotations for the day of such transactions received by the Administrative Agent from three federal funds brokers of recognized standing selected by it. If for any reason the Administrative Agent shall have determined (which determination shall be conclusive in the absence of manifest error) that it is unable to ascertain the Federal Funds Effective Rate, for any reason, including the inability or failure of the Administrative Agent to obtain sufficient quotations in accordance with the terms thereof, the Alternate Base Rate shall be determined without regard to clause (b) of the first sentence of this definition, as appropriate, until the circumstances giving rise to such inability no longer exist. Any change in the Alternate Base Rate due to a change in the Prime Rate or the Federal Funds Effective Rate shall be effective on the opening of business on the date of such change.

     "Alternate Base Rate Borrowing" shall mean a Borrowing comprised of Alternate Base Rate Loans.

     "Alternate Base Rate Loan" shall mean any Loan bearing interest at a rate determined by reference to the Alternate Base Rate in accordance with the provisions of Article II.

     "Applicable Percentage" shall mean, for any day, the rate per annum set forth below opposite the applicable level then in effect, it being understood that the Applicable Percentage for (i) Revolving Loans that are LIBOR Rate Loans shall be the percentage set forth under the column "LIBOR Rate Margin for Revolving Loans" and (ii) the Facility Fee shall be the percentage set forth under the column "Facility Fee":

Level Leverage
Ratio
LIBOR Rate Margin for
Revolving Loans
Alternate Base Rate Margin for
Revolving Loans
Facility
Fee
I › 0.40 to 1.0 but
0.50 to 1.0
1.00% 0.00% 0.25%
II › 0.30 to 1.0 but
0.40 to 1.0
0.80% 0.00% 0.20%
III 0.30 to 1.0 0.60% 0.00% 0.15%

2

     The Applicable Percentage shall, in each case, be determined and adjusted quarterly on the date five (5) Business Days after the date on which the Administrative Agent has received from the Borrower the financial information and certifications required to be delivered to the Administrative Agent and the Lenders in accordance with the provisions of Section 5.04(a), (b) and (c) (each an "Interest Determination Date"). Such Applicable Percentage shall be effective from such Interest Determination Date until the next such Interest Determination Date. The initial Applicable Percentages shall be based on Level II until the first Interest Determination Date occurring after the Closing Date. After the Closing Date, if the Borrower shall fail to provide the quarterly financial information and certifications in accordance with the provisions of Section 5.04(a), (b) and (c), the Applicable Percentage from such Interest Determination Date shall, on the date five (5) Business Days after the date by which the Borrower was so required to provide such financial information and certifications to the Administrative Agent and the Lenders, be based on Level I until such time as such information and certifications are provided, whereupon the Level shall be determined by the then current Leverage Ratio.

     "Board" shall mean the Board of Governors of the Federal Reserve System of the United States.

     "Borrowing" shall mean a Loan or group of Loans of a single Type made by the Lenders on a single date and as to which a single Interest Period is in effect.

     "Business Day" shall mean any day (other than a day which is a Saturday, Sunday or other day on which banks in Charlotte, North Carolina, Richmond, Virginia or New York, New York are authorized or required by law to close); provided, however, that, when used in connection with a LIBOR Rate Loan, the term "Business Day" shall also exclude any day on which banks are not open for dealings in dollar deposits in the London interbank market.

     "Capital Lease Obligations" of any person shall mean the obligations of such person to pay rent or other amounts under any lease of (or other arrangement conveying the right to use) real or personal property, or a combination thereof, which obligations are required to be classified and accounted for as capital leases on a balance sheet of such person under GAAP and, for the purposes of this Agreement, the amount of such obligations at any time shall be the capitalized amount thereof at such time determined in accordance with GAAP.

     A "Change in Control" shall be deemed to have occurred if (a) any person or group (within the meaning of Rule 13d-5 of the Securities and Exchange Commission as in effect on the date hereof) other than (i) any person or group whose beneficial ownership of common stock is reported on either Schedule 13D, filed with respect to the common stock of the Borrower on March 12, 2002, as amended prior to the date of this Agreement, (ii) spouses, children and lineal descendants of such persons, (iii) trusts created for the benefit of such persons, or (iv) any combination of the persons described in the foregoing subclauses (i), (ii) or (iii) (an "Exempt Person") shall own directly or indirectly, beneficially or of record, shares representing more than 25% of the aggregate ordinary voting power represented by the issued and outstanding capital stock of the Borrower; (b) a majority of the seats (other than vacant seats) on the board of directors of the Borrower shall at any time have been occupied by persons who were not Continuing Directors; or (c) any person or group other than an Exempt Person shall otherwise directly or indirectly Control the Borrower.

     "Closing Date" shall mean the date of this Agreement.

3

     "Code" shall mean the Internal Revenue Code of 1986, as the same may be amended from time to time.

     "Commitment" means, with respect to each Lender, the commitment of such Lender to make Revolving Loans in an aggregate principal amount at any time outstanding of up to such Lender's Revolving Committed Amount as specified in Schedule 2.01, as such amount may be reduced from time to time in accordance with the provisions hereof.

     "Commitment Period" means the period from and including the Closing Date to but not including the earlier of (i) the Termination Date, or (ii) the date on which the Commitments terminate in accordance with the provisions of this Agreement.

     "Commitment Transfer Supplement" shall mean a Commitment Transfer Supplement, substantially in the form of Exhibit C hereto.

     "Consolidated Net Income" with respect to any person for any period shall mean (a) the aggregate net income (or net loss) of such person for such period equal to net revenues and other proper income or gain of such person for such period (including gains on the sale of capital assets) less, without duplication of any items deducted in determining such net revenues, income or gain, the aggregate for such person during such period of, (i) cost of goods sold, (ii) interest expense, (iii) operating expense, (iv) selling, general and administrative expenses, (v) taxes, (vi) depreciation, depletion and amortization and (vii) any other items that are treated as expenses under GAAP, plus (b) write-downs of assets, losses from discontinued operations and other extraordinary losses (net of tax benefits), in each case to the extent taken into account in determining the net revenues, income or gain referred to in (a) above.

     "Consolidated Stockholders' Equity" shall mean, at any time (a) the sum of (i) the Borrower's issued capital stock taken at par or stated value at such time, (ii) the Borrower's capital surplus at such time and (iii) the Borrower's retained earnings at such time, less (b) the Borrower's treasury stock and minority interest in Subsidiaries at such time, all determined in accordance with GAAP.

     "Consolidated Total Capitalization" shall mean, at any time, the sum of Consolidated Total Debt and Consolidated Stockholders' Equity at such time.

     "Consolidated Total Debt" shall mean, at any time, all Indebtedness of the Borrower and its consolidated Subsidiaries at such time, computed and consolidated in accordance with GAAP.

     "Continuing Director" shall mean (a) any member of the Board of Directors of the Borrower on the date of this Agreement and (b) any person whose subsequent nomination for election or election to the Board of Directors was recommended or approved by a majority of the Continuing Directors serving as such at the time of such nomination.

4

     "Control" shall mean the possession, directly or indirectly, of the power to direct or cause the direction of the management or policies of a person, whether through the ownership of voting securities, by contract or otherwise.

     "Default" shall mean an event which upon notice or lapse of time or both would constitute an Event of Default.

     "Dollars" and the symbol "$" shall mean the lawful currency of the United States of America.

     "ERISA" shall mean the Employee Retirement Income Security Act of 1974, as the same may be amended from time to time.

     "ERISA Affiliate" shall mean any trade or business (whether or not incorporated) that is a member of a group of which the Borrower is a member and which is treated as a single employer under Section 414 of the Code.

     "Eurodollar Reserve Percentage" shall mean, for any day, the percentage (expressed as a decimal and rounded upwards, if necessary, to the next higher 1/100th of 1%) which is in effect for such day as prescribed by the Federal Reserve Board (or any successor) for determining the maximum reserve requirement (including without limitation any basic, supplemental or emergency reserves) in respect of Eurocurrency liabilities, as defined in Regulation T of such Board as in effect from time to time, or any similar category of liabilities for a member bank of the Federal Reserve System in New York City.

     "Event of Default" shall have the meaning assigned to such term in Article VII.

     "Facility Fee" shall have the meaning assigned to such term in Section 2.02(c).

     "Federal Funds Effective Rate" shall have the meaning set forth in the definition of "Alternate Base Rate."

     "Fees" shall mean the Administrative Fees and the Facility Fee.

     "Financial Officer" of any corporation shall mean the chief financial officer, principal financial officer, principal accounting officer, Treasurer or Controller of such corporation.

     "GAAP" shall mean generally accepted accounting principles.

     "Governmental Authority" shall mean any Federal, state, local or foreign court or governmental agency, authority, instrumentality or regulatory body.

5

     "Guarantee" of or by any person shall mean any obligation, contingent or otherwise, of such person guaranteeing or having the economic effect of guaranteeing any Indebtedness of any other person (the "primary obligor") in any manner, whether directly or indirectly, and including any obligation of such person, direct or indirect, (a) to purchase or pay (or advance or supply funds for the purchase or payment of) such Indebtedness or to purchase (or to advance or supply funds for the purchase of) any security for the payment of such Indebtedness, (b) to purchase property, securities or services for the purpose of assuring the owner of such Indebtedness of the payment of such Indebtedness or (c) to maintain working capital, equity capital or other financial statement condition or liquidity of the primary obligor so as to enable the primary obligor to pay such Indebtedness; provided, however, that the term Guarantee shall not include endorsements for collection or deposit, in either case in the ordinary course of business.

     "Indebtedness" of any person shall mean, without duplication, (a) all obligations of such person for borrowed money or with respect to deposits or advances of any kind, (b) all obligations of such person evidenced by bonds, debentures, notes or similar instruments, (c) all obligations of such person upon which interest charges are customarily paid (other than accounts payable), (d) all obligations of such person under conditional sale or other title retention agreements relating to property or assets purchased by such person, (e) all obligations of such person issued or assumed as the deferred purchase price of property or services, (f) all Indebtedness of others secured by (or for which the holder of such Indebtedness has an existing right, contingent or otherwise, to be secured by) any Lien on property owned or acquired by such person, whether or not the obligations secured thereby have been assumed, provided that the amount of such Indebtedness shall be deemed to be the lesser of (i) the outstanding principal amount of such Indebtedness plus all accrued and unpaid interest relating thereto and (ii) the fair market value of the property secured by any such Lien, (g) all Guarantees by such person of Indebtedness of others, (h) all Capital Lease Obligations of such person, (i) all obligations of such person in respect of interest rate protection agreements, foreign currency exchange agreements or other interest or exchange rate hedging arrangements and (j) all obligations of such person as an account party in respect of letters of credit and bankers' acceptances. The Indebtedness of any person shall include the Indebtedness of any partnership in which such person is a general partner unless such Indebtedness is without any recourse whatsoever to such person as a general partner of any such partnership.

     "Interest Determination Date" shall have the meaning set forth in the definition of "Applicable Percentage."

     "Interest Payment Date" means (a) as to any Alternate Base Rate Loan, the last day of each March, June, September and December and on the Termination Date and (b) as to any LIBOR Rate Loan the last day of such Interest Period.

     "Interest Period" means, as to any LIBOR Rate Loan, a period of one, two or three month's duration, as the Borrower may elect, commencing in each case, on the date of the borrowing (including conversions, extensions and renewals); provided, however, (A) if any Interest Period would end on a day which is not a Business Day, such Interest Period shall be extended to the next succeeding Business Day (except that in the case of LIBOR Rate Loans where the next succeeding Business Day falls in the next succeeding calendar month, then on the next preceding Business Day), (B) no Interest Period shall extend beyond the Termination Date, and (C) in the case of LIBOR Rate Loans, where an Interest Period begins on a day for which there is no numerically corresponding day in the calendar month in which the Interest Period is to end, such Interest Period shall end on the last Business Day of such calendar month.

6

     "Internal Financing Subsidiary" shall mean any Subsidiary (i) of which securities or other ownership interests representing 100% of the equity or 100% of the ordinary voting power are, at the time any determination is made, owned, controlled or held, directly or indirectly, by the Borrower, and (ii) which has no outstanding Indebtedness to any Person other than the Borrower or another wholly-owned Subsidiary.

     "Internal Financing Transaction" shall mean any incurrence of Indebtedness or other obligations by any wholly-owned Subsidiary in favor of an Internal Financing Subsidiary, any transfer of assets or liabilities or other transactions between an Internal Financing Subsidiary and the Borrower or any wholly-owned Subsidiary, or any other transaction reasonably related to the foregoing; provided, however, that in connection therewith neither the Borrower nor any wholly-owned Subsidiary shall incur any Indebtedness or transfer any assets to any Person other than the Borrower or another wholly-owned Subsidiary.

     "Lenders" shall have the meaning assigned to such term in the preamble to this Agreement.

     "Leverage Ratio" shall mean the ratio of the Consolidated Total Debt to Consolidated Total Capitalization.

     "LIBOR" shall mean, for any LIBOR Rate Loan for any Interest Period therefor, the rate per annum (rounded upwards, if necessary, to the nearest 1/100 of 1%) appearing on Telerate Page 3750 (or any successor page) as the London interbank offered rate for deposits in Dollars at approximately 11:00 a.m. (London time) two Business Days prior to the first day of such Interest Period for a term comparable to such Interest Period. If for any reason such rate is not available, the term "LIBOR" shall mean, for any LIBOR Rate Loan for any Interest Period therefor, the rate per annum (rounded upwards, if necessary, to the nearest 1/100 of 1%) appearing on Reuters Screen LIBO Page as the London interbank offered rate for deposits in Dollars at approximately 11:00 a.m. (London time) two Business Days prior to the first day of such Interest Period for a term comparable to such Interest Period; provided, however, if more than one rate is specified on Reuters Screen LIBO Page, the applicable rate shall be the arithmetic mean of all such rates (rounded upwards, if necessary, to the nearest 1/100 of 1%). If, for any reason, neither of such rates is available, then "LIBOR" shall mean the rate per annum at which, as determined by the Administrative Agent, Dollars in an amount comparable to the Loans then requested are being offered to leading banks at approximately 11:00 A.M. London time, two (2) Business Days prior to the commencement of the applicable Interest Period for settlement in immediately available funds by leading banks in the London interbank market for a period equal to the Interest Period selected.

     "LIBOR Borrowing" shall mean a Borrowing comprised of LIBOR Rate Loans.

     "LIBOR Rate" shall mean a rate per annum (rounded upwards, if necessary, to the next higher 1/100th of 1%) determined by the Administrative Agent pursuant to the following formula:

7

LIBOR Rate =                         LIBOR                        
  1.00 - Eurodollar Reserve Percentage

     "LIBOR Rate Loan" shall mean any Loan bearing interest at a rate determined by reference to the LIBOR Rate in accordance with the provisions of Article II.

     "Lien" shall mean, with respect to any asset, (a) any mortgage, deed of trust, lien, pledge, encumbrance, charge or security interest in or on such asset, (b) the interest of a vendor or a lessor under any conditional sale agreement, capital lease or title retention agreement relating to such asset and (c) in the case of securities, any purchase option, call or similar right of a third party with respect to such securities.

     "Loans" means the Revolving Loans made hereby, whether made as LIBOR Rate Loans or as Alternate Base Rate Loans.

     "Loan Documents" shall mean this Agreement (including all exhibits and schedules attached hereto) and the Revolving Notes and such other documents executed in connection with the foregoing from time to time.

     "Margin Stock" shall have the meaning given such term under Regulation U.

     "Material Adverse Effect" shall mean (a) a materially adverse effect on the business, assets, operations, prospects or condition, financial or otherwise, of the Borrower and the Subsidiaries taken as a whole, (b) material impairment of the ability of the Borrower to perform any of its obligations under any Loan Document to which it is or will be a party or (c) material impairment of the rights of or benefits available to the Lenders under any Loan Document.

     "Multiemployer Plan" shall mean a multiemployer plan as defined in Section 4001(a)(3) of ERISA to which the Borrower or any ERISA Affiliate (other than one considered an ERISA Affiliate only pursuant to subsection (m) or (o) of Section 414 of the Code) is making or accruing an obligation to make contributions, or has within any of the preceding five plan years made or accrued an obligation to make contributions.

     "Notice of Borrowing" shall mean the written notice of borrowing as referenced and defined in Section 2.01(b)(i).

     "Participants" shall have the meaning set forth in 9.04(b).

     "PBGC" shall mean the Pension Benefit Guaranty Corporation referred to and defined in ERISA.

     "person" shall mean any natural person, corporation, business trust, joint venture, association, company, partnership or government, or any agency or political subdivision thereof.

8

     "Plan" shall mean any pension plan (other than a Multiemployer Plan) subject to the provisions of Title IV of ERISA or Section 412 of the Code which is maintained for employees of the Borrower or any ERISA Affiliate.

     "Prime Rate" shall have the meaning set forth in the definition of "Alternate Base Rate."

     "Purchasing Lender" shall have the meaning set forth in Section 9.04(c).

     "Register" shall have the meaning given such term in Section 9.04(d).

     "Regulation T" shall mean Regulation T of the Board, as the same is from time to time in effect, and all official rulings and interpretations thereunder or thereof.

     "Regulation U" shall mean Regulation U of the Board, as the same is from time to time in effect, and all official rulings and interpretations thereunder or thereof.

     "Regulation X" shall mean Regulation X of the Board, as the same is from time to time in effect, and all official rulings and interpretations thereunder or thereof.

     "Reportable Event" shall mean any reportable event as defined in Section 4043(b) of ERISA or the regulations issued thereunder with respect to a Plan (other than a Plan maintained by an ERISA Affiliate which is considered an ERISA Affiliate only pursuant to subsection (m) or (o) of Section 414 of the Code).

     "Required Lenders" shall mean, at any time, Lenders having Commitments representing more than fifty percent (50%) of the Aggregate Revolving Committed Amount then in effect and, for purposes of acceleration pursuant to clause (ii) of Article VII and at any time when no Commitment is in effect, Lenders holding Loans representing more than fifty percent (50%) of the aggregate principal amount of the Loans outstanding.

     "Responsible Officer" of any corporation shall mean any executive officer or Financial Officer of such corporation and any other officer or similar official thereof responsible for the administration of the obligations of such corporation in respect of this Agreement.

     "Revolving Commitment Percentage" means, for each Lender, a fraction (expressed as a decimal) the numerator of which is the Commitment of such Lender at such time and the denominator of which is the Aggregate Revolving Committed Amount at such time. The initial Revolving Commitment Percentages are set out on Schedule 2.01.

     "Revolving Committed Amount" means, collectively, the aggregate amount of all of the Commitments and, individually, the amount of each Lender’s Commitment, as in effect from time to time, as specified in Schedule 2.01.

     "Revolving Loans" shall have the meaning set forth in Section 2.01.

9

     "Revolving Note" or "Revolving Notes" means the promissory notes of the Borrower in favor of each of the Lenders evidencing the Revolving Loan in substantially the form attached as Exhibit B, individually or collectively, as appropriate, as such promissory notes may be amended, modified, supplemented, extended or renewed from time to time.

     "Significant Subsidiary" shall mean any Subsidiary whose gross revenues or assets constitute 1% or more of consolidated gross revenues or consolidated assets of the Borrower and its Subsidiaries.

     "subsidiary" shall mean, with respect to any person (herein referred to as the "parent"), any corporation, partnership, association or other business entity (a) of which securities or other ownership interests representing more than 50% of the equity or more than 50% of the ordinary voting power or more than 50% of the general partnership interests are, at the time any determination is being made, owned, controlled or held, or (b) which is, at the time any determination is made, otherwise Controlled, by the parent or one or more subsidiaries of the parent or by the parent and one or more subsidiaries of the parent.

     "Subsidiary" shall mean any subsidiary of the Borrower.

     "Taxes" shall have the meaning assigned such term in Section 2.16(a).

     "Termination Date" means, as to each Lender, the date 364 days following the Closing Date, or if extended with the written consent of such Lender, such later date not more than 364 days following the then applicable Termination Date.

     "Transactions" shall have the meaning assigned to such term in Section 3.02.

     "Transferee" shall have the meaning set forth in Section 9.04(f).

     "Transfer Effective Date" shall have the meaning set forth in each Commitment Transfer Supplement.

     "Tredegar Investments" means Tredegar Investments, Inc., a Virginia corporation, and TGI Fund I, LC, TGI Fund II, LC, TGI Fund III, LLC, and TGI Fund IV, LLC and any other limited liability company or limited partnership of which Tredegar Investments, Inc. is the sole general manager or sole general partner, together with the successors and assigns of any of such entities.

     "Type", when used in respect of any Loan or Borrowing, shall refer to the Rate by reference to which interest on such Loan or on the Loans comprising such Borrowing is determined. For purposes hereof, "Rate" shall include the LIBOR Rate and the Alternate Base Rate.

     "Wachovia" means Wachovia Bank, National Association and its successors and assigns.

10

     "Withdrawal Liability" shall mean liability to a Multiemployer Plan as a result of a complete or partial withdrawal from such Multiemployer Plan, as such terms are defined in Part I of Subtitle E of Title IV of ERISA.

     Section 1.02 Terms Generally.

The definitions in Section 1.01 shall apply equally to both the singular and plural forms of the terms defined. Whenever the context may require, any pronoun shall include the corresponding masculine, feminine and neuter forms. The words "include", "includes" and "including" shall be deemed to be followed by the phrase "without limitation". All references herein to Articles, Sections, Exhibits and Schedules shall be deemed references to Articles and Sections of, and Exhibits and Schedules to, this Agreement unless the context shall otherwise require. Except as otherwise expressly provided herein, all terms of an accounting or financial nature shall be construed in accordance with GAAP, as in effect from time to time; provided, however, that, for purposes of determining compliance with any covenant set forth in Article VI, such terms shall be construed in accordance with GAAP as in effect on the date of this Agreement applied on a basis consistent with the application used in the Borrower's audited financial statements referred to in Section 3.04.

II.     THE CREDITS

     Section 2.01 Commitment.

     (a) Revolving Commitment. During the Commitment Period, subject to the terms and conditions hereof, each Lender severally agrees to make revolving credit loans in Dollars (the "Revolving Loans") to the Borrower from time to time in the amount of such Lender's Revolving Commitment Percentage of such Revolving Loans for the purposes hereinafter set forth; provided that (i) with regard to the Lenders collectively, the aggregate principal amount of Loans outstanding at any time shall not exceed the Aggregate Revolving Committed Amount, and (ii) with regard to each Lender individually, the aggregate principal amount of such Lender's Commitment of Revolving Loans outstanding at any time shall not exceed such Lender's Revolving Committed Amount. Revolving Loans may consist of Alternate Base Rate Loans or LIBOR Rate Loans, or a combination thereof, as the Borrower may request, and may be repaid and reborrowed in accordance with the provisions hereof.

     (b) Revolving Loan Borrowings.

     (i) Notice of Borrowing. The Borrower shall request a Revolving Loan borrowing by written notice (or telephone notice promptly confirmed in writing) to the Administrative Agent in the form of Exhibit A ("Notice of Borrowing") not later than 11:00 A.M. (Charlotte, North Carolina time) on the Business Day prior to the date of the requested borrowing in the case of Alternate Base Rate Loans, and on the third Business Day prior to the date of the requested borrowing in the case of LIBOR Rate Loans. Each such request for borrowing shall be irrevocable and shall specify (A) that a Revolving Loan is requested, (B) the date of the requested borrowing (which shall be a Business Day), (C) the aggregate principal amount to be borrowed, and (D) whether the borrowing shall be comprised of Alternate Base Rate Loans, LIBOR Rate Loans or a combination thereof, and if LIBOR Rate Loans are requested, the Interest Period(s) therefor. If the Borrower shall fail to specify in any such Notice of Borrowing (x) an applicable Interest Period in the case of a LIBOR Rate Loan, then such notice shall be deemed to be a request for an Interest Period of one month, or (y) the type of Revolving Loan requested, then such notice shall be deemed to be a request for a Alternate Base Rate Loan hereunder. The Administrative Agent shall give notice to each Lender promptly upon receipt of each Notice of Borrowing pursuant to this Section 2.01(b)(i), the contents thereof and each such Lender's share of any borrowing to be made pursuant thereto.

11


     (ii) Minimum Amounts. Each Revolving Loan shall be in a minimum principal amount of $5,000,000, in the case of LIBOR Rate Loans and integral multiples of $1,000,000 in excess thereof, or $1,000,000 (or the remaining Revolving Committed Amount, if less), in the case of Alternate Base Rate Loans, and integral multiples of $1,000,000 in excess thereof.


     (iii) Advances. Each Lender will make its Revolving Commitment Percentage of each Revolving Loan borrowing available to the Administrative Agent for the account of the Borrower by 12:00 noon at the office specified in Section 2.11 (Charlotte, North Carolina time) on the date specified in the applicable Notice of Borrowing in Dollars and in funds immediately available to the Administrative Agent. Such borrowing will then be made available to the Borrower by the Administrative Agent by crediting the account designated by the Borrower with the aggregate of the amounts made available to the Administrative Agent by the Lenders and in like funds as received by the Administrative Agent.


     (c) Repayment. The principal amount of all Revolving Loans shall be due and payable in full on the Termination Date.

     (d) Interest. Subject to the provisions of Section 2.03:

     (i) Alternate Base Rate Loans. During such periods as Revolving Loans shall be comprised in whole or in part of Alternate Base Rate Loans, each such Alternate Base Rate Loan shall bear interest at a per annum rate equal to the Alternate Base Rate plus the Applicable Percentage;


     (ii) LIBOR Rate Loans. During such periods as Revolving Loans shall be comprised in whole or in part of LIBOR Rate Loans, each such LIBOR Rate Loan shall bear interest at a per annum rate equal to the LIBOR Rate plus the Applicable Percentage.

Interest on Revolving Loans shall be payable in arrears on each applicable Interest Payment Date (or at such other times as may be specified herein).

12

     (e) Revolving Notes. Each Lender's Revolving Commitment Percentage of the Revolving Loans shall be evidenced by a duly executed Revolving Note in favor of such Lender in the form of Exhibit B attached hereto.

     (f) Maximum Number of LIBOR Rate Loans. The Borrower will be limited to a maximum number of six (6) LIBOR Rate Loans outstanding at any time. For purposes hereof, LIBOR Rate Loans with separate or different Interest Periods will be considered as separate LIBOR Rate Loans even if their Interest Periods expire on the same date.

     Section 2.02 Fees.

     (a) The Borrower agrees to pay to the Administrative Agent, for its own benefit and for the benefit of the Lenders, the fees identified in the fee letter agreement dated March 15, 2002, as amended and modified (the "Fee Letter"), among First Union National Bank (predecessor to Wachovia), First Union Securities, Inc. and the Borrower.

     (b) The Borrower agrees to pay to the Administrative Agent, for its own account, the annual administrative agent's fee provided in the Fee Letter (the "Administrative Fees").

     (c) The Borrower agrees to pay to the Administrative Agent, for the ratable benefit of the Lenders, a facility fee (the "Facility Fee") in an amount equal to the Applicable Percentage per annum on the amount of the Aggregate Revolving Committed Amount in effect at such time. The Facility Fee shall be due and payable quarterly in arrears on the 15th day following the last day of each calendar quarter for the prior calendar quarter.

     (d) All Fees shall be paid on the dates due, in immediately available funds, to the Administrative Agent for distribution, if and as appropriate, among the Lenders. Once paid none of the Fees shall be refundable under any circumstances.

     Section 2.03 Default Interest.

     If the Borrower shall default in the payment of the principal of or interest on any Loan or any other amount becoming due hereunder, by acceleration or otherwise, the Borrower shall on demand from time to time pay interest, to the extent permitted by law, on such defaulted amount up to (but not including) the date of actual payment (after as well as before judgment) at a rate per annum (computed on the basis of the actual number of days elapsed over a year of 360 days) 2% greater than the highest interest rate which would otherwise be applicable (or if no interest rate is then applicable, whether in respect of interest, fees or other amounts, then 2% greater than the Alternate Base Rate plus the Applicable Percentage).

     Section 2.04 Alternate Rate of Interest.

     In the event, and on each occasion, that on the day two Business Days prior to the commencement of any Interest Period for a LIBOR Rate Borrowing the Administrative Agent shall have determined that dollar deposits in the principal amounts of the Loans comprising such Borrowing are not generally available in the London interbank market, or that the rates at which such dollar deposits are being offered will not adequately and fairly reflect the cost to any Lender of making or maintaining its LIBOR Rate Loan during such Interest Period, or that reasonable means do not exist for ascertaining the LIBOR Rate, the Administrative Agent shall, as soon as practicable thereafter, give written or telex notice of such determination to the Borrower and the Lenders. In the event of any such determination, until the Administrative Agent shall have advised the Borrower and the Lenders that the circumstances giving rise to such notice no longer exist, any request by the Borrower for a LIBOR Rate Borrowing pursuant to Section 2.01 shall be deemed to be a request for an Alternate Base Rate Borrowing in the case of LIBOR Rate Borrowings. Each determination by the Administrative Agent hereunder shall be conclusive absent manifest error.

13

     Section 2.05 Prepayment.

     (a) The Borrower shall have the right at any time and from time to time to prepay (i) any Alternate Base Rate Borrowing in whole or in part, upon one Business Days' prior written or telex notice (or telephone notice promptly confirmed by written or telex notice) and (ii) any LIBOR Rate Borrowing in whole or in part, upon at least three Business Days' prior written or telex notice (or telephone notice promptly confirmed by written or telex notice) to the Administrative Agent; provided, however, that each partial prepayment shall be in an amount which is an integral multiple of $1,000,000 and not less than $5,000,000.

     (b) Each notice of prepayment shall specify the prepayment date and the principal amount of each Borrowing (or portion thereof) to be prepaid, shall be irrevocable and shall commit the Borrower to prepay such Borrowing by the amount stated therein on the date stated therein. All prepayments under this Section 2.05 shall be subject to Section 2.08 but otherwise without premium or penalty. All prepayments under this Section 2.05 shall be accompanied by accrued interest on the principal amount being prepaid to the date of payment.

     Section 2.06 Reserve Requirements; Change in Circumstances.

     (a) Notwithstanding any other provision herein, if after the date of this Agreement any change in applicable law or regulation or in the interpretation or administration thereof by any governmental authority charged with the interpretation or administration thereof (whether or not having the force of law) shall impose, modify or deem applicable any reserve, special deposit or similar requirement (other than Taxes) against assets of, deposits with or for the account of or credit extended by, such Lender (except any reserve requirement reflected in the LIBOR Rate), or shall impose on such Lender or the London interbank market any other condition (other than Taxes) affecting this Agreement or any LIBOR Rate Loan made by such Lender, and the result of any of the foregoing shall be to increase the cost to such Lender of making or maintaining any LIBOR Rate Loan or to reduce the amount of any sum received or receivable by such Lender hereunder (whether of principal, interest or otherwise) in respect thereof by an amount deemed by such Lender to be material, then the Borrower shall pay to such Lender upon demand such additional amount or amounts as will compensate such Lender for such additional cost incurred or reduction suffered.

14

     (b) If any Lender shall have determined that the applicability of any law, rule, regulation or guideline adopted pursuant to or arising out of the July 1988 report of the Basle Committee on Banking Regulations and Supervisory Practices entitled "International Convergence of Capital Measurement and Capital Standards", or the adoption after the date hereof of any other law, rule, regulation or guideline regarding capital adequacy, or any change in any of the foregoing or in the interpretation or administration of any of the foregoing by any governmental authority, central bank or comparable agency charged with the interpretation or administration thereof, or compliance by any Lender (or any lending office of such Lender) or any Lender's holding company with any request or directive regarding capital adequacy (whether or not having the force of law) of any such authority, central bank or comparable agency, has or would have the effect of reducing the rate of return on such Lender's capital or on the capital of such Lender's holding company, if any, as a consequence of this Agreement or the Loans made by such Lender pursuant hereto to a level below that which such Lender or such Lender's holding company could have achieved but for such adoption, change or compliance (taking into consideration such Lender's policies and the policies of such Lender's holding company with respect to capital adequacy) by an amount deemed by such Lender to be material, then from time to time the Borrower shall pay to such Lender such additional amount or amounts as will compensate such Lender or such Lender's holding company for any such reduction suffered.

     (c) A certificate of a Lender setting forth such amount or amounts as shall be necessary to compensate such Lender (or participating banks pursuant to Section 9.04) as specified in paragraph (a) or (b) above, as the case may be, shall be delivered to the Borrower and shall be conclusive absent manifest error. The Borrower shall pay each Lender the amount shown as due on any such certificate delivered by it within 10 days after its receipt of the same.

     (d) Failure on the part of any Lender to demand compensation for any increased costs or reduction in amounts received or receivable or reduction in return on capital with respect to any period shall not constitute a waiver of such Lender's right with respect to such period or any other period, provided that a Lender is entitled to compensation only for increased costs or other amounts incurred during the period of 90 days preceding the date of such Lender's demand therefor. The protection of this Section shall be available to each Lender regardless of any possible contention of invalidity or inapplicability of the law, rule, regulation, guideline or other change or condition which shall have been imposed.

     Section 2.07 Change in Legality.

     (a) Notwithstanding any other provision herein, if any change in any law or regulation or in the interpretation thereof by any Governmental Authority charged with the administration or interpretation thereof shall make it unlawful for any Lender to make or maintain any LIBOR Rate Loan or to give effect to its obligations as contemplated hereby with respect to any LIBOR Rate Loan, then, by written notice to the Borrower and to the Administrative Agent, such Lender may:

     (i) declare that LIBOR Rate Loans will not thereafter be made by such Lender hereunder, whereupon any request by the Borrower for a LIBOR Rate Borrowing shall, as to such Lender only, be deemed a request for an Alternate Base Rate Loan, unless such declaration shall be subsequently withdrawn;


15

     (ii) require that all outstanding LIBOR Rate Loans made by it be converted to Alternate Base Rate Loans in which event all such LIBOR Rate Loans shall be automatically converted to Alternate Base Rate Loans as of the effective date of such notice as provided in paragraph (b) below.

     In the event any Lender shall exercise its rights under (i) or (ii) above, all payments and prepayments of principal which would otherwise have been applied to repay the LIBOR Rate Loans that would have been made by such Lender or the converted LIBOR Rate Loans of such Lender shall instead be applied to repay the Alternate Base Rate Loans made by such Lender in lieu of, or resulting from the conversion of, such LIBOR Rate Loans.

     (b) For purposes of this Section 2.07, a notice to the Borrower by any Lender shall be effective as to each LIBOR Rate Loan as applicable, if lawful, on the last day of the Interest Period currently applicable to such LIBOR Rate Loan; in all other cases such notice shall be effective on the date of receipt by the Borrower.

     Section 2.08 Indemnity.

     The Borrower shall indemnify each Lender against any loss or expense which such Lender may sustain or incur as a consequence of (a) any failure by the Borrower to fulfill on the date of any Borrowing hereunder the applicable conditions set forth in Article IV, (b) any failure by the Borrower to borrow or to refinance or continue any Loan hereunder after irrevocable notice of such borrowing, refinancing or continuation has been given pursuant to Section 2.01, (c) any payment, prepayment or conversion of a LIBOR Rate Loan required by any other provision of this Agreement or otherwise made or deemed made on a date other than the last day of the Interest Period applicable thereto, (d) any default in payment or prepayment of the principal amount of any Loan or any part thereof or interest accrued thereon, as and when due and payable (at the due date thereof, by irrevocable notice of prepayment or otherwise) or (e) the occurrence of any Event of Default, including, in each such case, any loss or reasonable expense sustained or incurred or to be sustained or incurred in liquidating or employing deposits from third parties acquired to effect or maintain such Loan or any part thereof as a LIBOR Rate Loan. Such loss or reasonable expense shall include an amount equal to the excess, if any, as reasonably determined by such Lender, of (i) its cost of obtaining the funds for the Loan being paid, prepaid, converted or not borrowed (based on the LIBOR Rate for the period from the date of such payment, prepayment, conversion or failure to borrow to the last day of the Interest Period for such Loan (or, in the case of a failure to borrow, the Interest Period for such Loan which would have commenced on the date of such failure) over (ii) the amount of interest (as reasonably determined by such Lender) that would be realized by such Lender in reemploying the funds so paid, prepaid, converted or not borrowed for such period or Interest Period, as the case may be. A certificate of any Lender setting forth any amount or amounts which such Lender is entitled to receive pursuant to this Section shall be delivered to the Borrower and shall be conclusive absent manifest error.

16

     Section 2.09 Pro Rata Treatment.

     Except as required under Sections 2.06 and 2.07, each Borrowing, each payment or prepayment of principal of any Borrowing, each payment of interest on the Loans, and each reduction of the Commitments and each refinancing of any Borrowing with a Borrowing of any Type, shall be allocated pro rata among the Lenders in accordance with their respective Commitments (or, if such Commitments shall have expired or been terminated, in accordance with the respective principal amounts of their outstanding Loans). Each Lender agrees that in computing such Lender's portion of any Borrowing to be made hereunder, the Administrative Agent may, in its discretion, round each Lender's percentage of such Borrowing to the next higher or lower whole dollar amount.

     Section 2.10 Sharing of Setoffs.

     Each Lender agrees that if it shall, through the exercise of a right of banker's lien, setoff or counterclaim against the Borrower, or pursuant to a secured claim under Section 506 of Title 11 of the United States Code or other security or interest arising from, or in lieu of, such secured claim, received by such Lender under any applicable bankruptcy, insolvency or other similar law or otherwise, or by any other means, obtain payment (voluntary or involuntary) in respect of any Loan or Loans as a result of which the unpaid principal portion of its Loans shall be proportionately less than the unpaid principal portion of the Loans of any other Lender, it shall promptly purchase from such other Lender at face value a participation in the Loans of such other Lender, so that the aggregate unpaid principal amount of the Loans and participations in Loans held by each Lender shall be in the same proportion to the aggregate unpaid principal amount of all Loans then outstanding as the principal amount of its Loans prior to such exercise of banker's lien, setoff or counterclaim or other event was to the principal amount of all Loans outstanding prior to such exercise of banker's lien, setoff or counterclaim or other event; provided, however, that, if any such purchase or purchases or adjustments shall be made pursuant to this Section and the payment giving rise thereto shall thereafter be recovered, such purchase or purchases or adjustments shall be rescinded to the extent of such recovery and the purchase price or prices or adjustment restored without interest. The Borrower expressly consents to the foregoing arrangements and agrees that any Lender holding a participation in a Loan deemed to have been so purchased may exercise any and all rights of banker's lien, setoff or counterclaim with respect to any and all moneys owing by the Borrower to such Lender by reason thereof as fully as if such Lender had made a Loan directly to the Borrower in the amount of such participation.

     Section 2.11 Payments.

     (a) The Borrower shall make each payment (including principal of or interest on any Borrowing or any Fees or other amounts) hereunder and under any other Loan Document not later than 12:00 (noon), Charlotte, North Carolina time, on the date when due in Dollars to the Administrative Agent in immediately available funds at the address set forth below:

17

               Wachovia Bank, National Association
               301 S. College Street
               Charlotte, North Carolina 28288
               Attn: Agency Services
               Telephone: (704) 383-3721
               Telecopy: (704) 383-0288

     All payments to be made by the Borrower shall be made without condition or deduction for any counterclaim, defense, recoupment or setoff. All payments received by the Administrative Agent after 12:00 (noon) on any Business Day shall be deemed received on the next succeeding Business Day and any applicable interest shall be deemed to continue to accrue through the next succeeding Business Day.

     (b) Whenever any payment (including principal of or interest on any Borrowing or any Fees or other amounts) hereunder or under any other Loan Document shall become due, or otherwise would occur, on a day that is not a Business Day, such payment may be made on the next succeeding Business Day, and such extension of time shall in such case be included in the computation of interest or Fees, if applicable.

     Section 2.12 Taxes.

     (a) Except as otherwise expressly provided herein, any and all payments by the Borrower hereunder shall be made, in accordance with Section 2.11, free and clear of and without deduction for any and all present or future taxes, levies, imposts, deductions, charges or withholdings, and all liabilities with respect thereto, excluding taxes imposed on, or measured by, the Administrative Agent's or any Lender's income or gross receipts, and franchise taxes imposed on the Administrative Agent or any Lender, by the United States or any jurisdiction under the laws of which it is organized or conducts business or any political subdivision thereof (all such nonexcluded taxes, levies, imposts, deductions, charges, withholdings and liabilities being hereinafter referred to as "Taxes"). If the Borrower shall be required by law to deduct any Taxes from or in respect of any sum payable hereunder to the Lenders or the Administrative Agent (i) the sum payable shall be increased by the amount necessary so that after making all required deductions (including deductions applicable to additional sums payable under this Section 2.12) such Lender or the Administrative Agent (as the case may be) shall receive an amount equal to the sum it would have received had no such deductions been made, (ii) the Borrower shall make such deductions and (iii) the Borrower shall pay the full amount deducted to the relevant taxing authority or other Governmental Authority in accordance with applicable law.

     (b) In addition, the Borrower agrees to pay any present or future stamp or documentary taxes or any other excise or property taxes, charges or similar levies which arise from any payment made hereunder or from the execution, delivery or registration of, or otherwise with respect to, this Agreement or any other Loan Document (hereinafter referred to as "Other Taxes").

18

     (c) The Borrower will indemnify each Lender and the Administrative Agent for the full amount of Taxes and Other Taxes (including any Taxes or Other Taxes imposed by any jurisdiction on amounts payable under this Section 2.12) paid by such Lender or the Administrative Agent, as the case may be, and any liability (including penalties, interest and expenses) arising therefrom or with respect thereto, whether or not such Taxes or Other Taxes were correctly or legally asserted by the relevant taxing authority or other Governmental Authority, except with respect to any such liability arising from a Lender's or the Administrative Agent's, as the case may be, gross negligence or willful misconduct. Such indemnification shall be made within 30 days after the date any Lender or the Administrative Agent, as the case may be, makes written demand therefor; provided, however, that, notwithstanding any other provision of this Section 2.12, if the Administrative Agent or any Lender requests indemnification or compensation for Taxes or Other Taxes pursuant to this Section 2.12 more than 180 days after the earlier of (i) the date on which the Administrative Agent or such Lender, as the case may be, makes payment of such Taxes or Other Taxes, and (ii) the date on which the appropriate Governmental Authority makes written demand on the Administrative Agent or such Lender, as the case may be, for payment of such Taxes or Other Taxes, then the Borrower shall not be obligated to indemnify or reimburse the Lender for such Taxes or Other Taxes. If a Lender or the Administrative Agent shall become aware that it is entitled to receive a refund, credit or reduction in respect of Taxes or Other Taxes, it shall promptly notify the Borrower of the availability of such refund, credit or reduction and shall, within 30 days after receipt of a request by the Borrower, apply for such refund, credit or reduction at the Borrower's expense; provided, however, that the Administrative Agent or such Lender shall not be required to make any such application if and to the extent the Administrative Agent or such Lender determines in good faith that it may be adversely affected by making such application. If any Lender or the Administrative Agent receives a refund, credit or reduction in respect of any Taxes or Other Taxes for which such Lender or the Administrative Agent has received payment from the Borrower hereunder it shall promptly notify the Borrower of such refund, credit or reduction and shall, within 30 days after receipt of such refund, credit or reduction, repay the amount of such refund, credit or reduction to the Borrower without interest (other than any interest paid by the relevant Governmental Authority with respect to such refund, credit or reduction); provided, however, that the Borrower, upon the written request of such Lender or the Administrative Agent, agrees to return to such Lender or the Administrative Agent the amount of such refund, credit or reduction received by the Borrower in the event and to the extent that such Lender or the Administrative Agent is required to repay such refund, credit or reduction to any relevant Governmental Authority.

     (d) Within 30 days after the date of any payment of Taxes or Other Taxes withheld by the Borrower in respect of any payment to any Lender or the Administrative Agent, the Borrower will furnish to the Administrative Agent, at its address referred to in Section 2.11, the original or a certified copy of a receipt evidencing payment thereof.

     (e) Without prejudice to the survival of any other agreement contained herein, the agreements and obligations contained in this Section 2.12 shall survive the Termination Date and payment in full of the principal of and interest on all Loans made hereunder.

19

     (f) Each Lender which is not a United States person (within the meaning of Section 7701(a)(30) of the Code) shall promptly notify the Borrower of any change in its funding office. On or prior to the date of its execution and delivery of this Agreement in the case of each Lender listed on the signature pages hereof or prior to the date on which it becomes a Lender in the case of each other Lender, and from time to time thereafter upon written request of the Borrower, each Lender which is not a United States person (within the meaning of Section 7701(a)(30) of the Code) shall deliver to the Borrower such certificates, documents or other evidence, as required by the Code or Treasury Regulations issued pursuant thereto or any other forms or documents relating to the Lender's status reasonably requested by the Borrower, including (i) Internal Revenue Service Form W-8BEN or W-8ECI, as appropriate (or any successor form prescribed by the Internal Revenue Service), and any other certificate or statement of exemption required by Treasury Regulation Section 1.1441-1(a) or Section 1.1441-6(c) or any subsequent version thereof, properly completed and duly executed by such Lender establishing that payment hereunder is (A) not subject to withholding under the Code because such payment is effectively connected with the conduct by such Lender of a trade or business in the United States or (B) totally exempt from United States tax under a provision of an applicable tax treaty, (ii) Internal Revenue Service Form W-8 or W-9, as appropriate, or any successor form prescribed by the Internal Revenue Service, and (iii) any other form or certificate required by any taxing authority (including any certificate required by Sections 871(h) and 881(c) of the Code), certifying that such Lender is entitled to an exemption from tax on payments hereunder. Unless the Borrower and the Administrative Agent have received forms or other documents satisfactory to them indicating that payments hereunder are not subject to United States withholding tax or are subject to such tax at a rate reduced by an applicable tax treaty, the Borrower or the Administrative Agent shall withhold taxes from such payments at the applicable statutory rate in the case of payments to or for any Lender or assignee organized under the laws of a jurisdiction outside the United States.

     (g) For any period with respect to which a Lender has failed to provide the Borrower and the Administrative Agent with the appropriate form pursuant to Section 2.12(f) (unless such failure is due to a change in treaty, law, or regulation occurring subsequent to the date on which a form originally was required to be provided), then, notwithstanding any other provision of this Section 2.12, such Lender shall not be entitled to additional payment or indemnification under Section 2.12(a), 2.12(b), or 2.12(c) with respect to Taxes imposed by the United States; provided, however, that should a Lender, which is otherwise exempt from or subject to a reduced rate of withholding tax, become subject to Taxes because of its failure to deliver a form required hereunder, the Borrower shall take such steps as such Lender shall reasonably request to assist such Lender to recover such Taxes.

     (h) Any Lender claiming any additional amounts payable pursuant to this Section 2.12 shall file any certificate or document reasonably requested by the Borrower or shall use reasonable efforts to change the jurisdiction of its applicable lending office so as to eliminate or reduce to the greatest extent possible any such additional amounts which may thereafter accrue if such change would not, in the good faith judgement of such Lender, be otherwise disadvantageous to such Lender.

III. REPRESENTATIONS AND WARRANTIES

     The Borrower represents and warrants to each of the Lenders that:

20

     Section 3.01 Organization; Powers.

     Each of the Borrower and the Subsidiaries (a) is a corporation duly organized, validly existing and in good standing under the laws of the jurisdiction of its organization, (b) has all requisite power and authority to own its property and assets and to carry on its business as now conducted and as proposed to be conducted, (c) is qualified to do business in every jurisdiction where such qualification is required, except where the failure so to qualify would not result in a Material Adverse Effect, and (d) in the case of the Borrower, has the corporate power and authority to execute, deliver and perform its obligations under each of the Loan Documents and each other agreement or instrument contemplated thereby to which it is or will be a party and to borrow hereunder.

     Section 3.02 Authorization; Governmental Approvals.

     The execution, delivery and performance by the Borrower of each of the Loan Documents, the actions taken by the Borrower in connection with the borrowings hereunder (the "Transactions") (a) have been duly authorized by all requisite corporate and, if required, stockholder action and (b) will not (i) violate (A) any provision of law, statute, rule or regulation, or of the certificate or articles of incorporation or other constitutive documents or by-laws of the Borrower or any Subsidiary, (B) any order of any Governmental Authority applicable to the Borrower or (C) any provision of any indenture, agreement or other instrument to which the Borrower or any Subsidiary is a party or by which any of them or any of their property is or may be bound, (ii) be in conflict with, result in a breach of or constitute (alone or with notice or lapse of time or both) a default under any such indenture, agreement or other instrument or (iii) result in the creation or imposition of any Lien upon any property or assets of the Borrower or any Subsidiary except Liens set forth on Schedule 6.01. No authorization or approval or other action by, and no notice to or filing with, any governmental authority or regulatory body or other person is required for the due execution, delivery or performance by the Borrower of this Agreement, or any other Loan Document to which it is a party.

     Section 3.03 Enforceability.

     This Agreement has been duly executed and delivered by the Borrower and constitutes, and each other Loan Document when executed and delivered by the Borrower will constitute, a legal, valid and binding obligation of the Borrower enforceable against the Borrower in accordance with its terms.

     Section 3.04 Financial Statements.

     The Borrower has heretofore furnished to the Administrative Agent consolidated balance sheets and statements of income and changes in stockholders' equity and cash flows as of and for the fiscal year ended December 31, 2001, audited by and accompanied by the opinion of PricewaterhouseCoopers LLP, independent public accountants. Such financial statements present fairly the financial condition and results of operations of the Borrower and its consolidated Subsidiaries as of such dates and for such periods. Such balance sheets and notes thereto disclose all material liabilities, direct or contingent, of the Borrower and its Subsidiaries as of the dates thereof. Such financial statements were prepared in accordance with GAAP applied on a consistent basis.

21

     Section 3.05 No Material Adverse Change.

     There has been no material adverse change in the business, assets, operations, prospects or condition, financial or otherwise, of the Borrower and the Subsidiaries, taken as a whole, since December 31, 2001.

     Section 3.06 Title to Properties and Possession Under Leases.

     (a) Each of the Borrower and the Subsidiaries will on the Closing Date and at all times thereafter, have good and marketable title to, or valid leasehold interests in, all its material properties and assets, except for minor defects in title that do not interfere with its ability to conduct its business as currently conducted or to utilize such properties and assets for their intended purposes and except for Liens permitted by Section 6.01. All such material properties and assets are free and clear of Liens, other than Liens expressly permitted by Section 6.01.

     (b) Each of the Borrower and the Subsidiaries (or their respective predecessors) has complied with all obligations under all material leases to which it is a party and all such leases are in full force and effect. Each of the Borrower and the Subsidiaries enjoys peaceful and undisturbed possession under all such material leases.

     Section 3.07 The Subsidiaries and the Borrower.

     Schedule 3.07 sets forth as of the Closing Date a list of all Subsidiaries and the percentage ownership interest of the Borrower therein.

     Section 3.08 Litigation: Compliance with Laws.

     (a) There are not any actions, suits or proceedings at law or in equity or by or before any Governmental Authority now pending or, to the knowledge of the Borrower, threatened against or affecting the Borrower or any Subsidiary or any business, property or rights of any such person (i) which involve any Loan Document or the Transactions or (ii) as to which there is a reasonable possibility of an adverse determination and which, if adversely determined, could, individually or in the aggregate, result in a Material Adverse Effect.

     (b) Neither the Borrower nor any of the Subsidiaries is in violation of any law, rule or regulation, or in default with respect to any judgment, writ, injunction or decree of any Governmental Authority, where such violation or default could result in a Material Adverse Effect.

22

     Section 3.09 Agreements.

     (a) Neither the Borrower nor any of the Subsidiaries is a party to any agreement or instrument or subject to any corporate restriction that has resulted or, in the absence of a material default by the Borrower or such Subsidiary, could result in a Material Adverse Effect.

     (b) Neither the Borrower nor any of its Subsidiaries is in default in any manner under any provision of any indenture or other agreement or instrument evidencing Indebtedness, or any other material agreement or instrument to which it is a party or by which it or any of its properties or assets are or may be bound, where such default could result in a Material Adverse Effect.

     Section 3.10 Federal Reserve Regulations.

     (a) Neither the Borrower nor any of the Subsidiaries is engaged principally, or as one of its important activities, in the business of extending credit for the purpose of purchasing or carrying Margin Stock.

     (b) No part of the proceeds of any Loan will be used, whether directly or indirectly, and whether immediately, incidentally or ultimately, for any purpose which entails a violation of, or which is inconsistent with, the provisions of the Regulations of the Board, including Regulation U or X.

     Section 3.11 Investment Company Act; Public Utility Holding Company Act.

     Neither the Borrower nor any Subsidiary is (a) an "investment company" as defined in, or subject to regulation under, the Investment Company Act of 1940 or (b) a "holding company" as defined in, or subject to regulation under, the Public Utility Holding Company Act of 1935.

     Section 3.12 Use of Proceeds.

     The Borrower will use the proceeds of the Loans for working capital and other general corporate purposes.

     Section 3.13 Tax Returns.

     Each of the Borrower and the Subsidiaries has filed or caused to be filed all Federal, state and local tax returns required to have been filed by it and has paid or caused to be paid all taxes shown to be due and payable on such returns or on any assessments received by it, except taxes that are being contested in accordance with Section 5.03.

     Section 3.14 No Material Misstatements.

     No information, report, financial statement, exhibit or schedule furnished by or on behalf of the Borrower to the Administrative Agent or any Lender in connection with the negotiation of any Loan Document or included therein or delivered pursuant thereto contained, contains or will contain any material misstatement of fact or omitted, omits or will omit to state any material fact necessary to make the statements therein, in the light of the circumstances under which they were, are or will be made, not misleading.

23

     Section 3.15 Employee Benefit Plans.

     Each of the Borrower and its ERISA Affiliates is in compliance in all material respects with the applicable provisions of ERISA and the regulations and published interpretations thereunder. No Reportable Event has occurred as to which the Borrower or any ERISA Affiliate was required to file a report with the PBGC, and the present value of all benefit liabilities under each Plan (based on those assumptions used to fund such Plan) did not, as of the last annual valuation date applicable thereto, exceed by more than $1,000,000 the value of the assets of such Plan. Neither the Borrower nor any ERISA Affiliate has incurred any Withdrawal Liability that could result in a Material Adverse Effect. Neither the Borrower nor any ERISA Affiliate has received any notification that any Multiemployer Plan is in reorganization or has been terminated within the meaning of Title IV of ERISA, and no Multiemployer Plan is reasonably expected to be in reorganization or to be terminated where such reorganization or termination has resulted or could reasonably be expected to result, through increases in the contributions required to be made to such Plan or otherwise, in a Material Adverse Effect.

     Section 3.16 Environmental Matters.

     Each of the Borrower and the Subsidiaries, and each of their respective businesses, has complied in all material respects with all Federal, state, local and other statutes, ordinances, orders, judgments, rulings and regulations relating to environmental pollution or to environmental regulation or control. Neither the Borrower nor any Subsidiary has received notice of any failure so to comply which alone or together with any other such failure could result in a Material Adverse Effect. The Borrower's and the Subsidiaries', plants do not manage any hazardous wastes, hazardous substances, hazardous materials, toxic substances or toxic pollutants, as those terms are used in the Resource Conservation and Recovery Act, the Comprehensive Environmental Response Compensation and Liability Act, the Hazardous Materials Transportation Act, the Toxic Substance Control Act, the Clean Air Act or the Clean Water Act, in violation of any regulations promulgated pursuant thereto or in any other applicable law where such violation could result, individually or together with other violations, in a Material Adverse Effect.

     Section 3.17 Solvency.

     On the date hereof and on the date of each Borrowing hereunder after giving effect to each Loan to be made and the use of the proceeds thereof, (a) the fair salable value of the assets of the Borrower will exceed the amount that will be required to be paid on or in respect of the existing debts and other liabilities (including contingent liabilities) of the Borrower as they mature; (b) the assets of the Borrower will not constitute unreasonably small capital to carry out its business as conducted or as proposed to be conducted; and (c) the Borrower will not intend to, and will not believe that it will, incur debts beyond its ability to pay such debts as they mature (taking into account the timing and amounts of cash to be received by it and the amounts to be payable on or in respect of its obligations).

24

IV. CONDITIONS OF LENDING

     Section 4.01 All Borrowings.

     The obligations of the Lenders to make Loans hereunder on the date of each Borrowing hereunder shall be subject to satisfaction of the following conditions precedent:

     (a) The Administrative Agent shall have received a Notice of Borrowing as required by Section 2.01.


     (b) The representations and warranties set forth in Article III (excluding, in the case of a refinancing of a Borrowing with a new Borrowing that does not increase the aggregate principal amount of the Loans of any Lender outstanding, the representations set forth in Sections 3.05 and 3.08(a)) shall be true and correct in all material respects on and as of the date of such Borrowing with the same effect as if made on and as of such date, except to the extent that such representations and warranties expressly relate to an earlier date.


     (c) The Borrower shall be in compliance with all the terms and provisions set forth herein on its part to be observed or performed (including but not limited to, compliance with the financial ratios and restrictions set forth in Sections 6.02, 6.04, 6.05, 6.07 and 6.08), and at the time of and immediately after such Borrowing no Event of Default or Default shall have occurred and be continuing.


     (d) Prior to, or simultaneous with, the initial Borrowing under this Agreement, the Administrative Agent shall have received satisfactory evidence that the commitments under the prior $275 million revolving credit agreement dated as of July 9, 1997 have been terminated and all loans outstanding thereunder have been paid in full, or that the funds received from the initial Borrowing made hereunder will be used to terminate the commitments under the prior credit agreement and repay all loans outstanding thereunder.


Each Borrowing shall be deemed to constitute a representation and warranty by the Borrower on the date of such Borrowing as to the matters specified in paragraphs (b) and (c) of this Section 4.01.

     Section 4.02 Effectiveness of Agreement.

     The obligations of the Lenders to make Loans hereunder shall be subject to satisfaction on the Closing Date of the following additional conditions precedent:

     (a) Execution of Agreement and Loan Documents. The Administrative Agent shall have received this Agreement and each Loan Document, duly executed by each party thereto.


25

     (b) Legal Opinions of Counsel. The Administrative Agent shall have received (i) an opinion of Nancy M. Taylor, Esq., legal counsel for the Borrower, in the form of Exhibit D and (ii) an enforceability opinion from Moore & Van Allen PLLC dated as of the Closing Date and addressed to the Administrative Agent and the Lenders.


     (c) Authority Documents. The Administrative Agent shall have received the following:


     (i) Articles of Incorporation. A copy of the articles of incorporation or other charter documents, as applicable, of the Borrower certified to be true and complete as of a recent date by the appropriate governmental authority of the state of its incorporation.


     (ii) Resolutions. A copy of resolutions of the board of directors or comparable managing body of the Borrower approving and adopting the Loan Documents, the transactions contemplated therein and authorizing execution and delivery thereof, certified by an officer of the Borrower as of the Closing Date to be true and correct and in force and effect as of such date


       (iii) Bylaws. A copy of the bylaws or comparable operating agreement of the Borrower certified by an officer of the Borrower as of the Closing Date to be true and correct and in force and effect as of such date.

       (iv) Good Standing. Copies of a certificate of good standing, existence or its equivalent with respect to the Borrower certified as of a recent date by the appropriate governmental authorities of the state of incorporation.

       (v) Incumbency. An incumbency certificate of the Borrower certified by a secretary or assistant secretary to be true and correct as of the Closing Date.

     (d) Financial Statements. The Administrative Agent shall have received copies of the financial statements referred to in Section 5.04 hereof for the 2001 fiscal year in form and substance satisfactory to it.


     (e) Account Designation Letter. Receipt by the Administrative Agent of an executed counterpart of the Account Designation Letter.


     (f) Officer's Certificate. The Administrative Agent shall have received a certificate, dated the Closing Date and signed by a Financial Officer of the Borrower, confirming compliance with the conditions precedent set forth in paragraphs (b) and (c) of Section 4.01 and confirming that the representations and warranties set forth in Article III hereof are true and correct as of the Closing Date.


26

     (g) Fees. The Administrative Agent shall have received payment of the fees then due set forth in the Engagement Letter dated March 15, 2002, among the Administrative Agent, First Union Securities, Inc. and the Borrower in the amounts set forth therein.


     (h) Additional Matters. All other documents and legal matters in connection with the transactions contemplated by this Agreement shall be reasonably satisfactory in form and substance to the Administrative Agent and its counsel.


V. AFFIRMATIVE COVENANTS

     The Borrower covenants and agrees with each Lender and the Administrative Agent that so long as this Agreement shall remain in effect or the principal of or interest on any Loan, any Fees or any other expenses or amounts payable under any Loan Document shall be unpaid, unless the Required Lenders shall otherwise consent in writing, the Borrower will, and will cause each of the Subsidiaries to:

     Section 5.01 Existence; Businesses and Properties Compliance.

     (a) Do or cause to be done all things necessary to preserve, renew and keep in full force and effect its legal existence, except as otherwise expressly permitted under Section 6.04.


     (b) Do or cause to be done all things necessary to obtain, preserve, renew, extend and keep in full force and effect the rights, licenses, permits, franchises, authorizations, patents, copyrights, trademarks and trade names material to the conduct of its business; maintain and operate such business in substantially the manner in which it is presently conducted and operated; comply in all material respects with all applicable laws, rules, regulations and orders of any Governmental Authority, whether now in effect or hereafter enacted; and at all times maintain and preserve all property material to the conduct of such business and keep such property in good repair, working order and condition and from time to time make, or cause to be made, all needful and proper repairs, renewals, additions, improvements and replacements thereto necessary in order that the business carried on in connection therewith may be properly conducted at all times.


     Section 5.02 Insurance.

     Keep its insurable properties adequately insured at all times by financially sound and reputable insurers; maintain such other insurance, to such extent and against such risks, including fire and other risks insured against by extended coverage, as is customary with companies in the same or similar businesses, including public liability insurance against claims for personal injury or death or property damage occurring upon, in, about or in connection with the use of any properties owned, occupied or controlled by it; and maintain such other insurance as may be required by law.

27

     Section 5.03 Obligations and Taxes.

     Pay its Indebtedness and other obligations promptly and in accordance with their terms and pay and discharge promptly all taxes, assessments and governmental charges or levies imposed upon it or upon its income or profits or in respect of its property, before the same shall become delinquent or in default, as well as all lawful claims for labor, materials and supplies or otherwise which, if unpaid, might give rise to a Lien upon such properties or any part thereof; provided, however, that such payment and discharge shall not be required with respect to any such tax, assessment, charge, levy or claim so long as the validity or amount thereof shall be contested in good faith by appropriate proceedings and the Borrower shall have set aside on its books adequate reserves with respect thereto in accordance with GAAP.

     Section 5.04 Financial Statements, Reports, etc.

     In the case of the Borrower, furnish to the Administrative Agent and each Lender:

     (a) within 90 days after the end of each fiscal year, its consolidated balance sheets and related statements of income and cash flows, showing the financial condition of the Borrower and its consolidated Subsidiaries as of the close of such fiscal year and the results of its operations and the operations of such Subsidiaries during such year, all audited by PricewaterhouseCoopers LLP or other independent public accountants of recognized national standing acceptable to the Required Lenders and accompanied by an opinion of such accountants (which shall not be qualified in any material respect) to the effect that such consolidated financial statements fairly present the financial condition and results of operations of the Borrower on a consolidated basis in accordance with GAAP;


     (b) within 45 days after the end of each of the first three fiscal quarters of each fiscal year, its consolidated balance sheets and related statements of income and cash flows, showing the financial condition of the Borrower and its consolidated Subsidiaries as of the close of such fiscal quarter and the results of its operations and the operations of such Subsidiaries during such fiscal quarter and the then elapsed portion of the fiscal year, all certified by one of its Financial Officers as fairly presenting the financial condition and results of operations of the Borrower on a consolidated basis in accordance with GAAP, subject to normal year-end audit adjustments;


     (c) concurrently with any delivery of financial statements under (a) or (b) above, a certificate of the accounting firm or Financial Officer opining on or certifying such statements (which certificate, when furnished by an accounting firm, may be limited to accounting matters and disclaim responsibility for legal interpretations) (i) certifying that no Event of Default or Default has occurred or, if such an Event of Default or Default has occurred, specifying the nature and extent thereof and any corrective action taken or proposed to be taken with respect thereto and (ii) setting forth in the form of Exhibit F hereto, computations in reasonable detail satisfactory to the Administrative Agent demonstrating compliance with the covenants contained in Sections 6.05, 6.07 and 6.08;


28

     (d) promptly after the same become publicly available, copies of all periodic and other reports, proxy statements and other materials filed by it with the Securities and Exchange Commission, or any governmental authority succeeding to any of or all the functions of said Commission, or with any national securities exchange, or distributed to its shareholders, as the case may be; and


     (e) promptly, from time to time, such other information regarding the operations, business affairs and financial condition of the Borrower or any Subsidiary, or compliance with the terms of any Loan Document, as the Administrative Agent or any Lender may reasonably request.


     Section 5.05 Litigation and Other Notices.

     Furnish to the Administrative Agent and each Lender prompt written notice of the following:

     (a) any Event of Default or Default, specifying the nature and extent thereof and the corrective action (if any) proposed to be taken with respect thereto;


     (b) the filing or commencement of, or any threat or notice of intention of any person to file or commence, any action, suit or proceeding, whether at law or in equity or by or before any Governmental Authority, against the Borrower or any Affiliate thereof which, if adversely determined, could result in a Material Adverse Effect;


     (c) any development that has resulted in, or could reasonably be anticipated to result in, a Material Adverse Effect.

     Section 5.06 ERISA.

     (a) Comply in all material respects with the applicable provisions of ERISA and (b) furnish to the Administrative Agent and each Lender (i) as soon as possible, and in any event within 30 days after any Responsible Officer of the Borrower or any ERISA Affiliate either knows or has reason to know that any Reportable Event has occurred that alone or together with any other Reportable Event could reasonably be expected to result in liability of the Borrower to the PBGC in an aggregate amount exceeding $5,000,000, a statement of a Financial Officer setting forth details as to such Reportable Event and the action proposed to be taken with respect thereto, together with a copy of the notice, if any, of such Reportable Event given to the PBGC, (ii) promptly after receipt thereof, a Copy of any notice the Borrower or any ERISA Affiliate may receive from the PBGC relating to the intention of the PBGC to terminate any Plan or Plans (other than a Plan maintained by an ERISA Affiliate which is considered an ERISA Affiliate only pursuant to subsection (m) or (o) of Section 412 of the Code) or to appoint a trustee to administer any Plan or Plans, (iii) within 20 days after the due date for filing with the PBGC pursuant to Section 412(n) of the Code of a notice of failure to make a required installment or other payment with respect to a Plan, a statement of a Financial Officer setting forth details as to such failure and the action proposed to be taken with respect thereto, together with a copy of such notice given to the PBGC and (iv) promptly and in any event within 30 days after receipt thereof by the Borrower or any ERISA Affiliate from the sponsor of a Multiemployer Plan, a copy of each notice received by the Borrower or any ERISA Affiliate concerning (A) the imposition of Withdrawal Liability or (B) a determination that a Multiemployer Plan is, or is expected to be, terminated or in reorganization, in each case within the meaning of Title IV of ERISA.


29

     Section 5.07 Maintaining Records; Access to Properties and Inspections.

     Maintain all financial records in accordance with GAAP and permit any representatives designated by any Lender to visit and inspect the financial records and the properties of the Borrower or any Subsidiary at reasonable times and as often as requested and to make extracts from and copies of such financial records, and permit any representatives designated by any Lender to discuss the affairs, finances and condition of the Borrower or any Subsidiary with the officers thereof and independent accountants therefor.

VI. NEGATIVE COVENANTS

The Borrower covenants and agrees with each Lender and the Administrative Agent that, so long as this Agreement shall remain in effect or the principal of or interest on any Loan, any Fees or any other expenses or amounts payable under any Loan Document shall be unpaid, unless the Required Lenders shall otherwise consent in writing, the Borrower will not, and will not cause or permit any of the Subsidiaries to:

     Section 6.01 Liens.

     Create, incur, assume or permit to exist any Lien on any property or assets (including stock or other securities of any person, including any Subsidiary, but excluding Margin Stock to the extent that the value of such Margin Stock, determined in accordance with Regulation U, exceeds 25% of the value (as so determined) of the assets and properties that would be subject to this Section 6.01 without giving effect to this parenthetical, or such other maximum amount or percentage as is then provided for or permitted under Regulation U or any successor regulation in order that no Loan shall be deemed "indirectly secured" by Margin Stock for purposes of such regulation), now owned or hereafter acquired by it or on any income or rights in respect of any thereof, except:

     (a) Liens on property or assets of the Borrower and its Subsidiaries existing on the date hereof and set forth in Schedule 6.0l; provided that such Liens shall secure only those obligations which they secure on the date hereof;


     (b) any Lien existing on any property or asset prior to the acquisition thereof by the Borrower or any Subsidiary; provided that (i) such Lien is not created in contemplation of or in connection with such acquisition and (ii) such Lien does not apply to any other property or assets of the Borrower or any Subsidiary;


30

     (c) Liens for taxes not yet due or which are being contested in compliance with Section 5.03;


     (d) carriers', warehousemen's, mechanics', materialmen's, repairmen's or other like Liens arising in the ordinary course of business and securing obligations which are not due or which are being contested in compliance with Section 5.03;


     (e) pledges and deposits made in the ordinary course of business in compliance with workmen's compensation, unemployment insurance and other social security laws or regulations;


     (f) deposits to secure the performance of bids, trade contracts (other than for Indebtedness), leases (other than Capital Lease Obligations), statutory obligations, surety and appeal bonds, performance bonds and other obligations of a like nature incurred in the ordinary course of business;


     (g) zoning restrictions, easements, rights-of-way, restrictions on use of real property and other similar encumbrances incurred in the ordinary course of business which, in the aggregate, are not substantial in amount and do not materially detract from the value of the property subject thereto or interfere with the ordinary conduct of the business of the Borrower or any of its Subsidiaries;


     (h) purchase money security interests in real property, improvements thereto or equipment hereafter acquired (or, in the case of improvements, constructed) by the Borrower or any Subsidiary; provided that (i) such security interests are incurred, and the Indebtedness secured thereby is created, within 90 days after such acquisition (or construction), (ii) the Indebtedness secured thereby does not exceed 80% of the lesser of the cost or the fair market value of such real property, improvements or equipment at the time of such acquisition (or construction) and (iii) such security interests do not apply to any other property or assets of the Borrower or any Subsidiary; and


     (i) Liens other than those referred to in subparagraphs (a) through (h) above, provided that the sum of the aggregate amount of all Indebtedness or other obligations which are secured or evidenced by Liens other than those referred to in subparagraphs (a) through (h) above plus the fair market value in the aggregate of properties sold by the Borrower in the sale and lease-back transactions permitted under Section 6.02, does not at any time exceed an amount equal to 10% of Consolidated Stockholders' Equity.


     Section 6.02 Sale and Lease-Back Transactions.

     Enter into any arrangement, directly or indirectly, with any person whereby it shall sell or transfer any property, real or personal, used or useful in its business, whether now owned or hereafter acquired, and thereafter rent or lease such property or other property which it intends to use for substantially the same purpose or purposes as the property being sold or transferred; provided, however, that the Borrower shall be permitted to enter into any such arrangements to the extent that the sum of the fair market value in the aggregate of properties sold by the Borrower pursuant to all such arrangements, plus the aggregate amount of indebtedness secured by Liens under paragraph (i) of Section 6.01, is not greater than 10% of Consolidated Stockholders' Equity.

31

     Section 6.03 Obligations of Subsidiaries.

     Permit the Subsidiaries to incur Indebtedness, except for:

     (a) Indebtedness to the Borrower incurred by the Subsidiaries in the ordinary course of business;


     (b) Indebtedness incurred in connection with Internal Financing Transactions; and


     (c) Indebtedness which in the aggregate for all the Subsidiaries, exclusive of Indebtedness incurred in connection with Internal Financing Transactions to the Borrower or other wholly-owned Subsidiaries, constitutes not more than 10% of Consolidated Stockholders’ Equity at any time.


     Section 6.04 Mergers, Consolidations and Sales of Assets.

     (a) Merge into or consolidate with any other person, or permit any other person to merge into or consolidate with it, or sell, transfer, lease or otherwise dispose of (in one transaction or in a series of transactions) all or any substantial part of its assets (whether now owned or hereafter acquired) or any capital stock of any Subsidiary (other than any Margin Stock to the extent the value of such Margin Stock, determined in accordance with Regulation U, together with the value of other Margin Stock owned by the Borrower and its Subsidiaries, exceeds 25% of the aggregate value of the assets of the Borrower and its Subsidiaries), or purchase, lease or otherwise acquire (in one transaction or a series of transactions) all or any substantial part of the assets or capital stock of any other person; provided that nothing in the foregoing shall prohibit:

     (i) the Borrower and any of its Subsidiaries from purchasing or selling inventory in the ordinary course of business in arm's-length transactions;


(ii) if at the time thereof and immediately after giving effect thereto no Event of Default or Default shall have occurred and be continuing (A) any entity from merging into the Borrower or any wholly owned Subsidiary in a transaction in which the Borrower or such wholly owned Subsidiary, as the case may be, is the surviving corporation, and (B) the Borrower and any Subsidiary from acquiring all or any substantial part of the assets or capital stock of any other person;


     (iii) the Borrower and any of its Subsidiaries (other than Tredegar Investments ) from selling, transferring, leasing or otherwise disposing of (in one transaction or in a series of transactions) during any fiscal year in arm's-length transactions (A) assets the fair market value of which is not more than 10% of the consolidated assets of the Borrower calculated in accordance with GAAP, determined as of the beginning of such fiscal year; provided, however, that the sale of Therics, Inc. and Molecumetics, Ltd. shall be permitted notwithstanding anything to the contrary contained in this Section 6.04(a) and (B) any other assets to the extent the Revolving Loan is repaid with a corresponding reduction in the Commitments, or the commitments under other existing credit facilities are permanently reduced, by the amount of the proceeds received by the Borrower from the sale of such assets; and


32

     (iv) Tredegar Investments from selling, transferring, leasing or otherwise disposing of (in one transaction or in a series of transactions) any or all of its assets at any time; and


     (v) any Internal Financing Transaction.


     (b) Notwithstanding anything contained in clause (a) above, transfer operating assets from the Borrower or any of its Subsidiaries (other than Tredegar Investments) to Tredegar Investments.

     Section 6.05 Dividends and Distributions.

     Declare or pay, directly or indirectly, any dividend or make any other distribution (by reduction of capital or otherwise), whether in cash, property, securities or a combination thereof, with respect to any shares of its capital stock or set aside any amount for any such purpose; provided, however, that (a) any Subsidiary may declare and pay dividends or make other distributions to the Borrower, and any Internal Financing Subsidiary may declare and pay dividends or make other distributions to the Borrower or other wholly-owned Subsidiaries and (b) if no Event of Default or Default shall have occurred and be continuing, the Borrower may at any time declare and pay dividends in an aggregate amount not at any time to exceed $100,000,000 during the term of this Agreement.

     Section 6.06 Transactions with Affiliates.

     Sell or transfer any property or assets to, or purchase or acquire any property or assets from, or otherwise engage in any other transactions with, any of its Affiliates, except that as long as no Default or Event of Default shall have occurred and be continuing, the Borrower or any Subsidiary may engage in any of the foregoing transactions (a) in the ordinary course of business at prices and on terms and conditions not less favorable to the Borrower or such Subsidiary than could be obtained on an arm's-length basis from unrelated third parties, or (b) in connection with Internal Financing Transactions.

     Section 6.07 Consolidated Stockholders' Equity.

     Permit Consolidated Stockholders' Equity of the Borrower to be less than $380,000,000 at any time.

33

     Section 6.08 Debt Ratio.

     Permit the Leverage Ratio to exceed 0.50 to 1.00 at any time.

VII. EVENTS OF DEFAULT

     In case of the happening of any of the following events ("Events of Default"):

     (a) any representation or warranty made or deemed made in or in connection with any Loan Document or the borrowings hereunder, or any representation, warranty, statement or information contained in any report, certificate, financial statement or other instrument furnished in connection with or pursuant to any Loan Document, shall prove to have been false or misleading in any material respect when so made, deemed made or furnished;


     (b) default shall be made in the payment of any principal of any Loan when and as the same shall become due and payable, whether at the due date thereof or at a date fixed for prepayment thereof or by acceleration thereof or otherwise;


     (c) default shall be made in the payment of any interest on any Loan or any Fee or any other amount (other than an amount referred to in (b) above) due under any Loan Document, when and as the same shall become due and payable, and such default shall continue unremedied for a period of five Business Days;


     (d) default shall be made in the due observance or performance by the Borrower or any Subsidiary of any covenant, condition or agreement contained in Section 5.01(a) or 5.05 or in Article VI;


     (e) default shall be made in the due observance or performance by the Borrower or any Subsidiary of any covenant, condition or agreement contained in any Loan Document (other than those specified in (b), (c) or (d) above) and such default shall continue unremedied for a period of ten Business Days after notice thereof from the Administrative Agent or any Lender to the Borrower;


     (f) the Borrower or any Subsidiary shall (i) fail to pay any principal or interest, regardless of amount, due in respect of any Indebtedness in an aggregate principal amount in excess of $5,000,000, when and as the same shall become due and payable, or (ii) fail to observe or perform any other term, covenant, condition or agreement on its part to be performed under any agreement or instrument evidencing or governing any such Indebtedness if the effect of any failure referred to in this clause (ii) is to cause, or to permit the holder or holders of such Indebtedness or a trustee on its or their behalf (with or without the giving of notice, the lapse of time or both) to cause, such Indebtedness to become due prior to its stated maturity;


34

     (g) an involuntary proceeding shall be commenced or an involuntary petition shall be filed in a court of competent jurisdiction seeking (i) relief in respect of the Borrower or any Subsidiary, or of a substantial part of the property or assets of the Borrower or a Subsidiary, under Title 11 of the United States Code, as now constituted or hereafter amended, or any other Federal or state bankruptcy, insolvency, receivership or similar law, (ii) the appointment of a receiver, trustee, custodian, sequestrator, conservator or similar official for the Borrower or any Subsidiary or for a substantial part of the property or assets of the Borrower or a Subsidiary or (iii) the winding-up or liquidation of the Borrower or any Subsidiary; and such proceeding or petition shall continue undismissed for 60 days or an order or decree approving or ordering any of the foregoing shall be entered;


     (h) the Borrower or any Significant Subsidiary shall (i) voluntarily commence any proceeding or file any petition seeking relief under Title 11 of the United States Code, as now constituted or hereafter amended, or any other Federal or state bankruptcy, insolvency, receivership or similar law, (ii) consent to the institution of, or fail to contest in a timely and appropriate manner, any proceeding or the filing of any petition described in (g) above, (iii) apply for or consent to the appointment of a receiver, trustee, custodian, sequestrator, conservator or similar official for the Borrower or such Significant Subsidiary or for a substantial part of the property or assets of the Borrower or such Significant Subsidiary, (iv) file an answer admitting the material allegations of a petition filed against it in any such proceeding, (v) make a general assignment for the benefit of creditors, (vi) become unable, admit in writing its inability or fail generally to pay its debts as they become due or (vii) take any action for the purpose of effecting any of the foregoing;


     (i) one or more judgments for the payment of money in an aggregate amount in excess of $1,000,000 shall be rendered against the Borrower, any Subsidiary or any combination thereof and the same shall remain undischarged for a period of 30 consecutive days during which execution shall not be effectively stayed, or any action shall be legally taken by a judgment creditor to levy upon assets or properties of the Borrower or any Subsidiary to enforce any such judgment;


     (j) a Reportable Event or Reportable Events, or a failure to make a required installment or other payment (within the meaning of Section 412(n)(1) of the Code), shall have occurred with respect to any Plan or Plans that reasonably could be expected to result in liability of the Borrower to the PBGC or to a Plan in an aggregate amount exceeding $5,000,000 and, within 30 days after the reporting of any such Reportable Event to the Administrative Agent or after the receipt by the Administrative Agent of the statement required pursuant to Section 5.06, the Administrative Agent shall have notified the Borrower in writing that (i) the Required Lenders have made a determination that, on the basis of such Reportable Event or Reportable Events or the failure to make a required payment, there are reasonable grounds (A) for the termination of such Plan or Plans by the PBGC, (B) for the appointment by the appropriate United States District Court of a trustee to administer such Plan or Plans or (C) for the imposition of a lien in favor of a Plan and (ii) as a result thereof an Event of Default exists hereunder; or a trustee shall be appointed by a United States District Court to administer any such Plan or Plans; or the PBGC shall institute proceedings to terminate any Plan or Plans;


35

     (k) the Borrower or any ERISA Affiliate shall have been notified by the sponsor of a Multiemployer Plan that it has incurred Withdrawal Liability to such Multiemployer Plan, (ii) the Borrower or such ERISA Affiliate does not have reasonable grounds for contesting such Withdrawal Liability or is not in fact contesting such Withdrawal Liability in a timely and appropriate manner and (iii) the amount of the Withdrawal Liability specified in such notice, when aggregated with all other amounts required to be paid to Multiemployer Plans in connection with Withdrawal Liabilities (determined as of the date or dates of such notification), exceeds $5,000,000 or requires payments exceeding $1,000,000 in any year;


     (l) the Borrower or any ERISA Affiliate shall have been notified by the sponsor of a Multiemployer Plan that such Multiemployer Plan is in reorganization or is being terminated, within the meaning of Title IV of ERISA, if solely as a result of such reorganization or termination the aggregate annual contributions of the Borrower and its ERISA Affiliates to all Multiemployer Plans that are then in reorganization or have been or are being terminated have been or will be increased over the amounts required to be contributed to such Multiemployer Plans for their most recently completed plan years by an amount exceeding $1,000,000;


     (m) there shall have occurred any actual invalidity of this Agreement or any of the Revolving Notes or the Borrower shall have asserted any claim of invalidity related thereto; or


(n) there shall have occurred a Change in Control;


then, and in every such event (other than an event with respect to the Borrower described in paragraph (g) or (h) above), and at any time thereafter during the continuance of such event, the Administrative Agent may, with the consent of the Required Lenders, and at the request of the Required Lenders shall, by notice to the Borrower, take either or both of the following actions, at the same or either or both of different times: (i) terminate forthwith the Commitments and (ii) declare the Loans then outstanding to be forthwith due and payable, whereupon the principal of the Loans, together with accrued interest thereon and any unpaid accrued Fees and all other liabilities of the Borrower accrued hereunder and under any other Loan Document, shall become forthwith due and payable, without presentment, demand, protest or any other notice of any kind, all of which are hereby expressly waived by the Borrower, anything contained herein or in any other Loan Document to the contrary notwithstanding; and in any event with respect to the Borrower described in paragraph (g) or (h) above, the Commitments shall automatically terminate and the principal of the Loans then outstanding, together with accrued interest thereon and any unpaid accrued Fees and all other liabilities of the Borrower accrued hereunder and under any other Loan Document, shall automatically become due and payable, without presentment, demand, protest or any other notice of any kind, all of which are hereby expressly waived by the Borrower, anything contained herein or in any other Loan Document to the contrary notwithstanding.

36

VIII. THE ADMINISTRATIVE AGENT

     Section 8.01 Appointment.

     Each Lender hereby irrevocably designates and appoints Wachovia Bank, National Association as the Administrative Agent of such Lender under this Agreement, and each such Lender irrevocably authorizes Wachovia Bank, National Association, as the Administrative Agent for such Lender, to take such action on its behalf under the provisions of this Agreement and to exercise such powers and perform such duties as are expressly delegated to the Administrative Agent by the terms of this Agreement, together with such other powers as are reasonably incidental thereto. Notwithstanding any provision to the contrary elsewhere in this Agreement, the Administrative Agent shall not have any duties or responsibilities, except those expressly set forth herein, or any fiduciary relationship with any Lender, and no implied covenants, functions, responsibilities, duties, obligations or liabilities shall be read into this Agreement or otherwise exist against the Administrative Agent.

     Section 8.02 Delegation of Duties.

     The Administrative Agent may execute any of its duties under this Agreement by or through agents or attorneys-in-fact and shall be entitled to advice of counsel concerning all matters pertaining to such duties. The Administrative Agent shall not be responsible for the negligence or misconduct of any agents or attorneys-in-fact selected by it with reasonable care. Without limiting the foregoing, the Administrative Agent may appoint one of its affiliates as its agent to perform its the functions of the Administrative Agent hereunder relating to the advancing of funds to the Borrower and distribution of funds to the Lenders and to perform such other related functions of the Administrative Agent hereunder as are reasonably incidental to such functions.

     Section 8.03 Exculpatory Provisions.

     Neither the Administrative Agent nor any of its officers, directors, employees, agents, attorneys-in-fact or affiliates shall be (i) liable for any action lawfully taken or omitted to be taken by it or such Person under or in connection with this Agreement (except for its or such Person's own gross negligence or willful misconduct) or (ii) responsible in any manner to any of the Lenders for any recitals, statements, representations or warranties made by the Borrower or any officer thereof contained in this Agreement or in any certificate, report, statement or other document referred to or provided for in, or received by the Administrative Agent under or in connection with, this Agreement or for the value, validity, effectiveness, genuineness, enforceability or sufficiency of any of the Loan Documents or for any failure of the Borrower to perform their obligations hereunder or thereunder. The Administrative Agent shall not be under any obligation to any Lender to ascertain or to inquire as to the observance or performance by the Borrower of any of the agreements contained in, or conditions of, this Agreement, or to inspect the properties, books or records of the Borrower.

37

     Section 8.04 Reliance by Administrative Agent.

     The Administrative Agent shall be entitled to rely, and shall be fully protected in relying, upon any Revolving Note, writing, resolution, notice, consent, certificate, affidavit, letter, cablegram, telegram, telecopy, telex or teletype message, statement, order or other document or conversation believed by it in good faith to be genuine and correct and to have been signed, sent or made by the proper Person or Persons and upon advice and statements of legal counsel (including, without limitation, counsel to the Borrower), independent accountants and other experts selected by the Administrative Agent. The Administrative Agent may deem and treat the payee of any Revolving Note as the owner thereof for all purposes unless (a) a written notice of assignment, negotiation or transfer thereof shall have been filed with the Administrative Agent and (b) the Administrative Agent shall have received the written agreement of such assignee to be bound hereby as fully and to the same extent as if such assignee were an original Lender party hereto, in each case in form satisfactory to the Administrative Agent. The Administrative Agent shall be fully justified in failing or refusing to take any action under this Agreement unless it shall first receive such advice or concurrence of the Required Lenders as it deems appropriate or it shall first be indemnified to its satisfaction by the Lenders against any and all liability and expense which may be incurred by it by reason of taking or continuing to take any such action. The Administrative Agent shall in all cases be fully protected in acting, or in refraining from acting, under any of the Loan Documents in accordance with a request of the Required Lenders or all of the Lenders, as may be required under this Agreement, and such request and any action taken or failure to act pursuant thereto shall be binding upon all the Lenders and all future holders of the Revolving Notes.

     Section 8.05 Notice of Default.

     The Administrative Agent shall not be deemed to have knowledge or notice of the occurrence of any Default or Event of Default hereunder unless the Administrative Agent has received notice from a Lender or the Borrower referring to this Agreement, describing such Default or Event of Default and stating that such notice is a "notice of default". In the event that the Administrative Agent receives such a notice, the Administrative Agent shall give prompt notice thereof to the Lenders. The Administrative Agent shall take such action with respect to such Default or Event of Default as shall be reasonably directed by the Required Lenders; provided, however, that unless and until the Administrative Agent shall have received such directions, the Administrative Agent may (but shall not be obligated to) take such action, or refrain from taking such action, with respect to such Default or Event of Default as it shall deem advisable in the best interests of the Lenders except to the extent that this Agreement expressly requires that such action be taken, or not taken, only with the consent or upon the authorization of the Required Lenders, or all of the Lenders, as the case may be.

38

     Section 8.06 Non-Reliance on Administrative Agent and Other Lenders.

     Each Lender expressly acknowledges that neither the Administrative Agent nor any of its officers, directors, employees, agents, attorneys-in-fact or affiliates has made any representation or warranty to it and that no act by the Administrative Agent hereinafter taken, including any review of the affairs of the Borrower, shall be deemed to constitute any representation or warranty by the Administrative Agent to any Lender. Each Lender represents to the Administrative Agent that it has, independently and without reliance upon the Administrative Agent or any other Lender, and based on such documents and information as it has deemed appropriate, made its own appraisal of and investigation into the business, operations, property, financial and other condition and creditworthiness of the Borrower and made its own decision to make its Loans hereunder and enter into this Agreement. Each Lender also represents that it will, independently and without reliance upon the Administrative Agent or any other Lender, and based on such documents and information as it shall deem appropriate at the time, continue to make its own credit analysis, appraisals and decisions in taking or not taking action under this Agreement, and to make such investigation as it deems necessary to inform itself as to the business, operations, property, financial and other condition and creditworthiness of the Borrower. Except for notices, reports and other documents expressly required to be furnished to the Lenders by the Administrative Agent hereunder, the Administrative Agent shall not have any duty or responsibility to provide any Lender with any credit or other information concerning the business, operations, property, condition (financial or otherwise), prospects or creditworthiness of the Borrower which may come into the possession of the Administrative Agent or any of its officers, directors, employees, agents, attorneys-in-fact or affiliates.

     Section 8.07 Administrative Agent in Its Individual Capacity.

     The Administrative Agent and its affiliates may make loans to, accept deposits from and generally engage in any kind of business with the Borrower as though the Administrative Agent were not the Administrative Agent hereunder. With respect to its Loans made or renewed by it and any Revolving Note issued to it, the Administrative Agent shall have the same rights and powers under this Agreement as any Lender and may exercise the same as though it were not the Administrative Agent, and the terms "Lender" and "Lenders" shall include the Administrative Agent in its individual capacity.

     Section 8.08 Successor Administrative Agent.

     The Administrative Agent may resign as Administrative Agent upon 30 days' prior notice to the Borrower and the Lenders. If the Administrative Agent shall resign as Administrative Agent under this Agreement and the Revolving Notes, then the Required Lenders shall appoint from among the Lenders a successor agent for the Lenders, which successor agent shall be approved by the Borrower with such approval not to be unreasonably withheld (provided, however if an Event of Default shall exist at such time, no approval of the Borrower shall be required hereunder), whereupon such successor agent shall succeed to the rights, powers and duties of the Administrative Agent, and the term "Administrative Agent" shall mean such successor agent effective upon such appointment and approval, and the former Administrative Agent's rights, powers and duties as Administrative Agent shall be terminated, without any other or further act or deed on the part of such former Administrative Agent or any of the parties to this Agreement or any holders of the Revolving Notes. After any retiring Administrative Agent's resignation as Administrative Agent, the provisions of this Section 8.08 shall inure to its benefit as to any actions taken or omitted to be taken by it while it was Administrative Agent under this Agreement.

39

     Section 8.09 Nature of Duties.

     Except as otherwise expressly stated herein, any agent (other than the Administrative Agent) or co-lead arranger listed from time to time on the cover page of this Agreement shall have no obligations, responsibilities or duties under this Agreement or under any other Loan Document other than obligations, responsibilities and duties applicable to all Lenders in their capacity as Lenders; provided, however, that such agents and co-lead arrangers shall be entitled to the same rights, protections, exculpations and indemnifications granted to the Administrative Agent under this Article VIII in their capacity as an agent or co-lead arranger.

IX. MISCELLANEOUS

     Section 9.01 Notices.

     Notices and other communications provided for herein shall be in writing and shall be delivered by hand or overnight courier service, mailed or sent by telex, graphic scanning or other telegraphic communications equipment of the sending party, as follows:

     (a) if to the Borrower, to it at 1100 Boulders Parkway, Richmond, Virginia 23225, Attention of D. Andrew Edwards (Telecopy No. (804) 330-1259);


     (b) if to the Administrative Agent, to it at (i) Wachovia Bank, National Association, 301 S. College Street, Charlotte, North Carolina 28288-0760, Attn: Mr. Eric Tan, (Telecopy No. (704) 715-1117) and (ii) Wachovia Bank, National Association, 301 S. College Street,Charlotte, North Carolina 28288, Attn: Agency Services, (Telecopy: (704) 383-0288); and


     (c) if to a Lender, to it at its address (or telecopy number) set forth in Schedule 2.01.


     All notices and other communications given to any party hereto in accordance with the provisions of this Agreement shall be deemed to have been given on the date of receipt if delivered by hand or overnight courier service or sent by telex, graphic scanning or other telegraphic communications equipment of the sender, or on the date five Business Days after dispatch by certified or registered mail if mailed, in each case delivered, sent or mailed (properly addressed) to such party as provided in this Section 9.01 or in accordance with the latest unrevoked direction from such party given in accordance with this Section 9.01.

     Section 9.02 Survival of Agreement.

     All covenants, agreements, representations and warranties made by the Borrower herein and in the certificates or other instruments prepared or delivered in connection with or pursuant to this Agreement or any other Loan Document shall be considered to have been relied upon by the Lenders and shall survive the making by the Lenders of the Loans, regardless of any investigation made by the Lenders or on their behalf, and shall continue in full force and effect as long as the principal of or any accrued interest on any Loan or any Fee or any other amount payable under this Agreement or any other Loan Document is outstanding and unpaid and so long as the Commitments have not been terminated.

40

     Section 9.03 Binding Effect.

     This Agreement shall become effective when it shall have been executed by the Borrower and the Administrative Agent and when the Administrative Agent shall have received copies hereof which, when taken together, bear the signatures of each Lender, and thereafter shall be binding upon and inure to the benefit of the Borrower, the Administrative Agent and each Lender and their respective successors and assigns, except that the Borrower shall not have the right to assign its obligations or rights hereunder or any interest herein without the prior written consent of all the Lenders.

     Section 9.04 Successors and Assigns; Participations; Purchasing Lenders.

     (a) This Agreement shall be binding upon and inure to the benefit of the Borrower, the Lenders, the Administrative Agent, all future holders of the Revolving Notes and their respective successors and assigns; provided, however, that the Borrower may not assign or transfer any of its rights or obligations under this Agreement or the other Loan Documents without the prior written consent of each Lender, and no Lender may assign or otherwise transfer any of its rights or obligations hereunder except (i) to a Purchasing Lender pursuant to the provisions of paragraph (c) of this Section, (ii) by way of participation in accordance with the provisions of paragraph (b) of this Section, or (iii) by way of pledge or assignment pursuant to paragraph (h) of this Section (and any other attempted assignment or transfer by any party hereto shall be null and void).


     (b) Any Lender may, in the ordinary course of its commercial banking business and in accordance with applicable law, at any time sell to one or more banks ("Participants") participating interests in any Loan owing to such Lender, any Revolving Note held by such Lender, any Commitment of such Lender, or any other right and/or obligation of such Lender hereunder. In the event of any such sale by a Lender of participating interests to a Participant, such Lender's rights and/or obligations (as the case may be) under this Agreement to the other parties to this Agreement shall remain unchanged, such Lender shall remain solely responsible for the performance thereof, such Lender shall remain the holder of any such Revolving Note for all purposes under this Agreement, and the Borrower and the Administrative Agent shall continue to deal solely and directly with such Lender in connection with such Lender's rights and obligations under this Agreement. No Lender shall transfer or grant any participation under which the Participant shall have rights to approve any amendment to or waiver of this Agreement or any other Loan Document except to the extent such amendment or waiver would (i) extend the scheduled maturity of any Loan or Revolving Note or any installment thereon in which such Participant is participating, or reduce the stated rate or extend the time of payment of interest or fees thereon (except in connection with a waiver of interest at the increased post-default rate) or reduce the principal amount thereof, or increase the amount of the Participant's participation over the amount thereof then in effect (it being understood that a waiver of any Default or Event of Default shall not constitute a change in the terms of such participation, and that an increase in any Commitment or Loan shall be permitted without consent of any participant if the Participant's participation is not increased as a result thereof) or (ii) consent to the assignment or transfer by the Borrower of any of their rights and obligations under this Agreement. In the case of any such participation, the Participant shall not have any rights under this Agreement or any of the other Loan Documents (the Participant's rights against such Lender in respect of such participation to be those set forth in the agreement executed by such Lender in favor of the Participant relating thereto) and all amounts payable by the Borrower hereunder shall be determined as if such Lender had not sold such participation, provided that each Participant shall be entitled to the benefits and be bound by the obligations of Sections 2.06, 2.07, 2.08 and 9.05 with respect to its participation in the Commitments and the Loans outstanding from time to time; provided, that no Participant shall be entitled to receive any greater amount pursuant to such Sections than the transferor Lender would have been entitled to receive in respect of the amount of the participation transferred by such transferor Lender to such Participant had no such transfer occurred.


41

     (c) Any Lender may, in the ordinary course of its commercial banking business and in accordance with applicable law, at any time, sell or assign to any Lender or any Affiliate thereof (other than an Affiliate that is not a United States person within the meaning of Section 7701(a)(30) of the Code) and, with the consent of the Administrative Agent and, so long as no Event of Default has occurred and is continuing, the Borrower (in each case, which consent shall not be unreasonably withheld), to one or more additional banks or financial institutions ("Purchasing Lenders"), all or any part of its rights and obligations under this Agreement and the Revolving Notes in minimum amounts of $5,000,000 (or less if the entire amount of such Lender's obligations is transferred) with respect to its Commitment, its Revolving Loans, pursuant to a Commitment Transfer Supplement, executed by such Purchasing Lender and such transferor Lender (and, in the case of a Purchasing Lender that is not then a Lender or an Affiliate thereof, the Administrative Agent and, so long as no Event of Default has occurred and is continuing, the Borrower), and delivered to the Administrative Agent for its acceptance and recording in the Register; provided, however, that (i) any sale or assignment to an existing Lender or to an Affiliate thereof that is a United States person (within the meaning of Section 7701(a)(30) of the Code) shall not require the consent of the Administrative Agent or the Borrower nor shall any such sale or assignment be subject to the minimum assignment amounts specified herein and (ii) the parties hereto agree and acknowledge that it is reasonable for the Borrower to withhold its approval of an assignment to a Person that is not a United States person (within the meaning of Section 7701(a)(30) of the Code) if such Person does not provide to the Borrower the certification as to exemption from deduction or withholding of Taxes as required under Sections 2.12 and 9.04(g). Upon such execution, delivery, acceptance and recording, from and after the Transfer Effective Date specified in such Commitment Transfer Supplement, (i) the Purchasing Lender thereunder shall be a party hereto and, to the extent provided in such Commitment Transfer Supplement, have the rights and obligations of a Lender hereunder with a Commitment as set forth therein, and (ii) the transferor Lender thereunder shall, to the extent provided in such Commitment Transfer Supplement, be released from its obligations under this Agreement (and, in the case of a Commitment Transfer Supplement covering all or the remaining portion of a transferor Lender's rights and obligations under this Agreement, such transferor Lender shall cease to be a party hereto). Such Commitment Transfer Supplement shall be deemed to amend this Agreement to the extent, and only to the extent, necessary to reflect the addition of such Purchasing Lender and the resulting adjustment of Revolving Commitment Percentages arising from the purchase by such Purchasing Lender of all or a portion of the rights and obligations of such transferor Lender under this Agreement and the Revolving Notes. On or prior to the Transfer Effective Date specified in such Commitment Transfer Supplement, the Borrower, at its own expense, shall execute and deliver to the Administrative Agent in exchange for the Revolving Notes delivered to the Administrative Agent pursuant to such Commitment Transfer Supplement new Revolving Notes to the order of such Purchasing Lender in an amount equal to the Commitment assumed by it pursuant to such Commitment Transfer Supplement and, unless the transferor Lender has not retained a Commitment hereunder, new Revolving Notes to the order of the transferor Lender in an amount equal to the Commitment retained by it hereunder. Such new Revolving Notes shall be dated the Closing Date and shall otherwise be in the form of the Revolving Notes replaced thereby. The Revolving Notes surrendered by the transferor Lender shall be returned by the Administrative Agent to the Borrower marked "canceled".


42

     (d) The Administrative Agent shall maintain at its address referred to in Section 9.01 a copy of each Commitment Transfer Supplement delivered to it and a register (the "Register") for the recordation of the names and addresses of the Lenders and the Commitment of, and principal amount of the Loans owing to, each Lender from time to time. The entries in the Register shall be conclusive, in the absence of manifest error, and the Borrower, the Administrative Agent and the Lenders may treat each Person whose name is recorded in the Register as the owner of the Loan recorded therein for all purposes of this Agreement. The Register shall be available for inspection by the Borrower or any Lender at any reasonable time and from time to time upon reasonable prior notice.


     (e) Upon its receipt of a duly executed Commitment Transfer Supplement, together with payment to the Administrative Agent by the transferor Lender or the Purchasing Lender, as agreed between them, of a registration and processing fee of $3,500 for each Purchasing Lender (other than a Purchasing Lender that is an existing Lender or an Affiliate of an existing Lender) listed in such Commitment Transfer Supplement and the Revolving Notes subject to such Commitment Transfer Supplement, the Administrative Agent shall (i) accept such Commitment Transfer Supplement, (ii) record the information contained therein in the Register and (iii) give prompt notice of such acceptance and recordation to the Lenders and the Borrower.


     (f) The Borrower authorizes each Lender to disclose to any Participant or Purchasing Lender (each, a "Transferee") and any prospective Transferee any and all financial information in such Lender's possession concerning the Borrower and its Affiliates which has been delivered to such Lender by or on behalf of the Borrower pursuant to this Agreement or which has been delivered to such Lender by or on behalf of the Borrower in connection with such Lender's credit evaluation of the Borrower and its Affiliates prior to becoming a party to this Agreement, in each case subject to Section 9.15.


     (g) At the time of each assignment pursuant to this Section 9.04 to a Person which is not already a Lender hereunder and which is not a United States person (as such term is defined in Section 7701(a)(30) of the Code) for Federal income tax purposes, the respective assignee Lender shall provide to the Borrower and the Administrative Agent certification as to exemption from deduction or withholding of Taxes in accordance with Section 2.12 and shall be subject to the provisions of Section 2.12(c).


     (h) Nothing herein shall prohibit any Lender from pledging or assigning any of its rights under this Agreement (including, without limitation, any right to payment of principal and interest under any Revolving Note) to any Federal Reserve Bank in accordance with applicable laws or a trustee of such Lender for the benefit of its investors; provided that no such pledge or assignment shall release a Lender from any of its obligations hereunder or substitute any such pledge or assignee for such Lender as a party hereto.


     Section 9.05 Expenses; Indemnity.

     (a) Expenses. The Borrower agrees to pay all reasonable out-of-pocket expenses incurred by the Administrative Agent in connection with the preparation of this Agreement and the other Loan Documents (including those set forth in the Fee Letter dated March 15, 2002, among the Administrative Agent, First Union Securities, Inc. and the Borrower) or in connection with any amendments, modifications or waivers of the provisions hereof or thereof (whether or not the transactions hereby contemplated shall be consummated) or incurred by the Administrative Agent or any Lender in connection with the enforcement or protection of their rights in connection with this Agreement and the other Loan Documents or in connection with the Loans made hereunder, including the reasonable fees and disbursements of Moore & Van Allen, PLLC, counsel for the Administrative Agent, and, in connection with any such amendment, modification or waiver or any such enforcement or protection, the reasonable fees and disbursements of any other counsel for the Administrative Agent or any Lender.


     (b) Indemnification by Borrower. The Borrower agrees to indemnify the Administrative Agent, each Lender and its directors, officers, employees and agents (each such person being called an "Indemnitee") against, and to hold each Indemnitee harmless from, any and all losses, claims, damages, liabilities and related expenses, including reasonable counsel fees and expenses, incurred by or asserted against any Indemnitee arising out of, in any way connected with, or as a result of (i) the execution or delivery of this Agreement or any other Loan Document or any agreement or instrument contemplated thereby, the performance by the parties thereto of their respective obligations thereunder or the consummation of the Transactions, (ii) the use of the proceeds of the Loans or (iii) any claim, litigation, investigation or proceeding relating to any of the foregoing, whether or not any Indemnitee is a party thereto; provided that such indemnity shall not, as to any Indemnitee, be available to the extent that such losses, claims, damages, liabilities or related expenses are determined by a court of competent jurisdiction by final and nonappealable judgment to have resulted from the gross negligence or willful misconduct of such Indemnitee.


44

     (c) Indemnification by Lenders. The Lenders agree to indemnify the Administrative Agent in its capacity hereunder (to the extent not reimbursed by the Borrower and without limiting the obligation of the Borrower to do so), ratably according to their respective Revolving Commitment Percentages in effect on the date on which indemnification is sought under this Section, from and against any and all liabilities, obligations, losses, damages, penalties, actions, judgments, suits, costs, expenses or disbursements of any kind whatsoever which may at any time (including, without limitation, at any time following the payment of the Revolving Notes) be imposed on, incurred by or asserted against the Administrative Agent in any way relating to or arising out of any Loan Document or any documents contemplated by or referred to herein or therein or the transactions contemplated hereby or thereby or any action taken or omitted by the Administrative Agent under or in connection with any of the foregoing; provided, however, that no Lender shall be liable for the payment of any portion of such liabilities, obligations, losses, damages, penalties, actions, judgments, suits, costs, expenses or disbursements to the extent resulting from the Administrative Agent's gross negligence or willful misconduct, as determined by a court of competent jurisdiction. The agreements in this Section 9.05 shall survive the termination of this Agreement and payment of the Revolving Notes and all other amounts payable hereunder.


     (d) The provisions of this Section 9.05 shall remain operative and in full force and effect regardless of the expiration of the term of this Agreement, the consummation of the transactions contemplated hereby, the repayment of any of the Loans, the invalidity or unenforceability of any term or provision of this Agreement or any other Loan Document, or any investigation made by or on behalf of the Administrative Agent or any Lender. All amounts due under this Section 9.05 shall be payable on written demand therefor.


     Section 9.06 Right of Setoff.

     If an Event of Default shall have occurred and be continuing and any Lender shall have requested the Administrative Agent to declare the Loans immediately due and payable pursuant to Article VII, each Lender is hereby authorized at any time and from time to time, to the fullest extent permitted by law, to set off and apply any and all deposits (general or special, time or demand, provisional or final) at any time held and other indebtedness at any time owing by such Lender to or for the credit or the account of the Borrower against any of and all the obligations of the Borrower now or hereafter existing under this Agreement and other Loan Documents held by such Lender, irrespective of whether or not such Lender shall have made any demand under this Agreement or such other Loan Document and although such obligations may be unmatured. The rights of each Lender under this Section are in addition to other rights and remedies (including other rights of setoff) which such Lender may have.

45

     Section 9.07 Applicable Law.

     THIS AGREEMENT AND THE OTHER LOAN DOCUMENTS SHALL BE CONSTRUED IN ACCORDANCE WITH AND GOVERNED BY THE LAWS OF THE STATE OF NORTH CAROLINA.

     Section 9.08 Waivers; Amendment.

     (a) No failure or delay of the Administrative Agent or any Lender in exercising any power or right hereunder shall operate as a waiver thereof, nor shall any single or partial exercise of any such right or power, or any abandonment or discontinuance of steps to enforce such a right or power, preclude any other or further exercise thereof or the exercise of any other right or power. The rights and remedies of the Administrative Agent and the Lenders hereunder and under the other Loan Documents are cumulative and exclusive of any rights or remedies which they would otherwise have. No waiver of any provision of this Agreement or any other Loan Document or consent to any departure by the Borrower therefrom shall in any event be effective unless the same shall be permitted by paragraph (b) below, and then such waiver or consent shall be effective only in the specific instance and for the purpose for which given. No notice or demand on the Borrower in any case shall entitle the Borrower to any other or further notice or demand in similar or other circumstances.

     (b) Neither this Agreement nor any provision hereof may be waived, amended or modified except pursuant to an agreement or agreements in writing entered into by the Borrower and the Required Lenders; provided, however, that no such agreement shall (i) decrease the principal amount (other than on account of payment or prepayment) of, or extend or advance the maturity of or any date for the payment of any principal of or interest on, any Loan, or waive or excuse any such payment or any part thereof, or decrease the rate of interest on any Loan, without the prior written consent of each Lender affected thereby, (ii) change the Commitment of any Lender without the prior written consent of such Lender, or (iii) amend or modify the provisions of Section 2.08, the provisions of this Section or the definition of the "Required Lenders", without the prior written consent of each Lender; provided further that no such agreement shall amend, modify or otherwise affect the rights or duties of the Administrative Agent hereunder without the prior written consent of the Administrative Agent.

     Section 9.09 Interest Rate Limitation.

     Notwithstanding anything herein to the contrary, if at any time the applicable interest rate, together with all fees and charges which are treated as interest under applicable law (collectively, the "Charges") as provided for herein or in any other document executed in connection herewith, or otherwise contracted for, charged, received, taken or reserved by any Lender, shall exceed the maximum lawful rate (the "Maximum Rate") which may be contracted for, charged, taken, received or reserved by such Lender in accordance with applicable law, the rate of interest payable on such Loan, together with all Charges payable to such Lender, shall be limited to the Maximum Rate.

46

     Section 9.10 Entire Agreement.

     This Agreement, the other Loan Documents and the Fee Letter constitute the entire contract between the parties relative to the subject matter hereof. Any previous agreement among the parties with respect to the subject matter hereof is superseded by this Agreement and the other Loan Documents. Nothing in this Agreement or in the other Loan Documents, expressed or implied, is intended to confer upon any party other than the parties hereto any rights, remedies, obligations or liabilities under or by reason of this Agreement or the other Loan Documents.

     Section 9.11 Waiver of Jury Trial.

     Each party hereto hereby waives, to the fullest extent permitted by applicable law, any right it may have to a trial by jury in respect of any litigation directly or indirectly arising out of, under or in connection with this Agreement or any of the other Loan Documents. Each party hereto (a) certifies that no representative, administrative agent or attorney of any other party has represented, expressly or otherwise, that such other party would not, in the event of litigation, seek to enforce the foregoing waiver and (b) acknowledges that it and the other parties hereto have been induced to enter into this Agreement and the other Loan Documents, as applicable, by, among other things, the mutual waivers and certifications in this Section 9.11.

     Section 9.12 Severability.

     In the event any one or more of the provisions contained in this Agreement or in any other Loan Document should be held invalid, illegal or unenforceable in any respect, the validity, legality and enforceability of the remaining provisions contained herein and therein shall not in any way be affected or impaired thereby. The parties shall endeavor in good-faith negotiations to replace the invalid, illegal or unenforceable provisions with valid provisions the economic effect of which comes as close as possible to that of the invalid, illegal or unenforceable provisions.

     Section 9.13 Counterparts.

     This Agreement may be executed in two or more counterparts, each of which shall constitute an original but all of which when taken together shall constitute but one contract, and shall become effective as provided in Section 9.03.

     Section 9.14 Headings.

     Article and Section headings and the Table of Contents used herein are for convenience of reference only, are not part of this Agreement and are not to affect the construction of, or to be taken into consideration in interpreting, this Agreement.

47

     Section 9.15 Confidentiality.

     Any information obtained by the Administrative Agent or any of the Lenders from the Borrower shall not be disclosed by the Administrative Agent or such Lender to any other person if such information is not otherwise in the public domain except (i) to its officers, directors, employees, administrative agents, independent accountants, Affiliates and legal counsel (it being understood that the persons to whom such disclosure is made will be informed of the confidential nature of such information and instructed to keep such information confidential), (ii) pursuant to statutory and regulatory requirements or requests of regulatory authorities, (iii) pursuant to any mandatory court order, subpoena or other legal process, (iv) to the Administrative Agent or any other Lender, (v) pursuant to any agreement heretofore or hereafter made between such Lender and the Borrower which permits such disclosure, (vi) in connection with the exercise of any remedy under or litigation in connection with the Loan Documents or (vii) subject to Section 9.04(f), to any participant in or assignee of, or prospective participant in or assignee of, any Loan or Commitment.

     Section 9.16 Jurisdiction; Consent to Service of Process.

     (a) The Borrower hereby irrevocably and unconditionally submits, for itself and its property, to the nonexclusive jurisdiction of any North Carolina State court or Federal court of the United States of America sitting in North Carolina, and any appellate court from any thereof, in any action or proceeding arising out of or relating to this Agreement or the other Loan Documents, or for recognition or enforcement of any judgment, and each of the parties hereto hereby irrevocably and unconditionally agrees that all claims in respect of any such action or proceeding may be heard and determined in such North Carolina State court or, to the extent permitted by law, in such Federal court. Each of the parties hereto agrees that a final judgment in any such action or proceeding shall be conclusive and may be enforced in other jurisdictions by suit on the judgment or in any other manner provided by law. Nothing in this Agreement shall affect any right that any Lender may otherwise have to bring any action or proceeding relating to this Agreement or the other Loan Documents against the Borrower or its properties in the courts of any jurisdiction.

     (b) The Borrower hereby irrevocably and unconditionally waives, to the fullest extent it may legally and effectively do so, any objection which it may now or hereafter have to the laying of venue of any suit, action or proceeding arising out of or relating to this agreement or the other Loan Documents in any North Carolina State court or Federal court. Each of the parties hereto hereby irrevocably waives, to the fullest extent permitted by law, the defense of an inconvenient forum to the maintenance of such action or proceeding in any such court.

     (c) Each party to this Agreement irrevocably consents to service of process in the manner provided for notices in Section 9.01. Nothing in this Agreement will affect the right of any party to this Agreement to serve process in any other manner permitted by law.

48

     IN WITNESS WHEREOF, the Borrower, the Administrative Agent and the Lenders have caused this Agreement to be duly executed by their respective authorized officers as of the day and year first above written.

BORROWER: TREDEGAR CORPORATION


  By:          /s/D. Andrew Edwards        
  Name: D. Andrew Edwards
  Title: Vice President, Finance and Treasurer
LENDERS: WACHOVIA BANK, NATIONAL ASSOCIATION
  individually as a Lender and as Administrative Agent


  By:          /s/Gerald P. Hullinger        
  Name: Gerald P. Hullinger
  Title: Vice President

  [Signature Pages Continue]
  BANK OF AMERICA, N.A.
  as a Lender


  By:          /s/Richard C. Hardison        
  Name: Richard C. Hardison
  Title: Vice President

  [Signature Pages Continue]
  SUNTRUST BANK
  as a Lender


  By:          /s/Mark A. Flatin        
  Name: Mark A. Flatin
  Title: Director

Schedule 2.01

Lenders and Commitments

Lender Credit Contact Operations Contact Commitment
Wachovia Bank, National
Association
301 S. College Street
Charlotte, NC 28288-0760
Attn: Eric Tan
Phone: 704.383.5332
Fax: 704.715.1117
201 S. College Street, 8th Floor
Charlotte, NC 28288
Attn: Brandy Coffield
Phone: 704.383.6882
Fax: 704.383.0288
$40,000,000
SunTrust Bank 919 East Main Street
Richmond, VA 23219
Attn: Mark Flatin
Phone: 804.782.5449
Fax: 804.782.5413
1001 Semmes Ave.
Richmond, VA 23244
Attn: Beth Fisher
Phone: 804.319.3118
Fax: 804.319.1736
$35,000,000
Bank of America, N.A. 100 N. Tryon Street, 17th Floor
Charlotte, NC 28255
NC1-007-17-12
Attn: Richard Hardison
Phone: 704.386.1185
Fax: 704.386.3271
101 N. Tryon Street
Charlotte, NC 28255
NC1-001-15-05
Attn: Qweli Moore
Phone: 704.387.5374
Fax: 704.409.0634
$25,000,000
    TOTAL $100,000,000

SCHEDULE 3.07
Part I      

Part I

UNITED STATES SUBSIDIARIES

  Percentage of
Common Stock
Owned Directly
or Indirectly
by the Company
AUS Corporation 100%
Bon L Aluminum LLC 100%
Bon L Campo Limited Partnership 100%
Bon L Holdings Corporation 100%
Bon L Manufacturing Company 100%
Bon L Manufacturing Company of Virginia 100%
The William L. Bonnell Company, Inc. 100%
Capital Square Insurance Company 100%
Idlewood Properties, Inc. 100%
Molecumetics Institute, Ltd.1 90.5%
Molecumetics, Ltd. 90.5%
TGI Fund I, LC 100%
TGI Fund II, LC 100%
TGI Fund III, LLC 100%
TGI Fund IV, LLC 100%
Therics, Inc. 100%
Tredegar Development Corporation 100%
Tredegar Far East Corporation 100%
Tredegar Film Products Corporation 100%
Tredegar Film Products (Europe), Inc. 100%
Tredegar Film Products (Japan) Ltd. 100%
Tredegar Film Products - Lake Zurich, Inc. 100%
Tredegar Film Products (Latin America), Inc. 100%
Tredegar Film Products - Pottsville, Inc. 100%
Tredegar Film Products (U.S.) LLC 100%
Tredegar Films Development, Inc. 100%
Tredegar Investments Inc. 100%
Tredegar Reserves, Inc. 100%

                
1This company is a wholly-owned subsidiary of Molecumetics, Ltd., of which the Company owns 90.5% of the outstanding common stock.

SCHEDULE 3.07
Part II      

Part II

NON-UNITED STATES SUBSIDIARIES

  Percentage of
Common Stock
Owned Directly
or Indirectly
by the Company
ADMA srl 100%
Bon L Canada Inc. 100%
Goodlands Holding S.A. 100%
Guangzhou Tredegar Films Company Limited 98%
PROMEA Engineering srl 100%
TFP Netherlands C.V. 100%
Tredegar Brazil Industria De Plasticos Ltda. 100%
Tredegar Film Products Argentina S.A. 99.99%
Tredegar Film Products, B.V. 100%
Tredegar Film Products Italia S.r.l. 100%
Tredegar Film Products Kft. 100%
Tredegar Film Products Co. Shanghai, Ltd. 100%
Tredegar Foreign Sales Corporation 100%

SCHEDULE 6.01

LIENS

     1. Uniform Commercial Code Liens*

Debtor Secured Party Jurisdiction File No. File Date Collateral
Therics, Inc. Tredegar Industries, Inc. Mercer County, NJ 199902110113 2/11/99 Blanket Lien
Therics, Inc. Finova Technology
Finance, Inc.
New Jersey
Department of
Treasury
1736359




Partial Release
11/27/96




7/29/98
Certain property leased pursuant to Master Equipment Lease Agreement dated September 27, 1996

Partial release
Therics, Inc. Finova Technology
Finance, Inc.
New Jersey
Department of
Treasury
1736361




Partial Release
11/27/96




7/29/98
All equipment and other personal property under the Master Equipment Lease Agreement dated September 27, 1996

Partial release
Therics, Inc. Finova Technology
Finance, Inc.
New Jersey
Department of
Treasury
1740655




Partial Release
12/23/96




7/29/98
Certain property leased equipment pursuant to Master Equipment Lease Agreement dated October 17, 1996

Partial release
Therics, Inc. Finova Technology
Finance, Inc.
New Jersey
Department of
Treasury
1752976 3/4/97 Certain property leased pursuant to Master Equipment Lease Agreement dated September 27, 1996
Therics, Inc. Finova Technology
Finance, Inc.
New Jersey
Department of
Treasury
1815628




Partial Release
1/29/98




7/29/98
Certain property leased pursuant to Master Equipment Lease Agreement dated September 27, 1996

Partial release
Therics, Inc. Finova Technology
Finance, Inc.
New Jersey
Department of
Treasury
1784737




Partial Release
8/1/97




7/29/98
Certain property leased equipment pursuant to Master Equipment Lease Agreement dated September 27, 1996

Partial release
Therics, Inc. Tredegar Industries, Inc. New Jersey
Department of
Treasury
1888174 2/10/99 Blanket Lien
Therics, Inc. Great America Leasing Company New Jersey
Department of
Treasury
2094972-3 4/1/02 Xerox Equipment and Accessories

                
*A copy of each UCC filing listed herein has been delivered to the Agent.

2.    Liens/encumbrances on certain equipment and machinery purchased by ADMA srl and PROMEA Engineering srl
       and financed pursuant to Italian Law n. 341/95 (the "Sabatini Law") and other low interest, European government loan
       programs.

EXHIBIT A

[FORM OF]
NOTICE OF BORROWING FOR LOANS

[Date]

Wachovia Bank, National Association, as Administrative Agent
       under the Credit Agreement referred to below
One First Union Center, TW-10
301 South College Street
Charlotte, North Carolina 28288-0680
Attn: Syndication Agency Services

Ladies and Gentlemen:

      Pursuant to subsection 2.01(b)(i) of the Credit Agreement (as amended, supplemented or otherwise modified from time to time, the "Credit Agreement") dated as of [________], 2002 among TREDEGAR CORPORATION, a Virginia corporation (the "Borrower"), the banks and other financial institutions from time to time party thereto (the "Lenders") and WACHOVIA BANK, NATIONAL ASSOCIATION, as Administrative Agent for the Lenders, the Borrower hereby requests that the following:

I.          Revolving Loans be made on [date] as follows (the "Proposed Borrowing"):
  (1)          Total Amount of Loans $
 
  (2)          Amount of (1) to be allocated
               to LIBOR Rate Loans
 
$
 
  (3)          Total Amount of Loans
               to Alternate Base Rate Loans
 
$
 
  (4)          Interest Periods and amounts to be allocated
               thereto in respect of LIBOR Rate Loans
               (amounts must total (2)):
   
                      (i)          one month $
 
                      (ii)          two months $
 
                      (iii)          three months $
 
                      Total LIBOR Rate Loans $
 

  NOTE: BORROWINGS MUST BE IN MINIMUM AMOUNTS OF (A) $5,000,000 WITH RESPECT TO LIBOR RATE LOANS AND $1,000,000 INCREMENTS IN EXCESS THEREOF AND (B) $1,000,000 WITH RESPECT TO ALTERNATE BASE RATE LOANS AND $1,000,000 INCREMENTS IN EXCESS THEREOF.

      Terms defined in the Credit Agreement shall have the same meanings when used herein.

      The undersigned hereby certifies that the following statements are true on the date hereof and will be true on the date of the Proposed Borrowing:

             (A) the applicable representations and warranties contained in Article III of the Credit Agreement are and will be true and correct in all material respects, both before and after giving effect to the Proposed Borrowing and to the application of the proceeds thereof, with the same effect as though such representations and warranties had been made on and as of the date of such Proposed Borrowing (it being understood that any representation or warranty which by its terms is made as of a specified date shall be required to be true and correct in all material respects only as of such specified date); and

             (B) no Default or Event of Default has occurred and is continuing, or would result from such Proposed Borrowing or from the application of the proceeds thereof.

  Very truly yours,

  TREDEGAR CORPORATION
a Virginia corporation


  By:                                                            
  Name:                                                            
  Title:                                                            

EXHIBIT B

FORM OF REVOLVING NOTE

$__________

_________, 2002

      FOR VALUE RECEIVED, TREDEGAR CORPORATION, a Virginia corporation (the "Borrower"), hereby promises to pay to the order of _________________, its successors and assigns (the "Bank"), in such amounts and on such dates as set forth in the Agreement (as defined below) to the office of the Administrative Agent in immediately available funds as provided in the Agreement, $__________, together with interest thereon at the rates and as provided in the Agreement.

      This Revolving Note is one of the Revolving Notes referred to in the Credit Agreement dated as of the date hereof (as amended and modified, the "Agreement") among the Borrower, the Lenders identified therein and Wachovia Bank, National Association as Administrative Agent. Terms used but not otherwise defined herein shall have the meanings provided in the Agreement.

      The holder may endorse and attach a schedule to reflect borrowings evidenced by this Revolving Note and all payments and prepayments thereon; provided that any failure to endorse such information shall not affect the obligation of the Borrower to pay amounts evidenced hereby.

      Upon the occurrence of an Event of Default, all amounts evidenced by this Revolving Note may, or shall, become immediately due and payable as provided in the Agreement without presentment, demand, protest or notice of any kind, all of which are waived by the Borrower. In the event payment of amounts evidenced by this Revolving Note is not made at any stated or accelerated maturity, the Borrower agrees to pay, in addition to principal and interest, all costs of collection, including reasonable attorneys' fees.

      This Revolving Note and the Loans and amounts evidenced hereby may be transferred only as provided in the Agreement.

      This Revolving Note shall be governed by, and construed and interpreted in accordance with, the law of the State of North Carolina.

      IN WITNESS WHEREOF, the Borrower has caused this Revolving Note to be duly executed by its duly authorized officer as of the day and year first above written.

  TREDEGAR CORPORATION
a Virginia corporation


  By:                                                            
  Name:
  Title:

EXHIBIT C

[FORM OF]
COMMITMENT TRANSFER SUPPLEMENT

      Reference is made to the Credit Agreement, dated as of [________], 2002 (as amended, supplemented or otherwise modified from time to time, the "Credit Agreement"), among TREDEGAR CORPORATION, a Virginia corporation (the "Borrower"), the banks and financial institutions from time to time parties thereto (the "Lenders") and Wachovia Bank, National Association, as administrative agent for the Lenders (in such capacity, the "Administrative Agent"). Unless otherwise defined herein, terms defined in the Credit Agreement and used herein shall have the meanings provided in the Credit Agreement.

      ___________________________ (the "Transferor Lender") and _________________________ (the "Purchasing Lender") agree as follows:

      1. The Transferor Lender hereby irrevocably sells and assigns to the Purchasing Lender without recourse to the Transferor Lender, and the Purchasing Lender hereby irrevocably purchases and assumes from the Transferor Lender without recourse to the Transferor Lender, as of the Transfer Effective Date (as defined below), in and to the Transferor Lender's rights and obligations under the Credit Agreement with respect to those credit facilities contained in the Credit Agreement as are set forth on Schedule 1 attached hereto (individually, an "Assigned Facility"; collectively, the "Assigned Facilities"), in a principal amount for each Assigned Facility as set forth on such Schedule 1 (collectively, the "Assigned Interest"), together with the Commitment Percentage corresponding to each such principal amount.

      2. The Transferor Lender (a) makes no representation or warranty and assumes no responsibility with respect to any statements, warranties or representations made in or in connection with the Credit Agreement or with respect to the execution, legality, validity, enforceability, genuineness, sufficiency or value of the Credit Agreement, any other Credit Document or any other instrument or document furnished pursuant thereto, other than that the Transferor Lender has not created any adverse claim upon the interest being assigned by it hereunder and that such interest is free and clear of any such adverse claim; (b) makes no representation or warranty and assumes no responsibility with respect to the financial condition of the Borrower or any other obligor or the performance or observance by the Borrower or any other obligor of any of their respective obligations under the Credit Agreement or any other Credit Document or any other instrument or document furnished pursuant hereto or thereto; and (c) attaches any Revolving Note(s) held by it evidencing the Assigned Facilities and (i) requests that the Administrative Agent exchange the attached Revolving Note(s) for a new Revolving Note(s) payable to the Purchasing Lender and (ii) if the Transferor Lender has retained any interest in the Assigned Facility, requests that the Administrative Agent exchange the attached Revolving Note(s) for a new Revolving Note(s) payable to the Transferor Lender, in each case in amounts which reflect the assignment being made hereby (and after giving effect to any other assignments which have become effective on the Transfer Effective Date).

      3. The Purchasing Lender (a) represents and warrants that it is legally authorized to enter into this Commitment Transfer Supplement; (b) confirms that it has received a copy of the Credit Agreement, together with copies of the financial statements referred to in Section 3.04 thereof, the financial statements delivered pursuant to Section 5.04 thereof, if any, and such other documents and information as it has deemed appropriate to make its own credit analysis and decision to enter into this Commitment Transfer Supplement; (c) agrees that it will, independently and without reliance upon the Transferor Lender, the Administrative Agent or any other Lender and based on such documents and information as it shall deem appropriate at the time, continue to make its own credit decisions in taking or not taking action under the Credit Agreement, the other Credit Documents or any other instrument or document furnished pursuant hereto or thereto; (d) appoints and authorizes the Administrative Agent to take such action as agent on its behalf and to exercise such powers and discretion under the Credit Agreement, the other loan documents or any other instrument or document furnished pursuant hereto or thereto as are delegated to the Administrative Agent by the terms thereof, together with such powers as are incidental thereto; and (e) agrees that it will be bound by the provisions of the Credit Agreement and will perform in accordance with its terms all the obligations which by the terms of the Credit Agreement are required to be performed by it as a Lender including, if it is organized under the laws of a jurisdiction outside the United States, its obligations pursuant to Section 2.12 of the Credit Agreement.

      4. The effective date of this Commitment Transfer Supplement shall be ________ ___, 20__ (the "Transfer Effective Date"). Following the execution of this Commitment Transfer Supplement, it will be delivered to the Administrative Agent for acceptance by it and recording by the Administrative Agent pursuant to the Credit Agreement, effective as of the Transfer Effective Date, along with any registration and processing fee due and payable to the Administrative Agent pursuant to Section 9.04 of the Credit Agreement.

      5. Upon such acceptance and recording, from and after the Transfer Effective Date, the Administrative Agent shall make all payments in respect of the Assigned Interest (including payments of principal, interest, fees and other amounts) to the Purchasing Lender whether such amounts have accrued prior to the Transfer Effective Date or accrue subsequent to the Transfer Effective Date. The Transferor Lender and the Purchasing Lender shall make all appropriate adjustments in payments by the Administrative Agent for periods prior to the Transfer Effective Date or, with respect to the making of this assignment, directly between themselves.

      6. From and after the Transfer Effective Date, (a) the Purchasing Lender shall be a party to the Credit Agreement and, to the extent provided in this Commitment Transfer Supplement, have the rights and obligations of a Lender thereunder and under the other Credit Documents and shall be bound by the provisions thereof and (b) the Transferor Lender shall, to the extent provided in this Commitment Transfer Supplement, relinquish its rights and be released from its obligations under the Credit Agreement.

      7. This Commitment Transfer supplement shall be governed by and construed in accordance with the laws of the State of North Carolina.

      IN WITNESS WHEREOF, the parties hereto have caused this Commitment Transfer Supplement to be executed as of the date first above written by their respective duly authorized officers on Schedule 1 hereto.

SCHEDULE 1
TO COMMITMENT TRANSFER SUPPLEMENT

Name of Transferor Lender:

Name of Purchasing Lender:

Transfer Effective Date of Assignment:

                                            Credit                     Principal Commitment
             Facility Assigned          Amount Assigned                 Percentage Assigned 1
             -----------------          ---------------                ---------------------

                                       $______________                 _________________%



[NAME OF PURCHASING LENDER]                          [NAME OR TRANSFEROR LENDER]


By                                                            By
  ------------------------------------------                    ------------------------------------------
    Name:                                                        Name:
    Title:                                                       Title:


Accepted (if required):                                       Consented to (if required):

WACHOVIA BANK, NATIONAL ASSOCIATION TREDEGAR CORPORATION


By:                                                           By:
   -----------------------------------------                     -----------------------------------------
    Name:                                                        Name:
    Title:                                                       Title:


                         

1Calculate the Commitment Percentage that is assigned to at least 10 decimal places and show as a percentage of the aggregate commitments of all Lenders.

Exhibit D

Tredegar Letterhead

_______________________, 2002

To the Lenders party to the Credit Agreement
referred to below
In care of Wachovia Bank, National Association,
          as Administrative Agent
[Address]
Charlotte, North Carolina _____

Gentlemen:

      I am Vice President-Administration and Corporate Development and Secretary of Tredegar Corporation, a Virginia corporation (the "Borrower"), and perform the duties of General Counsel, a title that I held until _________. I am a member of the Virginia Bar. I have acted as counsel to the Borrower in connection with the Credit Agreement (as the same may be modified, amended, extended or restated from time to time, the "Credit Agreement") dated as of ________________, 2002 among the Borrower, the Lenders named in the Credit Agreement and Wachovia Bank, National Association, as Administrative Agent, providing for loans to be made to the Borrower in the aggregate principal amount of $100,000,000. Unless otherwise noted, terms defined in the Credit Agreement are used herein as defined therein.

      In connection with the foregoing, I have reviewed the Credit Agreement. I have also examined and relied upon copies, certified or otherwise authenticated to my satisfaction, of documents reflecting corporate action of the Borrower with respect to the Credit Agreement and certificates of public officials, and have reviewed such other documents and matters of law as I have deemed necessary to enable me to express the opinions set forth herein. As to questions of fact material to my opinion, I have relied upon certificates of officers of the Borrower and representations in the Credit Agreement by the Borrower.

      I do not purport to express an opinion on any laws other than those of the Commonwealth of Virginia and the United States of America, except that I have assumed that the laws of the State of North Carolina are the same as the Commonwealth of Virginia with respect to the opinions expressed in Paragraph 3 below.

      Based upon and subject to the foregoing, and to the further limitations and qualifications stated below, I am of the opinion that:

      1. Each of the Borrower and the Subsidiaries of the Borrower listed on Schedule 3.07 (Part I) of the Credit Agreement (the "United States Subsidiaries" and each a "United States Subsidiary") (a) is a corporation, partnership or limited liability company duly incorporated or organized, validly existing and in good standing under the laws of the jurisdiction of its incorporation or organization, and is duly qualified to transact business in each state where the failure to so qualify would have a material effect on the business or financial condition of the Borrower and the Subsidiaries taken as a whole and (b) has all requisite power and authority to own its property and assets and to carry on its business as now conducted and as proposed to be conducted. The Borrower has the necessary corporate power to enter into and perform its obligations under the Credit Agreement and to borrow under the Credit Agreement.

      2. The execution and delivery by the Borrower of, and the performance by the Borrower of its obligations under, the Credit Agreement, the borrowings by the Borrower under the Credit Agreement (a) have been duly authorized by all necessary corporate action of the Borrower and all requisite stockholder action, and do not and will not violate any provision of the articles of incorporation or by-laws of the Borrower or any United States Subsidiary or any provision of law or regulation, including Regulations U and X, (b) do not, to the best of my knowledge, result in the breach of, or constitute a default or require any consent under, or result in the creation of any Lien upon any of its properties, revenues or assets pursuant to, any indenture or other agreement or instrument to which the Borrower or any United States Subsidiary is a party or by which the Borrower or any United States Subsidiary or their properties may be bound, or (c) result in the creation or imposition of any Lien upon property or assets of the Borrower or any United States Subsidiary except Liens permitted by Section 6.01 of the Credit Agreement.

      3. The Credit Agreement constitutes the legal, valid and binding obligation of the Borrower enforceable in accordance with its terms, except, in each case, as such enforceability may be limited by (a) bankruptcy, insolvency, reorganization, moratorium or other similar laws of general applicability affecting the enforcement of creditors' rights and (b) the application of general principles of equity (regardless of whether such enforceability is considered in a proceeding in equity or at law).

      4. To the best of my knowledge, there are no legal or arbitral proceedings, and no proceedings by or before any Governmental Authority, pending or threatened against or affecting the Borrower or any properties or rights of the Borrower that, if adversely determined, would have a Material Adverse Effect.

      5. No authorizations, consents, approvals, licenses, filings or registrations, with any Governmental Authority are required in connection with the execution, delivery or performance by the Borrower of its obligations under the Credit Agreement, other than those the failure of which to obtain would not give rise to a Material Adverse Effect.

      6. To the best of my knowledge, neither the Borrower nor any of the United States Subsidiaries is in violation of any law, rule or regulation, or in default with respect to any judgment, writ, injunction or decree of any Governmental Authority, where such violation or default could result in a Material Adverse Effect.

      7. Neither the Borrower nor any United States Subsidiary is (a) an "investment company" as defined in, or subject to regulation under, the Investment Borrower Act of 1940 or (b) a "holding company" as defined in, or subject to regulation under, the Public Utility Holding Borrower Act of 1935.

      I have not been asked to and do not express any opinion with respect to any matters except as expressly set forth above. This opinion is solely for your benefit and may not be distributed to or relied upon by any other person, quoted in whole or in part or otherwise reproduced in any other document without my prior written consent.

  Sincerely,

   

  Nancy M. Taylor

Exhibit E

NOTICE OF ACCOUNT DESIGNATION

[Date]

Wachovia Bank, National Association
One First Union Center, TW-10
301 South College Street
Charlotte, North Carolina 28288-0680
Attn: Syndication Agency Services

Ladies and Gentlemen:

      This Notice of Account Designation is delivered to you by TREDEGAR CORPORATION, a Virginia corporation (the "Borrower"), under the Credit Agreement dated as of [________], 2002 (as amended, restated or otherwise modified, the "Credit Agreement") by and among the Borrower, the Lenders party thereto and WACHOVIA BANK, NATIONAL ASSOCIATION, as Administrative Agent.

      The Administrative Agent is hereby authorized to disburse all Loan proceeds into the following account, unless the Borrower shall designate, in writing to the Administrative Agent, one or more other accounts:

[______________________]
ABA Routing Number [_______]
Account #[__________]

      Notwithstanding the foregoing, on the closing date of the Credit Agreement, funds borrowed under the Credit Agreement shall be sent to the institutions and/or persons designated on the attached payment instructions.

      IN WITNESS WHEREOF, the undersigned has executed this Notice of Account Designation this ____ day of _________, 2002.

  TREDEGAR CORPORATION
a Virginia corporation


  By:                                                            
  Name:                                                            
  Title:                                                            

Exhibit F

[FORM OF]
COMPLIANCE CERTIFICATE

I, ______________________, __________________ [Title] of TREDEGAR CORPORATION, a Virginia corporation (the “Borrower”), hereby certify on behalf of the Borrower that, with respect to that certain Credit Agreement dated as of _______, 2002 (as amended, modified, restated or supplemented from time to time, the “Credit Agreement”; all of the defined terms in the Credit Agreement are incorporated herein by reference) among the Borrower, the Lenders party thereto and Wachovia Bank, National Association, as Administrative Agent, (a) delivered herewith are detailed calculations demonstrating compliance by the Credit Parties with the financial covenants contained in Sections 6.05, 6.07 and 6.08 of the Credit Agreement as of the last day of the fiscal quarter ending __________________ and (b) to the best of my knowledge, the Borrower during the period covered by the financial statements delivered in connection with this Compliance Certificate observed or performed in all material respects all of its covenants and other agreements, and satisfied in all material respects every condition, contained in the Credit Agreement to be observed, performed or satisfied by it, and that I have obtained no knowledge of any Default or Event of Default except as specified on an attachment hereto.

This ______ day of ___________, ______.

  TREDEGAR CORPORATION
a Virginia corporation


  By:                                                            
  Name:                                                            
  Title:                                                            

Attachment to Officer's Certificate

Computation of Financial Covenants

A.          Section 6.05          Dividends and Distributions.

  1.          Aggregate amount of dividends paid by Borrower $
 
  Maximum permitted aggregate amount of dividends
paid by Borrower during the term of the Agreement:
 
$100,000,000
 

B.          Section 6.07          Consolidated Stockholders' Equity.

  1.          Borrower's issued capital stock taken at par
               or stated value
 
$
 
  2.          Borrower's capital surplus $
 
  3.          Borrower's retained earnings $
 
  4.          Other amounts included directly in equity
               under GAAP
 
$
 
  5.          Borrower's treasury stock and minority interest
               in Subsidiaries
 
$
 
  6.          Consolidated Stockholders' Equity
               (Line 1 + Line 2 + Line 3 + Line 4 - Line 5)
 
$
 
  Maximum Consolidated Stockholders' Equity
not to be less than:
 
$380,000,000
 

C.          Section 6.08          Leverage Ratio.

  1.          Consolidated Total Debt $
 
  2.          Consolidated Total Capitalization
               (the sum of Consolidated Total Debt and
               Consolidated Stockholders' Equity
$
 
  3.          Leverage Ratio (Line 1 divided by Line 2) $
 
  Maximum Leverage Ratio permitted: 0.50 to 1.00